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The work described in this thesis is divided into two chapters; of which the first chapter 
explores the asymmetric synthesis of tertiary thiols by lithiation-electrophilic trapping of 
secondary dialkyl thiobenzoates and the second chapter investigates the lithiation-borylation 
chemistry of cyclobutyl benzoates. 
Chapter 1: The lithiation-electrophilic trapping of secondary dialkyl thiobenzoates 
 
The synthesis of enantioenriched tertiary thiols remains a challenging, under-developed area 
in the field of organic synthesis. In addition, the prevalence of enantioenriched thiols in nature 
and biologically active molecules warrants further development in this field. Previous work 
has shown dialkyl thiobenzoates to undergo facile deprotonation and subsequent reaction with 
an electrophile to furnish a tertiary thiobenzoate, followed by reduction of the thiobenzoate 
group to produce a tertiary thiol centre. However, the thiobenzoate carbenoid was shown to be 
configurationally labile, thus limiting the application in asymmetric synthesis. In this work, we 
have identified conditions for the lithiation-electrophilic trapping of enantioenriched secondary 




Scheme A: Synthesis of enantioenriched tertiary thiols. 
 
Having established suitable reaction conditions, a range of substrates was screened and 
lithiation-electrophile trapping reactions were conducted via in-situ IR spectroscopy to 
understand the course of the reaction and the fate of the reactants. Finally, a kinetic study was 






Chapter 2: The lithiation-borylation chemistry of cyclobutyl benzoates 
 
The well-established lithiation-borylation methodology using secondary dialkyl benzoates 
provides a powerful tool for the synthesis of enantioenriched tertiary boronic esters. However, 
studies into the lithiation-borylation of small ring benzoates, such as cyclobutanes remains 
underdeveloped. As cyclobutyl scaffolds offer a rigid, sp3 bioisostere analogous to aromatic 
rings that are found in biologically active natural products with antibacterial, anticancer and 
antimicrobial properties, such scaffolds are synthetically relevant and medicinally valuable 
(Scheme B). 
 
Scheme B: Studies into the lithiation-borylation of cyclobutyl benzoates for the synthesis of 1,1-disubstituted 
cyclobutanes. 
 
Herein, we report the lithiation-borylation of cyclobutyl benzoates for the synthesis of 1,1 
disubstituted cyclobutanes. We have reported a wide functional group tolerance, for both 
primary, secondary and sp2 boronic esters, with homologated products isolated in low to high 
yields (29-72%). Application to biologically relevant molecules, such as a lithocholic acid 
derivate and enantioenriched boronic esters, showed that this reaction has a broad substrate 
tolerance. In addition, various substituted cyclobutyl and oxetanyl and azetdinyl benzoate 
derivatives were tested in the lithiation-borylation methodology. Finally, functional group 
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1. The Asymmetric Synthesis of Tertiary Thiols by Lithiation-Electrophilic 
Trapping of Secondary Dialkyl Thiobenzoates 
1.1. Introduction 
1.1.1. Importance of Thiol Derivatives  
 
In 2011, organosulfur containing molecules represented a quarter of the top 200 selling 
pharmaceutical compounds worldwide (Scheme 1).1 Similarly, more than 30% of fungicides, 
herbicides and insecticides produced by the agrochemical industry contained an organosulfur-
based functional group.2,3 Furthermore, sulfur-containing motifs are present in cysteine and 
methionine, both proteinogenic amino acids, and natural products (such as 3-methyl-3-
sulfanylhexan-1-ol (onion-like smell, found in human sweat), thioterpineol (responsible for the 










Despite the prevalence of organosulfur compounds in nature, biological and agrochemical/ 
medicinal chemistry, a lack of synthetic methodology limits the manipulation of such 
molecules, which in turn hampers further scientific developments. There are growing pressures 
on the commercial R&D sector,4 such as in the pharmaceutical industry, to produce more 
efficacious medicines. In addition, there is an apparent need to “escape from flatland” by 
shifting from the high-throughput synthetic methodologies ideal for creating achiral, aromatic 
molecules (sp2-hybridised), to other methods to access chiral, sp3-hybridised molecules with 
more spatial diversity, ideal for probing biological receptors. For example, as shown in Figure 
2, dimethylpiperidine is a superior substituent for exploring 3D chemical space than the 
analogous sp2-hybridised dimethylpyridine; there are more structural isomers possible in the 
former (5 vs 34) to facilitate such exploration in a controlled manner. This emphasises the need 






Figure 2: Isomer count comparison for sp2 to sp3 hybridised heterocyclic analogues. 
 
Sulfur is an exceptionally versatile element due to the wide range of oxidation states it can 
access: -2, -1, 0, +2, +3, +4, +5 and +6. This allows sulfur to bond with most elements (using 








Figure 3: Common organosulfur compounds. 
 
There are a vast range of sulfur-containing functional groups, including thiols[II]7, thioethers[II]8, 
sulfonium salts[III]9, sulfoxides[IV]9, sulfinate salts[IV]9, sulfoxonium[V]10, sulfilimines[VI]11 and 
sulfates[VI]11,12 (Figure 3). Many named reactions in literature are based upon the manipulation 
of such organosulfur compounds, or use organosulfur-derived reagents: Pummerer 
rearrangement,13,14 Corey-Chaykovsky reaction, Stevens rearrangement,15 Herz reaction,16 
Swern oxidation,17 aza-Mislow-Evans reaction,18–20 retro-Michael21,22 and Morin 
rearrangements23, for example.  
 
In recent years, further developments into the synthesis of enantiopure organosulfur 
compounds have been explored, with chirality residing on either the carbon (thiols and 
thioethers8) or sulfur (sulfonium14, sulfoxide24, sulfoxonium25) atoms. Owing to a lack of 
literature protocols, most syntheses of enantiopure thiols focus on secondary thiols (or 
thioethers), with methods for the synthesis of enantioenriched tertiary thiols few and far 
between.  
 
By comparison, asymmetric syntheses of tertiary alcohols are more prevalent in the literature, 
partially due to the ease of synthesis of such molecules in comparison to the analogous tertiary 
thiols.26–29 For example, nucleophilic addition to a prochiral ketone can be achieved through 








Scheme 1: Tertiary alcohol synthesis via nucleophilic addition to a ketone by asymmetric induction. 
 
Unfortunately, the analogous reaction with a thioketone is challenging due to its instability and 
the preferential nucleophilic reaction at the sulfur heteroatom rather than the carbon centre.30 
The lack of synthetic protocols to access enantiopure tertiary thiols renders any developments 
to access such molecules highly beneficial for the advancement of synthesis in chemistry.7 
 
 
1.1.2. Disconnections in the Synthesis of Tertiary Thiols 
 
The majority of literature surrounding the synthesis of asymmetric tertiary thiols considers one 
of four retrosynthetic disconnections: (a) C-S bond formation by thio-nucleophile addition to 
a tertiary carbon centre, (b) C-S bond formation by electrophilic sulfenylation,31–35 (c) C-C 
bond formation by electrophilic addition to a secondary thiol derivative, or (d) C-C bond 
formation by addition to a C=S bond36 (Scheme 2). Many of the above routes utilise organo- 
or metal-based catalysts. Whilst disconnections (a), (b) and (c) have been plenty explored, (d) 
is a lesser-developed method for the synthesis of tertiary organosulfur molecules. This chapter 
will discuss literature methods based upon disconnections (a) and (c), as these are the most 







Scheme 2: Retrosynthetic analysis of tertiary thiols. 
 
 
1.1.3. Tertiary Thiols via Carbon-Sulfur Bond Formation (a) 
 
The vast majority of methods for the asymmetric formation of carbon-sulfur bonds produce 
only secondary stereocentres, despite great advances in the field over the last decade.37 For 
comprehensive reviews on this topic please refer to the referenced articles.38 The processes for 
carbon-sulfur bond formation in the synthesis of tertiary thiols can be simplified into two 
reaction types: SN2 reaction and conjugate addition.  
 
1.1.3.1 SN2 Sisplacement by Thiol Derivatives 
 
It could be envisaged that a thiol nucleophile, such as phenyl thiolate, could stereospecifically 
attack a quaternary carbon centre 1 with the explusion of a mesyl group (a good leaving group), 






Scheme 3: SN2 reaction pathway vs SN1. 
 
This type of SN2 reaction pathway (B) would provide a facile way to construct enantiopure 
tertiary stereocentres 3. Typically, steric congestion hinders nucleophilic attack at quaternary 
centres and the tendency for such carbon centres to form carbocations would facilitate a SN1 
reaction pathway (A) over SN2 (B). In turn the generation of a formal (planar) carbocation 4 
would destroy the carbon stereogenic centre, therefore giving rise to racemic product 5 
(Scheme 3).  
 
Consequently, there have been reports that utilise this SN1 pathway to access tertiary thiols 
from tertiary alcohols 6, albeit achirally, through the abstraction of the hydroxy group. The 
lithium-catalyzed alkylation of thiol 7 for the synthesis of 3-sulfanyl-oxetanes reported by Bull 






Scheme 4: Bull’s synthesis of tertiary thiols using tertiary carbocations. 
 
There have been reports of successful SN2 reactions at quaternary stereocentres, such as the 
reaction of thiophenol with α-mesylate esters 8 with displacement of the mesyl group to give 
9 (Scheme 5).41 The presence of the electron-withdrawing ester group prevents the competing 
SN1 pathway by destabilising carbocation formation. In addition, the lack of steric congestion 
in these molecules, owing to the adjacent sp2 centre, promotes SN2 attack by the thiophenolate 
nucleophile.  
 
Scheme 5: α-mesylate esters in SN2 reactions for the synthesis of quaternary stereocentres. 
 
Unfortunately, Tunge and co-workers found that this approach was not applicable to all 
substrates.41 In the case of α-aryl-α-hydroxy esters 10, this reaction gave products 11 in poor 




side-product was also obtained, resulting from the elimination of the thiophenolate to form the 
α,β-unsaturated ester, which underwent conjugate addition. The activated alcohol intermediate 
is also prone to SN1 dissociation, which accounted for the poor enantiomeric ratio obtained in 
the desired product. Better results were achieved by exchanging α-aryl-α-hydroxy for α,α-
dialkyl hydroxy esters. 
 
 
Scheme 6: α-mesylate esters in SN2 reactions with competing product formation. 
 
Similarly, α-(sulfonyloxy)nitriles 13 can also undergo a SN2 reaction with thioacetic acid, with 
displacement of the mesyl group, in good yield and enantioselectivities to produce acetyl 
protected 14 (Scheme 7).42 However, some of these reactions were very slow; using potassium 
thioacetate/DMF after 72 hours gave 35% conversion. This was circumvented by conducting 
the reaction in toluene at 55 °C. This methodology was successfully applied to the 
enantioselective synthesis of the natural product spirobrassinin43 15 (Scheme 7), which 






Scheme 7: Displacement of a mesyl group in tertiary cyanohydrin 13 and total synthesis of (R)-(+)-
spirobrassinin 15. 
 
Peregrina et al. redeveloped this methodology for the synthesis of functionalised β-amino acids 
(Scheme 8).44–46 Here the intramolecular ring opening of sulfamidate 16 by nucleophilic SN2 
displacement used a range of thiolate nucleophiles, acid-cleavage of the sulfonamide bond 
furnished enantioenriched thioether 17. Subsequent carbamate hydrolysis by reflux under 
acidic conditions gave thioether β-amino acid 18. In cases where the thiolate R group was acid-








A similar SN2 epoxide ring opening strategy was explored by Nelson and co-workers, for the 
synthesis of tertiary thiols, in their synthesis of 10β-thiol analogue of androstenedione 21 
(Scheme 9).47 Here, a strained epoxide 19 in a steroidal system under basic conditions 
facilitated nucleophilic potassium hydrosulfide addition to furnish tertiary enantiopure thiol 20, 
which was then further manipulated to access the desired natural product 21.  
 
 
Scheme 9: Nelson’s androstenedione synthesis. 
 
Similar ring opening strategies have also been reported by other groups.48–52 The methods 
discussed so far cannot be used generally for the synthesis of simple enantioenriched tertiary 
thiols. The substrate functional group pre-requisite, such as an adjacent electron-withdrawing 
group or strained system, means that only a certain class of sulfur-containing molecules can be 
synthesised through these protocols. 
 
 1.1.3.2. The Mitsunobu Reaction  
 
In 1967, Mitsunobu and co-workers reported a method to convert primary and secondary 
alcohols into different functional groups.  By activating the alcohol group to inversive SN2 
displacement using DIAD/DEAD and triphenylphosphine, simple, non-activated alcohols can 







Scheme 10: Mitsunobu reaction employing thiol nucelophiles. 
 
This reaction provides a powerful tool to create carbon-heteroatom stereocentres and, as a 
result, many ethers, azides, amines and thioethers have been prepared using this approach 
(Scheme 11).54,55 The mild reaction conditions and wide substrate scope tolerance makes the 
Mitsunobu reaction versatile. 
 
 
Scheme 11: Mitsunobu reaction to convert tertiary alcohols. 
 
The ease in synthesis of enantioenriched alcohols and their abundance in natural products 
makes their conversion to tertiary thiols a viable synthetic route. However, the reaction is 
sensitive to steric crowding thus the synthesis of tertiary thiols via this route is often not 
feasible. 
 
More recently, the Mukaiyama group has reported several modified Mitsunobu reactions, 
expanding the substrate scope and allowing access to tertiary thiol derivates, with inversion of 
stereochemistry with respect to the starting alcohol.56,57 In this modified procedure, DIAD and 
triphenylphosphine are replaced by benzoquinone derivate 29 and chlorodiphenylphosphine 28 
respectively. A stereodefined tertiary alcohol 22 is reacted with chlorodiphenylphosphine, 
using DMAP and trimethylamine to generate phosphinite 23 (Scheme 12). Subsequent 
oxidation of phosphinite 23 by 29 gives intermediate 24, followed by nucleophilic SN2 





Scheme 12: Mukaiyama-modified Mitsunobu reaction. 
  
 
The Mukaiyama protocol provides a route for stereodefined hindered tertiary alcohols to be 
converted to the corresponding thiol derivatives with stereoinversion. A range of alcohol 
substituents (alkyl, alkenyl, aryl and esters) are tolerated, producing corresponding thioethers 
in excellent yields. The reaction of simple alkyl alcohols, however, is less successful, as this 
chemistry requires an α-ester group for the reaction to produce positive results. Usefully, the 
BtzSH 26 group can be reduced using lithium aluminium hydride and so, thioether 30 can be 
unmasked to give the free thiol 31 (Scheme 13).57  
 
Scheme 13: Reduction of a BtzSH group to unmask a thiol. 
 
This methodology was further simplified to a one-pot methodology to access tertiary thiols, by 




benzoquinones DBBQ, DMBQ and DMOBQ were used as oxidising agents in this protocol 
(Scheme 14). The reaction mechanism is analogous to that discussed before. A range of tertiary 
alcohols was successfully employed in the substrate scope of this protocol. 
 
 
Scheme 14: One-pot optimised Mitsunobu (Mukaiyama). 
 
 
1.1.3.3. Michael Addition 
 
Another route to access tertiary thiols is through conjugate addition (Michael reaction) of a 
thiol nucleophile to a β,β-disubstituted olefin, pending an electron withdrawing substituent, 
through facially selective nucleophilic addition (Scheme 15). The facial selectivity can be 
achieved through intra or intermolecular control (substrate control) or using a chiral auxiliary.59 
 
 




However, the limited literature precedent of asymmetric tertiary thiols synthesised by this 
method can be attributed to the challenges in controlling the stereoselective addition and the 
poor reactivity of β,β-disubstituted olefins to nucleophilic addition.59,60 This results in both 
poor product yield and e.r. Additionally, a competing addition-elimination pathway produces 
a mixture of stereoisomers. These issues were exemplified by Shibasaki and co-workers when 
exploring the conjugate nucleophilic addition of thiols 33 to cyclic enones. With β-methylated 
substrate the product yield and e.r. of 34 were lower than when non-β-substituted enone was 




Scheme 16: Shibasaki’s Michael Addition of a thiol nucleophile to an alkene. 
 
Subsequently, in 2009 Xiao and co-workers reported the organocatalytic enantioselective 
sulfa-Michael addition reaction of thiols 37 to β,β-disubstituted nitroacrylate 36 to generate 
tertiary α-ester β-nitrosulfides 38 in near quantitative yields with high e.r. (Scheme 17).60 The 
reaction utilised a bifunctional cinchona-derived thiourea organocatalyst 40. The products from 
these reactions were carried forward towards the synthesis of α-thio-β-2,2-amino-acids 39, 







Scheme 17: Xiao’s enantioselective Michael Addition of a thiol nucleophile to a β,β-disubstituted nitroalkene. 
 
More recently, Ellman and co-workers reported a catalytic enantioselective Michael Addition 
of a thiol 42 to a trisubstituted nitroalkene 41 using the same cinchona-derived catalyst 40, 
giving rise to 1,1-disubstituted cyclobutanes, azetidines and oxetanes 43 in excellent 
enantioselectivity. In this case, the chiral centre resides on the nitro group carbon (Scheme 
18).62 
 




1.1.4. Tertiary Thiols via Carbon-Carbon Bond Formation (c) 
 
Previous advancements in carbon-carbon bond formation in organic synthesis have led to the 
awarding of the Nobel Prize in Chemistry, in 2010.63 However, carbon-carbon bond formation 
with absolute control of stereochemistry still remains remains a challenging theme and it has 
not been fully solved.  
 
Carbon-carbon bond formation requires a difference in electron density between the bonding 
atoms, such that one of the two carbon atoms is relatively more electron-rich and the other 
more electron-deficient by comparison, which can be influenced by the presence of functional 
groups on the carbon atoms.  
 
Developments in organometallic chemistry, starting with Grignard reagents in 1900, have 
provided a novel source of carbon nucleophiles suitable for synthesising carbon-carbon bonds. 
This field has since expanded to accommodate the enantiospecific construction of carbon bonds 
at stereogenic carbon centres.64 
 
Organolithium reagents, with a carbon-lithium bond, have played a key role in this field. In 
1950, Letsinger and co-workers reported the first enantioenriched organolithium, and 
established a new era of chiral organometallic reagents for use in organic synthesis.65 Here, 
they reported an enantioenriched organolithium reagent 46, generated by lithium-iodine 
exchange of (‒)-2-iodononane 45 at ‒70 oC in petroleum ether/diethyl ether mixture (Scheme 
19). The subsequent electrophile trapping with carbon dioxide afforded (‒)-2-methylnonanoic 
acid 47 in 20% e.e.65 The use of polar solvents or higher reaction temperatures reduced the 










Subsequent studies by Nozaki and co-workers showed that deprotonation of ethylbenzenes in 
the presence of nBuLi/(‒)-sparteine followed by electrophilic trapping furnished 
enantioenriched products, albeit with poor selectivities.66 A Hoffmann test of this substrate 
showed the intermediate organolithium to be configurationally labile (see § 1.1.4.4.).67 
 
It was not until the 1980s when the first configurationally stable α-alkoxyorganolithiums 49 
were reported by Still and co-workers (Scheme 20).68 Here, dipole- and α-heteroatom-
stabilised lithium carbenoids were generated from tin-lithium transmetalation of 48 and were 
shown to retain stereochemical information for several minutes at -78 oC, followed by trapping 
with acetone or trimethylchlorosilane, to give the corresponding enantioenriched product 50. 
In addition, the stereoretentive methylation of α-alkoxyorganolithium 52 (derived from 51) 
with dimethyl sulfate to generate enantiopure 2-butanol 54 (referenced with (R)-2-butanol) 




Scheme 20: α-Alkoxyorganolithiums in stereospecific alkylation reactions. 
 
In recent years, the development of chiral α-heteroorganolithium reagents (α-O, α-S, α-N and 
α-Se) has provided a powerful tool for the stereospecific synthesis of enantioenriched alcohols, 
thiols, amines and selenides.69,70 For these reactions to be successful, the enantioenriched 





1.1.4.1. Electrophilic Trapping of α-Thioenolates 
 
Kellogg and co-workers explored the alkylation of α-thioenolates via diastereoselective control 
to access enantioenriched thioethers, which were subsequently cleaved by acid hydrolysis to 
produce the first general method for the synthesis of enantiopure tertiary thiols 62 and 63 
(Scheme 21).71  
 
Scheme 21: Kellogg’s diastereoselective alkylation of α-thioenolates. 
 
Using conditions reported by Seebach, the authors synthesised 1,3-oxathiolan-4-one 
diastereomers trans-56 and cis-57 (50-92%), through a condensation reaction between 
pivaldehyde and α-thiocarboxylic acid 55.71 The reaction proceeded with preferential 
diastereoselectivity for the cis-57 isomer (2:1 to 8:1 cis:trans selectivity), and the product could 
be further enriched by recrystallisation to exclusively obtain the cis product. Subsequent 
deprotonation, using a lithium base (LDA or LiHMDS) at -80 ˚C, of the trans-56 and cis-57 
diastereomers gave enolates 58 and 59, respectively. Based on Seebach’s theme of “self-
regeneration of chirality” in which producing the enolate destroys the α-stereocentre, this 
stereocentre is regenerated upon alkylation of enolates 58 and 59 to furnish product 60 and 61 
in excellent diastereoselectivity 60-92%, d.r. 80:20 to >99:1).72 The diastereoselectivity in this 
reaction is controlled by steric bias of the distil tbutyl stereocentre, which forces the incoming 
addition to take place on the opposite face to the tbutyl group. It should be noted that enolates 
58 and 59 are sensitive intermediates and therefore limit the electrophile scope; whilst alkyl 
and benzyl halides were competent electrophiles giving the desired product in high yields and 




lower yields and diastereoselectivity. Finally, acid hydrolysis of alkylated oxathiolanones 60 
and 61 produced enantioenriched chiral tertiary α-mercaptocarboxylic acids 62 and 63 (≥78% 
e.e.). 
 
Townsend et al. utilised this methodology by for the synthesis of (5R)-thiolactomycin 71 with 
>99:1 e.r. (Scheme 22),73 a naturally occurring antibiotic active against mycobacteria. 
Condensation of thiol 64 with pivaldehyde produced cis/trans diastereomers 65 and 66 
respectively, then diastereoselective addition of (E)-2-methylbut-2-enal to the cis-diastereomer 
65 produced to produce allylic alcohol 67. 
 




The 1,4 dehydration of allylic alcohol 67 was achieved by using 2,4-dinitrobenzenesulfenyl 
chloride to generate a sulfenate ester intermediate which underwent a [2,3]-sigmatropic 
rearrangement to the allylic sulfoxide. Subsequently, a syn-elimination of the sulfoxide was 
achieved by heating the reaction mixture to produce 1,3-diene 68 in 75% yield. Finally, ring 
opening of oxathiolanone 68 generated thiol derivative 69, which was not isolated due to issues 
with the stability of the thiol molecule. Instead, protection of thiol 69 as the acyl derivative 70 
allowed isolation of the thioester, which was converted to the desired natural product (5R)-
thiolacomycin 71 via a thio-Dieckman condensation reaction. 
 
1.1.4.2. Lithiation of α-Thiocarbamates 
 
Beak reported the first achiral deprotonation of primary alkyl thiocarbamate 72, employing 
sBuLi/TMEDA, which generated lithiated species 73, that were then trapped with various 
electrophiles to produce 74 in good to excellent yields (Scheme 23).74 Beak also reported an 
attempt at deprotonating S-isopropyl N,N-diethylthiocarbamate 75 at –98 °C, but this proved 
unsuccessful. No further conditions were reported for this substrate. 
 
Scheme 23: Beak’s study into primary α-lithiothiocarbamate 72. 
 
Subsequently, Hoppe and co-workers reported the first primary α-lithiothiocarbamate 77, via 
the stereoselective deprotonation of thiocarbamate 76 using sBuLi/(‒)-sparteine (Scheme 24).75 
The α-lithiothiocarbamate 77 was trapped with various electrophiles to furnish secondary α-
thiocarbamates 78 in poor to moderate enantioselectivity. Further studies to establish the cause 





Scheme 24: Hoppe’s study into lithiation-electrophile trapping of primary α-lithiothiocarbamate 77. 
 
To address this issue, Hoppe investigated the configurational stability of 77. This was achieved 
through a kinetic H/D isotope labelling study, which had been previously reported on similar 
compounds.76 A racemic mixture of (R)-79 and (S)-79 was lithiated with sBuLi/(‒)-sp. and 
trapped with trimethylsilyl chloride (Scheme 25). The high deuterium incorporation yield 
(>99%) suggested that both enantiomers were lithiated, but the reaction outcome is non-




Scheme 25: Hoppe’s study into the configurational stability of α-lithiothiocarbamate 77. 
 
To induce stability in the organolithium, the bulkier, secondary α-trimethylsilyl thiocarbamate 
81 was prepared according to the above methodology in 73:27 e.r. and studies into the 
lithiation-deuteration of these species were conducted (Scheme 26). Due to a lack of 
enantiotopic protons, (‒)-sparteine was not required and substituted for achiral TMEDA. After 
lithiation (2.5 hours) at -78 °C and deuteration, α-trimethylsilyl thiocarbamate 80 was obtained 
in 72:28 e.r., with retention of configuration. This suggested that the intermediate 





Scheme 26: Hoppe’s study into secondary α-trimethylsilyl thiocarbamate 81. 
 
Successive lithiation-electrophile trapping studies of benzylic thiocarbamate 82 found that the 
corresponding thioorganolithium 83 exhibited exceptional macroscopic configurational 
stability and was successfully trapped with a range of electrophiles (Scheme 27).77–79 The 
electrophile addition to produce 84 proceeded with retention of stereochemistry. Subsequent, 
DIBAL-H reduction or acid hydrolysis of the carbamate provided enantiomerically pure 
tertiary thiol 85.  
 
 
Scheme 27: Lithiation-electrophile trapping studies of benzylic thiocarbamate 82. 
 
Expanding upon this theme, Hoppe investigated cyclohexenyl thiocarbamate 86.80,81 Here 
cyclohexenyl organolithium was found to be configurationally stable at -78 oC in THF (not 
Et2O as used before) and underwent reaction with methyl iodide to produce regioisomers 87 
(21%) and 88 (41%) (Scheme 28). Interestingly, the reaction favoured γ-substituted product 





Scheme 28: Lithiation-electrophile trapping studies of cyclohexenyl thiocarbamate 86. 
 
The regioselectivity issue was addressed by substituting the secondary amide for a tertiary 
amide. Here, it was found that a diisopropyl protecting group on 89 gave solely α-substituted 
90 in excellent yield and e.r. (Scheme 29). The reaction proceeded with inversion of 
stereochemistry and the reaction scope tolerated a range of organohalides. Finally, reduction 
of 90 with lithium aluminium hydride furnished the desired tertiary thiols 91 in high e.r. 
 




1.1.4.3. Lithiation of α-Thiolithiums and α-Thiobenzoates 
 
 
In the previously discussed carbamate examples, the α-thioenolates required an α-carboxylic 
acid or ester moiety to be present for the reaction to procced. However, there have been studies 
into the lithiation of enantioenriched secondary thiol derivatives (Scheme 30), which provides 









Scheme 30: Lithiation of enantioenriched secondary thiol derivatives. 
 
Studies into the lithiation of α-oxylithium and α-aminolithium compounds by Hoppe and Beak, 
showed these class of molecules to be “macroscopically configurationally stable”, ie. these 
organolithiums were stable after 10 mins.82,83 As a result, there have been numerous studies 
into the lithiation of configurationally stable α-oxy-alkyl-84, -allyl-85–90, -cinnamyl-91 and -
benzyl-lithium92 species, alongside α-lithiocyclohexylamine93,94, α-amino-cinnamyl93,95–97 and 
various other -allyl-lithium98 species. 
 
In comparison, studies into α-thioorganolithium species have been challenging, due to their 
configurational instability, even at temperatures as low as ‒80 oC. Therefore, these 
organolithium species are microscopically configurationally stable.  
 
Studies by McDougal and co-workers showed that thioether 92 could be lithiated using sBuLi 
to form organolithium 93, and then trapped by trimethylsilyl chloride in 98:2 d.r. to produce 




Scheme 31: McDougal’s study into the lithiation-electrophile trapping of thioether 92.  
 
Interestingly, as shown in Scheme 32, when either diastereomer of enantioenriched thioether 
95 and 96 underwent tin-lithium exchange at ‒78 °C to produce lithiated intermediates 93 and 
97, which underwent electrophilic trapping with TMSCl, only one diastereomer product 94 
was obtained through either reaction. McDougal rationalised the difference in diastereomeric 
ratio between starting materials 95/96 and the product 94 was due to a thermodynamic 






Scheme 32: McDougal’s study of 94.  
 
Studies by Beak in the 1980’s into the lithiation-electrophilic trapping of lithiated α-
thiobenzoates proved somewhat challenging due to their configurational lability, unlike the α-
thiocarbamate substrates discussed previously.74 Though Beak studied the lithiation of S-
methyl 2,4,6-trialkylthiobenzoate and S-ethyl 2,4,6-triethylthiobenzoate, but no asymmetric 
deprotonations have been reported for the latter. An interesting observation was the facile 
deprotonation of S-isopropyl 2,4,6-triisopropylthiobenzoate 98 (Scheme 33), in comparison to 
the analogous S-isopropyl N,N-diethylcarbamate.74 The lithiated thiobenzoates 99 were 
successfully trapped with various electrophiles to give 100 in poor to good yields. 
 
 
Scheme 33: Lithiation-electrophilic trapping of enantioenriched S-isopropy 2,4,6-triisopropylthiobenzoate 98. 
 
Attempts to render this reaction asymmetric were less fruitful (Scheme 34). Compound 101 
was successfully deprotonated to give 102 and quenched with MeOD to give 103 with 66% 
deuterium incorporation and 68% racemisation (quantified using optical rotation). The authors 






Scheme 34: Reaction of enantioenriched S-thiobenzoate 101. 
 
Similar issues were encountered in the lithiation of cis- and trans- diastereoisomers of 4-tbutyl-
-cyclohexyl 2,4,6-triisopropylbenzoates 104 and 105, in which trapping with either MeOD or 
MeI gave only the trans product 106 (Scheme 35).74 Based on these findings, Beak concluded 
that “α-lithio thioesters are configurationally equilibrated either in the formation of the lithiated 




Scheme 35: Configurational lability of cyclohexyl S-thiobenzoates cis-104 and trans-105. 
 
However, many of Beak’s conclusions in this study were based on incomplete results. For 
example, THF, the only solvent reported in this study, is known to decrease configurational 
stability of α-thioorganolithiums.79 This is a reflection on the lack of reaction conditions 
explored in this study. In addition, by drawing on conclusions from primary α-oxo and α-amino 




of configuration.79 However, it has since been discovered that whether the trapping is invertive 
or retentive depends on the choice of electrophile. 
 
These findings prompted further study into the configurational stability of α-
thioorganolithiums to help understand the mechanism of epimerisation, as shown in the works 
of Reich and Hoffmann.69,70  
 
1.1.4.4. Configurational Stability of α-Thioorganolithiums 
 
The configurational stability of an enantioenriched organometallic species can be studied 
through the rate of inversion under specific conditions. This term is generally applied to a 
system under a specific temperature and timescale (microscopic and macroscopic), however 
other factors such as additives and solvents can affect the configurational stability of an 
organolithium species.100 The microscopic stability of an organolithium species can be assessed 
by the time taken for the organometallic species to react with an electrophile. The Hoffmann 
test provides a practical method to assess the configurational stability of an organolithium.  
 
The Hoffmann test requires two separate experiments to evaluate the organolithium species. In 
the first experiment a racemic organolithium is reacted with an achiral electrophile to produce 
diastereomers, from which the kinetic resolution selectivity factor is ascertained. In the second 
experiment of this study, the same racemic organolithium is reacted with an enantiopure 
electrophile, ensuring that the reaction can reach completion. In the case of configurationally 
stable organolithium species the reaction outcome from the second experiment will result in a 
product with 50:50 d.r. However, if a non-identical product d.r. is obtained from the two 
experiments (i.e. not 50:50), then the organolithium species are deemed configurationally 
unstable, since the organolithium species have been kinetically resolved. If a distinct d.r. is 
obtained in both experiments then the organolithium is configurationally stable. These 
outcomes are relative to the timescale on which the reaction been conducted. 
 
Understanding the mechanism of racemisation is difficult due to the multicomponent aspect of 
an apparently simple, single step process. Previous studies into the epimerisation of α-
heterobenzyllithiums took into consideration the following factors: i) the nature of the 




carbanionic centre was secondary or tertiary, iv) the degree of carbanionic centre 
pyramidalisation, and v) the solvent.  
 
However, subsequent work by Hoffman into the mechanism of enantiomerisation of α-thio 
(and α-seleno and α-telluroorganolithium) 107 and 112 suggested that the mechanism of 
racemisation can be broken down into three distinct steps: 
 
A. Dissociation into solvent separated ion pair (108 and 111).  
B. Inversion of the stereogenic carbanionic centre and rotation of the hyperconjugated 
sulfur–carbon bond at the carbanionic centre (109 and 110). 
C. Recombination of the ion pair to give opposite enantiomer (108 and 111). 
 
 
Scheme 36: Mechanism of racemisation of α-thioorganolithiums 107 and 112. 
 
As several groups reported, negative hyperconjugation also plays an important role in the 
racemisation of α-thioorganolithiums. It is necessary for the carbanionic centre lone pair to be 
anti-periplanar to the S-R bond, as shown in Scheme 36. This ensures the lone pair is 
delocalised into the σ*X-R-orbital. Therefore, during step B, where the carbanionic centre 
undergoes inversion, the C-S bond must rotate to ensure the anti-periplanar relationship is 
maintained. 
 
The proposed mechanism outlined above was probed with further studies. Initially, α-




for racemisation. It was understood that co-ordinating solvents (such as THF) would stabilise 
the solvent separated ion pair and establish an equilibrium between the separated and contact 
ion pairs (Table 1). 
 




Solvent ΔGǂ (kcal/mol) 
Et2O 12.6 
THF 12.5 
Toluene + THF (1.0 eq.) 12.2 
Toluene + THF (2.0 eq.) 11.8 
Toluene + THF (3.0 eq.) 11.9 
 
The energy barrier to racemisation (ΔGǂ) was calculated from the coalescence of the 
diastereotopic benzylic protons (1H NMR) upon enantiomerisation. The authors screened 
ethereal solvents, such THF or Et2O, and toluene:THF solvent mixtures (with 1.0-3.0 eq. THF) 
(Table 1). However, it was found that the choice of solvent had minimal effect upon the barrier 
to racemisation. These results led the authors to conclude that the rate-determining step was 
either carbanionic inversion or rotation about the C-Se bond. 
 
Subsequent studies by various groups found the barriers to inversion of α-thiocarbanions to be 
low, with values for the carbanion of dimethyl sulfide69 114 and ethylmethyl sulfide101 115 
measured at 0.5 and 1.1 kcalmol-1 respectively (Scheme 37). This led to the assumption that 







Scheme 37: Hoffman’s study on α-thiocarbanions 114 and 115. 
 
As a result, further studies into the barrier to rotation about the C-S bond were explored. It was 
understood that if C-X (X = S, Se or Te) rotation was rate limiting, then the presence of bulky 
substituents on the heteroatom would further increase the barrier to enantiomerisation. 
Modelling studies of the minimum-energy conformation of phenylthio methyllithium 
suggested that the thiolithium had a planar geometry to allow for negative hyperconjugation 
(C-S) and sulfur lone pair delocalisation into the π*-orbital of the phenyl group, rendering the 
molecule completely planar. During rotation about the C-S bond, the phenyl group is forced to 
rotate past either the carbanion hydrogen or the methyl group. However, in the latter, the syn-
pentane interaction between the methyl and aryl group forces rotation about the S-phenyl bond. 
This disrupts the n-π* delocalisation and raising the barrier to rotation. On this basis, a 
substituted aryl ring would further raise the barrier to rotation and therefore increase the barrier 
to racemisation. 
 
To probe this hypothesis, various α-thio, α-seleno and α-telluroorganolithium derivatives 116 

















X R ΔGǂ (kcal mol-1) 
S H 11.3 
S 3-CF3 11.4 
S 4-OMe 11.4 
S 2,3,5,6-Me4 >13.9 
Se H 12.4 
Se 2-Me 12.7 
Se 4-Me 12.3 
Se 2,4,6-Me3 >14.3 
Se 2,3,5,6-Me4 >14.5 
Te H 11.8 
Te 2,3,5,6-Me4 13.9 
 
 
The results suggest that as the steric bulk increased on the aryl ring, the barrier to racemisation 
increased. This implied that the rotation about the C-X bond was rate determining in the 








Scheme 38: Reich’s 7Li NMR spectroscopy to explore solvent effect on barrier to enantiomerisation of 117. 
 
Subsequent 7Li NMR studies by Reich70 aimed to underpin the concentration of HMPA needed 
to produce solvent separated ion pairs for α-silyl, α-thioorganolithiums 117 (Scheme 38). It 
was found that 3.0 eq. HMPA were sufficient to achieve this. The presence of HMPA decreased 
racemisation by a factor of 20 when compared to the control reaction (with no HMPA), due to 
stabilisation of the solvent separated ion pairs 118. This verified Hoffman’s finding that the 







1.2. Previous Work 
All previous work reported in this section on the lithiation-electrophile trapping of 122 was 
conducted by Dr. Alex Pulis (AP), and the contents of this work were reported in his Ph.D 
thesis.102  
 
Dr. Pulis re-investigated the work reported by Beak and co-workers on α-thio organolithiums74, 
since a single test condition was used to draw conclusions on the stability/ reactivity of an 
entire class of carbenoid. Given the facile deprotonation of S-2,4,6-triisopropyl thiobenzoates 
and configurational stability of secondary S-thiocarbamates, dialkyl α-thio organolithiums may 
provide synthetically useful carbenoid intermediates. Additional interest in enantioenriched 
thiobenzoates came from wanting to explore a different source of chiral lithium carbenoid for 
application in lithiation-borylation methodology (see Chapter 2.1 for further information on 
lithiation-borylation methodology). 
 
Initially, Dr. Pulis tested lithiation-deuteration conditions on racemic thiobenzoate 119 
(Scheme 39), which was synthesised by esterification of butane-2-thiol in 91% yield. Next, 
thiobenzoate 119 was lithiated in the presence of sBuLi and TMEDA in Et2O at -78 °C for 1 
hour, after which MeOD was added to the reaction mixture. Pleasingly, this reaction furnished 
D-incorporated thiobenzoate 120 quantitatively with >95% D incorporation. 
 
Scheme 39: Synthesis and lithiation-deuteration of dialkyl S-thiobenzoate 119. 
 
 
Having established lithiation and deuteration of the chiral racemic carbenoid, Dr. Pulis sought 
to test the enantioenriched S-thiobenzoate 122 in the same reaction. This would provide insight 
into the configurational stability of the carbenoid generated. However, the synthesis of the 
enantioenriched secondary thiobenzoate 122 (Scheme 40) required a different synthetic 




triisopropylbenzothioic acid (TIBSH) 123, with full stereoinversion. The O-substituted 
thiobenzoate 122a was also isolated in 18% yield. 
 
Scheme 40: Synthesis of secondary thiobenzoate 122 via Mitsunobu reaction. 
 
 
However, the TIBSH 123 is not commercially available and was synthesised in house by 
reacting the corresponding 2,4,6-triisopropylbenzoyl chloride (TIBCl) and sodium sulfide 
under anhydrous anaerobic conditions. It was crucial to maintain anaerobic conditions to 
minimise disulfide 124 formation, which was still present in the isolated product (5%) (Scheme 
41). The presence of disulfide 124 did not affect the subsequent Mitsunobu reaction. 
Furthermore, the excess sodium sulfide generated toxic H2S gas when the reaction was 




Scheme 41: Synthesis of TIBSH 123. 




Subsequently, enantioenriched S-2,4,6-triisopropyl dialkyl thiobenzoate 122 was fully 
deprotonated using sBuLi/TMEDA in Et2O at –78 °C after 1 hour. However, reaction of the 
deprotonated α-thio organolithium 125 with EtB(pin), EtB(neo) or EtB(gly), followed by 
heating under reflux, failed to give tertiary alcohol 126 after oxidation (Scheme 42), instead 
ketone 127 was isolated in various yields (0-50%). The addition of Lewis acid, MgBr2•OEt2, 
did not remedy the reaction outcome. In contrast, reaction of α-thio organolithium 125 with 
triethyl borane furnished tertiary alcohol 126 following oxidation of crude reaction mixture, 
with a high yield (76%), but poor enantiospecificity (82:18 e.r., 64% e.s.). The change in 
enantiomeric ratio raised concerns over the configurational stability of the carbenoid generated 
in this reaction. Further optimisations were required to address this issue, such as variation in 
temperature, solvent and reagent additives. However, no further optimisations were reported 
in Dr. Pulis’s thesis.  
 
 
Scheme 42: Lithiation-borylation of secondary thiobenzoate 122. 
 
Due to thiobenzoate 122 only reacting with boranes in lithiation-borylation reactions and the 
poor enantiospecificity observed in these reactions, all further studies into the use of a 
thiobenzoate carbenoid in lithiation-borylation methodology were stopped at this stage. 
Carbenoids formed by lithiation of O-benzoates have been found to display much higher 
macroscopic configuration stability than the corresponding thiobenzoate. Therefore, the O-




1.3. Project Aims 
 
Having shown that thiobenzoate 122 could be lithiated, it was confirmed that the carbenoid 
was configurationally unstable, leading to loss of enantiomeric excess over time. For this 
reason, thiobenzoate 122 was deemed unsuitable for lithiation-borylation methodology. Based 
on the lithiation-deuteration study for thiobenzoate 122, it was envisaged that optimising 
lithiation conditions for thiobenzoate 128, to improve configuration stability of the lithiated 
species could enable the carbenoid to react with a range of electrophiles to produce 129 with 
high e.r. if the electrophile trapping process were to proceed in a rapid and irreversible manner. 
Therefore, such a process would give access to enantioenriched tertiary thiobenzoates 129, 




Scheme 43: Synthesis of enantioenriched tertiary thiols 130. 
 
First, we will establish optimal conditions for the lithiation-deuteration on a model 
thiobenzoate substrate and then test this with a range of suitable electrophiles. This 
methodology will be expanded to analogous thiobenzoate substrates by varying the R group. 
Similarly, a range of thiobenzoate-containing natural products will be tested using this 
methodology to showcase broader application.  
 
Subsequently, in-situ IR spectroscopy will be employed to monitor and understand the reaction 
profile for various electrophiles used in this methodology. Furthermore, Excitation-Sculptured 
Indirect-Detection Experiment (EXSIDE) NMR spectroscopy103 will be conducted to elucidate 
the stereochemistry of the lithiation-electrophile trapping product. Finally, a study to determine 




1.4. Results and Discussion 
 
1.4.1 Collaboration Disclaimer 
 
Parts of this project have been completed in collaboration with Dr. Alex Pulis (AP), Dr. Ana 
Varela (AV) and Dr. Cinzia Citti (CC) which form the basis of the publication.104 The work of 
the above collaborators has been included to provide a complete story for this chapter. All work 
completed by myself has been marked with my initials PS. Only the molecules synthesised by 
myself (PS) have been reported in the Experimental Chapter. 
 
1.4.2. Synthesis of Starting Materials 
 
1.4.2.1. Synthesis of Thiobenzoates  
 
Initially, focus was turned to improving enantiomeric ratio of the secondary thiobenzoate, 
which for thiobenzoate 122, was 98:2 e.r. as reported by Dr. Pulis (Scheme 44). In the original 
synthesis of thiobenzoate 122, a Noyori asymmetric hydrogenation ruthenium catalyst 
(RuCl2[(R)-DM-BINAP][(R)-DAIPEN] was used to convert (E)-4-phenylbut-3-en-2-one 131 
to enantioenriched alcohol 132 in 98% yield and 98:2 e.r, as shown in Scheme 44. Then alcohol 
132 was converted by hydrogenation to alcohol 121, using palladium on charcoal and hydrogen 
gas in 92% yield. The saturated enantioenriched secondary alcohol 121 was then reacted via 
Mitsunobu to furnished secondary thiobenzoate 122 in 61% yield and 98:2 e.r.  
 
Unfortunately, attempts to recrystallize enantioenriched thiobenzoate 122 to improve 
enantiomeric ratio of this material were unsuccessful. A combination of solvent systems were 
screened to this extent, however due to solubility issues, thiobenzoate 122 failed to dissolve or 






Scheme 44: Original synthesis of thiobenzoate 122, using Noyori hydrogenation catalyst. 
 
 
An alternate route to thiobenzoate 122, in high e.r., without the need for recrystallisation was 
also explored (Scheme 45). In this route, (E)-4-phenylbut-3-en-2-one 131 was reduced with 
NaBH4 to afford the racemic alcohol rac-132. Then lipase-catalysed enzymatic resolution of 
this alcohol generated 132 and 133 both of which were isolated in >99:1 e.r. Subsequent 
hydrogenation reaction afforded 121 and then Mitsunobu reaction yielded desired thiobenzoate 
122 in 63% yield and >99:1 e.r. The only concern with this route is that the NaBH4 reduction 
results in a racemic mixture of alcohol rac-132, which ultimately means at least half the 






Scheme 45: Using enzymatic resolution for the synthesis of secondary alcohol 121. 
 
Finally, the synthesis of desired secondary alcohol 121, was simplified to a single step, by 
adding benzyl magnesium bromide (Grignard reagent) to (S)-2-methyloxirane in the presence 
of CuI (Scheme 46). Though this route simplified the route to synthesise enantioenriched 
alcohol 121 without compensating the enantiomeric excess (99:1 e.r.), the Grignard reagent 
addition led to the formation of regioisomer 134, due to competing ring-opening of the epoxide. 
This side product was inseparable by column chromatography and distillation. The production 
of regioisomers 134 was circumvented by adding a diluted solution of Grignard reagent in a 
drop-wise manner (~1 drop per 2 seconds using a syringe pump) to a cooled solution of epoxide 
and copper iodide. Similarly, preparing a fresh batch of the Grignard reagent rather than using 










1.4.2.2. Synthesis of Thiobenzoate Analogues 
 
Using the epoxide ring-opening protocol towards the synthesis of enantioenriched secondary 
alcohols provided a more facile and versatile route towards the synthesis of analogous 
secondary thiobenzoates, as shown in scheme 47. Using allyl magnesium bromide in this 
protocol generated the allylic alcohol 135 via ring-opening of (S)-2-methyloxirane, which was 
converted to thiobenzoate 136 via Mitsunobu esterification. Subsequently, reductive 
ozonolysis of thiobenzoate 136 cleaved the terminal alkene to produce primary alcohol 137. 
Finally, primary alcohol 137 was protected using 3,4-Dihydropyran (DHP), to give THPO-
thiobenzoate analogue 138 in good yield and high e.r. The synthesis and electrophile trapping 





Scheme 47: Synthesis of allylic secondary thiobenzoate 136 and THPO thiobenzoate 138. 
 
In addition, commercially available (S)-2-ethyloxirane (99:1 e.r.), Scheme 48, was reacted with 
benzylmagnesium bromide to produce alcohol 139 in high e.r. and yield, which was taken 
through into a Mitsunobu esterification to produce ethyl branched thiobenzoate 140 in 








Scheme 48: Synthesis of ethyl branched secondary thiobenzoate 140. 
 
Furthermore, commercially available (S)-(+)-2-pentanol was also subjected to Mitsunobu 
esterification to furnish thiobenzoate 141, as shown in Scheme 49. The absence of a functional 
group tether in this analogue should be highlighted in this thiobenzoate. The synthesis and 
electrophile trapping of this substrate was carried out by Dr. Citti (CC). 
 
 
Scheme 49: Mitsunobu esterification of (S)-(+)-2-pentanol 141. 
 
Similarly, S-((cis)-4-(tert-Butyl)cyclohexyl) 2,4,6-triisopropylbenzothioate 104, which has 
been previously shown by Beak74 to undergo thermodynamic equilibration to the more stable 
trans-organolithium when lithiated, was re-evaluated using our modified conditions. It was 
envisaged that the shorter lithiation times would reduce thermodynamic equilibration, thus 
gaining access to the previous unobtainable cis-isomer product. The mixture of cis- and trans- 
142 diastereoisomers were separated by column chromatography and the trans-142 isomer was 







Scheme 50: Synthesis of S-((cis)-4-(tert-butyl)cyclohexyl) 2,4,6-triisopropylbenzothioate 104. 
 
To broaden the thiobenzoate scope, natural product containing carbocycles, such as cholesterol 
and (‒)-menthol were utilised. In a similar manner to the example above, the alcohol functional 
groups on cholesterol and (‒)-menthol were successfully reacted with thioic acid 123 in a 
Mitsunobu esterification to furnished cholesterol-derived thiobenzoate 143 and (‒)-menthol-
derived thiobenzoate 144 in high yield and diastereoselectivity (Scheme 51). The poor yield 
observed in the menthol Mitsunobu reaction is due to steric hindrance from the adjacent 
isopropyl group, which is on the same face as the TIBS group in the product 144. 
 
  






1.4.2.3. Exploring an Alternate Strategy in the Synthesis of TIBSH  
 
The route to synthesise TIBSH 123 was developed by Dr. Pulis using TIBCl and sodium 
sulfide, however, during this project TIBCl became difficult to obtain from suppliers. With a 
lack of TIBCl an alternate route to synthesise this in-house material was warranted. Given that 
we had access to 2,4,6-triisopropyl benzoic acid (TIBOH), we attempted to access TIBCl from 
TIBOH using thionyl chloride. However, only a difficult to purify, gummy oil was obtained 
from this route.  
 
Ideally, a protocol to convert the carboxylic acid directly into the thioic acid could solve two 
issues. Firstly, the corresponding thioic acid should be accessible in one-step and secondly, it 
would circumvent the use of Na2S, which posed a safety issue when working on scale. Previous 
work by Danishefsky and co-workers105, reported a protocol for the conversion of carboxylic 
acids to the analogous thioic acid with Lawesson’s reagent, using a microwave reactor, as 
shown in Scheme 52.  
 




Table 3 shows conditions screened to find optimal reaction temperature (°C) and time (mins). 
Given that the aryl C-H shift (1H NMR spectra) of the TIBOH (7.00 ppm), TIBSH (7.02 ppm) 
and disulfide (7.08 ppm) are similar, this reaction could only be monitored via GCMS or 
change in the quaternary carbonyl signal seen in the 13C NMR spectrum. The initial reaction 
(Entry 1) using literature conditions, showed conversion of the carboxylic acid to desired 
product (95 % conversion by 13C NMR). Attempts to improve conversion were achieved by 
heating the reaction for prolonged time (15 (Entry 2) and 20 mins (Entry 3)), however 
prolonged heating led to a difficult to purify crude mixture, possibly due to competing side 
reactions. Unfortunately, the impurities could not be separated and isolated nor were the 
impurities identified. It was found that heating for 15 mins at 80 °C showed complete 
consumption of TIBOH without the pink impurity being generated (Entry 4). Following 
purification (under N2 to avoid disulfide formation) an isolated yield of 83 % was obtained. 
For the scale-up reaction it was found that to ensure full conversion, reaction mixtures had to 
be kept below 0.25 M, otherwise stirring was inefficient in the microwave reactor. It is also 
crucial to purify the crude reaction mixture under nitrogen to avoid formation of disulfide. As 
expected, leaving the crude reaction mixture over a prolonged period in the presence of air 
resulted in quantitative disulfide formation. 
Table 3: Optimisation of conditions for the synthesis of thiobenzoate 123 using Lawesson’s reagent. 
 






1 10 100 >95:5 62 
2 20 100 100:0 ND 
3 15 100 100:0 ND 
4 15 80 100:0 83 
5 10 60 50:50 37 
 
Danishefsky and co-workers105 postulated a mechanism for this reaction, as shown in Scheme 
52, which requires the generation of ylide 145, derived from Lawesson’s reagent. 
Subsequently, the carboxylic acid undergoes nucleophilic addition onto the phosphorus 
heteroatom of ylide 145 to give intermediate 146. Then intramolecular cyclisation facilitated 
through the sulfur atom, furnished intermediate 147, which then undergoes a “Wittig-like” 




1.4.3. Optimising Reaction Conditions 
 
 
This work was jointly carried out by Dr. Citti (CC) and myself (PS). We investigated both the 
lithiation efficiency and configurational stability of Li-122 via a lithiation-deuteration 
experiment (Table 4). This optimisation was achieved using thiobenzoate 122 with 98:2 e.r. 
 
Table 4: Optimisation of lithiation conditions for thiobenzoate 122. 
 
 





1 THF 15[c] TMEDA 88 56:44 
2 Et2O 60
[c] TMEDA 100 84:16 
3 Et2O 15
[c] TMEDA 100 90:10 
4 Et2O 15
[c] - 11 97:3 
5 CPME 60[c] TMEDA 100 92:8 
6 CPME 15[c] TMEDA 100 94:6 
7 TBME 60[d] TMEDA 100 93:7 
8 TBME 15[d] TMEDA 100 96:4 
9 TBME 5[d] TMEDA 100 97:3 
10 TBME 15[c] (−)-sparteine 7 98:2 
11 TBME 15[c] TMCDA 58 97:3 
12 TBME 15[c] PMDTA 6 ND 
13 TBME 15[c] DME 14 93:7 
14 Toluene 60[c] TMEDA 85 95:5 
15 Toluene 15[c] TMEDA 78 94:6 
16 Et2O/hexane (1:10) 60
[c] TMEDA 100 92:8 
17 Et2O/hexane (1:10) 15
[c] TMEDA 100 94:6 
Yield of 122 and 149 was ≥90% in all cases. [a]Determined by 1H NMR. [b]Determined by HPLC on the 
crude mixture of 122 and 149. TMEDA = N,N,N’,N’-tetramethylethylene diamine; TMCDA = (rac,trans) 
N,N,N’,N’- tetramethylcyclohexane-1,2-diamine; PMDTA = N,N,N′,N′,N′′- pentamethyldiethylenetriamine; 







As shown in Table 4, it was found that reducing the lithiation time for the conditions reported 
by Beak and co-workers (Entry 1) gave good levels of D-incorporation (88%), but poor 
enantiospecificity (near racemic product). Since both solvents and additives effect lithiation, 
we studied this by modifying these parameters to maximise both efficiency and configurational 
stability. In Entry 2, exchanging THF solvent for Et2O aided the configurational stability of Li-
122, with quantitative D-incorporation and 84:16 e.r. after 60 mins lithiation. Similarly, under 
the same conditions, reducing lithiation time to 15 mins (Entry 3), improved the product 
enantiomeric ratio (90:10 e.r.), with no detriment to product yield. It was evident that shorter 
lithiation periods were crucial to the stability of the Li-122 generated in the reaction. Attempts 
to repeat the reaction in the absence of additive (Entry 4) further improved the enantiomeric 
ratio (97:3 e.r.), however resulted in poor D-incorporation (11%), suggesting that the ligand 
played an important role in facilitating lithiation.  
 
Having seen improvements in the configurational stability of Li-122 when switching from THF 
to Et2O, we suspected that controlling the solvent oxygen lone-pair availability could control 
the reaction outcome. We envisaged that using bulkier groups on the ethereal solvent would 




Scheme 53: Solvent-effects on Li-122 configurational stability. 
 
Whilst screening additional ethereal solvents, such as CPME and TBME (Entry 5-13), it was 
found that CPME (Entry 5) as solvent enabled better configurational stability after 60 mins 
lithiation time (92:8 e.r. with 100% D incorporation), which was further improved by reducing 
reaction time to 15 mins (Entry 6). Using TBME produced promising results: after 60 mins 
(Entry 7) 93:7 e.r. and 15 mins (Entry 8) 96:4 e.r. were obtained. At this stage a 5-minute 
lithiation period was attempted to see if this could produce better results (Entry 9). In our 




In an attempt to optimise these conditions, we altered the diamine ligand used in the reaction 
to (−)-sparteine (Entry 10), to see if this chiral ligand had a mis-match effect on the lithiation. 
Though high e.r. was observed, the D-incorporation was poor. Using other diamine ligands 
also produced poor results: in TMCDA only 58% D-incorporation was observed, though in 
high e.r. Similarly, PMDTA (Entry 11) did not remedy the situation and resulted in the lowest 
D-incorporation reported in this table (Entry 12, 6%). Furthermore, using 1,2-dimethoxyethane 
(DME) (Entry 13) resulted in poor D incorporation (14%) demonstrating that diamine ligands 
were a better choice for this reaction. In addition, toluene was also tested (Entry 14/15) and 
though both reactions produced comparable enantiomeric ratios after 15 mins or 60 mins, the 
D-incorporation for both products were low. Finally, Entry 16/17 showed the use of mixed 
solvent systems on the lithiation profile of this reaction, with both reactions resulting in 
quantitative D-incorporation after 60 mins and 15 mins, respectively, but lower e.r. than the 
conditions reported in Entry 9. 
 
Whilst these results clearly demonstrate that Li-122 configurational stability can be enhanced 
by reducing lithiation periods and using bulky ethereal solvents. We decided to use Entry 9 as 
our optimised conditions for the lithiation of thiobenzoates in this work. The next stage of this 
study requires testing these reaction conditions against various electrophiles to develop a 



















1.4.4. Substrate Scope 
 
 
Scheme 54: Substrate scope developed for the lithiation-electrophile trapping of thiobenzoates. 
 
Using the most suitable conditions identified for the lithiation of thiobenzoate 122, and trapping 
with MeOD, we assessed the scope of electrophiles that could be utilised in this protocol. As 
shown in Scheme 54, the trapping of the non-stabilized, tertiary thiobenzoate organolithium 
species derived from thiobenzoates 122, 136, 138, 140 and 141, gave products in good to high 
yields and high enantioselectivities in all cases except for allylbromide 160, trimethylsilyl 




As shown in Scheme 54, trapping Li-122 with methyl chloroformate gave the methyl ester 150 
in high yield and e.r. To understand the reaction profile for the methyl chloroformate 150 
reaction, an in-situ IR spectroscopy was conducted to study the behaviour and fate of the Li-
122 (Scheme 55). Here it is shown that the lithiation of thiobenzoate 122 was rapid, upon 
addition of sBuLi (~ 8 mins), with consumption of thiobenzoate 122 species (red line) to 
produce Li-122 (blue line). After 5 minutes the methyl chloroformate was added to the 
reaction, resulting in consumption of all Li-122 to produce thiobenzoate product 150. The 
reaction profile observed in the IR study suggested that fast electrophile trapping is important 




 Scheme 55: In-situ IR spectroscopy of the ClCO2Me trapping of thiobenzoate 122. 
Similarly, secondary amides (151 and 152) were also obtained from the corresponding 
isocyanates, with both electron rich (benzyl-) and electron deficient (pBr-C6H4-) substituents 





In addition, DMF could be used with Li-122 to furnish the aldehyde 153. Similarly, 
benzaldehyde and isobutyraldehyde were also shown to react with Li-122 to furnish desired 
secondary alcohols 154 and 155, respectively. The diastereomer ratio for both 154 and 155, 
were low, due to poor selectivity in the reaction. The moderate yields obtained for 
isobutyraldehyde 155, were due to competing α-deprotonation of the aldehyde starting 
material, which prevented the electrophile from reacting with the Li-122. 
 
 
Scheme 56: In-situ IR spectroscopy of the TMSCl trapping of thiobenzoate 122. 
 
The reaction of TMSCl, produced the silylated product 156 in low e.r. (60:40). This was 
attributed to the slow reactivity of the electrophile with Li-122. It was observed that upon 
addition of the electrophile, allowing the lithiated species to racemise before being quenched 
at a higher temperature. The use of the more reactive TMSOTf gave only marginally improved 





To understand the poor enantiomeric ratio obtained from this reaction an in-situ IR 
spectroscopy was conducted to study the behaviour and fate of the Li-122 (Scheme 56). Here 
it is shown that the lithiation of thiobenzoate 122 is rapid, with consumption of thiobenzoate 
122 (red line) to produce Li-122 (blue line), with full lithiation observed as expected from the 
previous study. After 5 mins of lithiation the TMSCl electrophile was added and the reaction 
monitored. The gradual decline in the concentration of Li-122 over time, suggested that the 
electrophile was not sufficiently reactive with Li-122 and after 60 mins the reaction was still 
not complete. Subsequent addition methanol immediately quenched any unreacted Li-122 (~ 
70 mins). 
 
When using trimethyltin chloride to access product 158, the organolithium trapping proceeded 
with retentive addition (SE2 ret), whereas for tributyltin chloride to access product 157, 
inversion was observed (SE2 inv). The absolute configurations of both 157 and 158 were 
determined after tin–lithium exchange and protonation of the resultant organolithium species. 
The resultant product 122 was analysed using HPLC and the traces compared with that of the 
authentic thiobenzoate 122 sample. 
 
An in-situ IR spectroscopy study in the behaviour of trimethyltin chloride, as shown in Scheme 
57, showed that the reaction showed a similar IR reaction profile to the profile observed for 
methyl chloroformate, with rapid lithiation (~1 min) and trapping (~5 mins) of the Li-122. This 
suggested that the tin electrophile was a good partner to the Li-122, so there was no observable 
reason to justify the inversion/retention phenomenon observed in ClSnMe3 and ClSnBu3, other 
than a steric argument for the latter.  
 
The use of CO2 to quench the Li-122, was also well tolerated giving desired carboxylic acid 
159 in good yield and high e.r. However, the use of allyl bromide gave product 160 in moderate 
yield, but poor enantioselectivity (near racemic). This issue can be attributed to the electrophile, 
which can form stabilised allyl radicals, which reacts preferentially via a radical pathway with 








Scheme 57: In-situ IR spectroscopy of the ClSnMe3 trapping of thiobenzoate 122. 
 
Finally using thiobenzoate analogues 136, 138, 140 and 141  ̧Dr. Citti and Dr. Varela showed 
that various functional group modifications to the model thiobenzoate 122 dialkyl chain, did 
not substantially affect reactivity of the thiobenzoate organolithium. Dr. Citti showed that 
simple dialkyl benzoate 141 could be successfully trapped to furnish methyl ester product 161 
in high yield and e.r., Similarly, increasing steric congestion by introducing an ethyl branch in 
thiobenzoate 140 did not hamper reactivity, with product 162 obtained in moderate yield and 
higher e.r. when quenched with para-bromophenyl isocyanate as the electrophile of choice. 
Furthermore, the allylic thiobenzoate 136 gave product 163 in high yield and e.r. Finally, 
THPO-protected thiobenzoate 138, also reacted with para-bromophenyl isocyanate in moderate 
yield and consistently high e.r. to give 164. Overall, this shows that the lithiation-electrophile 
trapping of the thiobenzoate containing molecules is not influences by the presence of a 




1.4.5. Application to Various Natural Product Derivatives 
 
1.4.5.1. Cholesterol Thiobenzoate Derivative 
 
This work was conducted by Pradip Songara. We further extended the methodology to the 
STIB-cholesterol derivative 143, prepared via Mitsunobu esterification of cholesterol, which, 
after exposure to the optimized reaction conditions gave product 165 (ClCO2Me quench) in 
excellent yield (92%) and as a single diastereoisomers, as shown in Scheme 58. This example 
is mechanistically important because: (i) the Li atom adopts an equatorial position which, 
according to Beak74 and Reich106, is unfavorable (the bulky TIBS group prefers to go 
equatorial) and should readily epimerise to axial and (ii) the -lithiation of homoallylic systems 
is frequently plagued by competing elimination of the directing group (TIBS in this case). The 
success of this example shows the remarkably high kinetic acidity of -S proton and the 
configurational stabilization provided by the reaction conditions.  
 




1.4.5.2. Confirming the Stereochemistry of Cholesterol Thiobenzoate Derivative 
 
Initial attempts to harvest crystals for X-ray crystallography proved difficult for products 
obtained from thiobenzoate 122. As most products obtained after electrophile quench were oils. 
For the materials which were solids crystallisation proved difficult as these materials dissolved 
in all organic solvents except water. For this purpose, we attempted both evaporation and 
diffusion crystallisation techniques, but neither gave crystalline product. As a result, we wanted 
to see whether the cholesterol derivative (not crystalline after electrophile trapping) could be 
used to understand the configuration of the electrophile trapped products. Though this example 




Figure 4: EXSIDE NMR technique to elucidate the stereochemistry of 165. 
 
As a result, NMR analysis was used to confirm the absolute stereochemistry of the newly 
created quaternary stereocenter adjacent to the STIB moiety. Normally, conventional 1H – 
1H coupling constants (3JHH in this case) can be used to assign stereochemical relationship 
between adjacent protons that are three bonds apart, using the Karplus equation (curve). Since 
this approach is not possible for quaternary centers, long range 1H – 13C coupling constants 
(nJCH, where n = 2,3) have been used instead as these also bear a Karplus-type relationship to 
dihedral angle between a 1H and any 13C three bonds away (3JCH for instance) or between the 
1H and a heteroatom also three bonds away (2JCH for instance). Since the stereocenter of interest 
in our molecule have no protons attached, the latter method was used. 
 
The stereochemistry of the stereocentre of interest was assigned using nJCH values from the 
diastereotopic protons (H4a and H4b, Figure 4). These 
nJCH values were obtained with the 




coupling constants even to non-protonated centres. Of particular interest was the 2JCH values 
as the 3JCH values of these protons to the carbon of the carboxylic acid moiety were similar. 
The diastereotopic allylic protons (H4a and H4b) in question were assigned with 
1D NOESY 
studies to determine proton signals which were axial and equatorial. This was possible only 
after the protons and carbons of rings A and B, STIB and the ester signals were assigned using 
1H, 13C NMRs in combination with HMBC, H2BC and HSQC, PYSCHE and HSQC 
experiments. For the purpose of this study, only the signals of ring A and B would be 
considered thus making analysis of this molecule straight forward. This allowed us to confirm 
that the electrophile trapping event does take place with retention in the case of cholesterol. 
 
1.4.5.3. 4-(tert-Butyl)cyclohexyl Thiobenzoate Derivative 
 
Though the example with cholesterol is important, there is a degree of structural rigidity that 
increases the stability of the -S organolithium to epimerisation. To probe this we utilised S-
((cis)-4-(tert-butyl)cyclohexyl) 2,4,6-triisopropylbenzothioate 104, which has been previously 
shown by Beak to undergo thermodynamic equilibration to the more stable trans-
organolithium when lithiated. As a result, Beak found that the only product isolated in the 
lithiation and electrophile trapping of the cis-isomer is the trans- product. Using our optimised 
conditions, we obtained product 166 in good yields (53% with pbromophenyl isocyanate as the 
electrophile) as the cis-diastereoisomers (>97:3 d.r.) as shown in Scheme 59. Therefore, this 
exemplified that our conditions provided a synthetic viable route to access the previously 








To confirm the stability of our cis-organolithium result we conducted a lithiation-deuteration 
study in which we quenched the lithiated thiobenzoate at different time intervals to assess the 
degree of interconversion from cis- organolithium to trans- organolithium. For this experiment 
we found that after 1 hr the ratio of the lithiated thiobenzoate was 70:30 cis:trans and 
surprisingly after 7 hrs the ratio was 40:60 cis:trans. This work overcomes the synthetic 
challenges reported by Beak, which showed that after 2 hrs in THF (-78 °C) generated solely 
the trans-isomer product when the organolithium is quenched with MeI. 
 
 
1.4.5.4. (–)-Menthol Thiobenzoate Derivative 
 
 
Scheme 60: Failed (−)-menthol thiobenzoate 144. 
 
Based on the above findings on cyclic substrates, the menthol thiobenzoate derivative 144 
derived by Mitsunobu esterification of (–)-menthol, was subjected to our lithiation conditions, 
for which the deuterated product 167 was isolated in high yield and diastereomeric ratio. 
Unfortunately, this did not transpire when any larger electrophiles were utilised, such as, 
pBrC6H4NCO. This was attributed to the steric congestion at the carbanion site which renders 












Scheme 61: Reduction of thiobenzoate 154 to the corresponding tertiary thiol. 
 
Dr. Varela successfully showed that the reduction of thiobenzoate 154 could be achieved using 
lithium aluminium hydride under refluxing conditions, as shown in Scheme 61. The desired 




1.4.7. Evaluating the Barrier to Racemisation and Eyring Plot Studies 
 
To place the chemistry on firmer foundations, we decided to determine the thermodynamic 
parameters, ∆H≠ and ∆S≠ of racemisation. Initial studies by Hoffmann and co-workers 
identified ΔG≠rac(−78 °C)= +15 kcal mol
−1 and ΔG≠rac(−90 °C)= +13 kcal mol
−1 of racemisation for 
S-Ph and S-duryl at –78 ºC (as the lower limit that ensures the configurational stability of 
thioorganolithiums).108–110 We have performed detailed kinetic studies on thiobenzoate 122. 
 
Scheme 62: Barrier to rotation for thiobenzoate 122. 
As shown in Scheme 62, thiobenzoate 122 is lithiated, followed by equilibration at –78, –70, –
65 and –60 ºC. This is followed by cooling to –78 ºC and quenching with pBrC6H4NCO to give 
thiobenzoate 152 with varying levels of enantioenrichment (e.r. determined by HPLC). 
In chemical kinetics, the Eyring equation is used to describe changes in the rate of a chemical 
reaction against temperature. Assuming electrophile trapping is rapid and irreversible, the 
enantiomeric ratio of 152 (determined by chiral HPLC) should reflect the enantiomeric ratio of 
the organolithium species R/S-Li-122 at the point of trapping. The kinetic data for the study 
was treated under reversible first-order conditions by using the following equation, which was 
derived using the Arrhenius equation and Gibbs equation:107  
1
2
𝑙𝑛 (T − 2 ((
[𝑆]
100
) T) ) =  −𝑘𝑡 +  𝑐 
Where T = total conc. of 122 (0.125 mmol), [S] = conc. S-enantiomer [S-Li-122], k = 
constant, t = time (secs). 
Since thiobenzoate 122 has an enantiomeric ratio of >99:1, this composition can be treated as 




concentration of 122, (T), is equal to the % of R-enantiomer. Therefore, as T = [R] = 100, the 




𝑙𝑛 (100 − 2 ((
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100




𝑙𝑛(100 − 2([𝑆])  =  −𝑘𝑡 +  𝑐 
Since the enanotiomeric excess is a difference between the percentage of major enantiomer and 
minor enantiomer, which in our example is [Rmajor] – [Sminor]. Mathematically, this difference 
is the same as 100 – 2([S]). For example, if a pair of enantiomers has 96:4 e.r. or 92 % e.e, then 
100 – 2([4]) = 92. On that basis, it is possible to say that 100 - 2([S]) = e.e. of 152. This further 
simplies the equation to give the final form: 
1
2
𝑙𝑛(𝑒. 𝑒. )  =  −𝑘𝑡 +  𝑐 
 
Based on the values calculated for individual temperature sets, Table 5, was generated to show 
the increase in rate of racemisation with temperature (which was plotted in Chart 1). Based on 
these values a half-life (t½) for these organolithium species was calculated, which gave a more 
comprehensive value for the affect temperature plays on the rate of racemisation (Table 5). 
 
Chart 1: Log plot for the racemisation of Li-122 with 1.2 eq. of TMEDA in TBME. 
y = -3E-05x + 2.2681
R² = 0.9814
y = -0.0001x + 2.2898
R² = 0.9974
y = -0.0002x + 2.283
R² = 0.9982



























Table 5: Thiobenzoate 152 e.e. values determined by HPLC measurement (shown graphically in Chart 1) and 
calculation of half-life and reaction parameters at different temperatures (K). 
Temperature °C (K) Time (secs) e.e. 0.5ln(e.e.) 
– 78 (195) 0 96.46 2.285 
 1800 85.52 2.2185 
 3600 73.04 2.1455 
 7200 59.94 2.0467 
 10800 51.94 1.9754 
–70 (203) 0 96.73 2.2860 
 900 81.24 2.1987 
 1800 64.61 2.0842 
 2700 56.66 1.9914 
–65 (208) 0 97.79 2.2914 
 900 67.01 2.1024 
 1800 44.89 1.9021 
 2700 31.53 1.7255 
 3600 22.93 1.5663 
–60 (213) 0 98.60 2.2956 
 300 70.07 2.1247 
 600 52.31 1.9786 
 900 38.00 1.8188 
 1200 29.21 1.6872 
 
 Temperature (K) 
 195 (-78 oC) 203 (-70 oC) 208 (-65 oC) 213 (-60 oC) 
k (secs-1) –2.86149E-05 –0.000110931 –0.000203037 –0.000507544 
ln (k/T) –15.73458235 –14.41980848 –13.83966253 –12.94721853 
1/T (secs-1) 0.005128205 0.004926108 0.004807692 0.004694836 
t1/2 (secs) 24223.3 6248.5 3413.9 1365.7 





The observed erosion of enantiomeric ratio in these experiments gave rise to an Eyring plot 
(Chart 2) from which the activation parameters were extracted (for ∆H≠ and ∆S≠ of +13 kcal 



















Here y = ln(k/T), m = (–∆H/R), x = (1/T) and c = ln(kkB/h)+∆S/R; in which kB = Boltzmann 
constant, h = Planck’s constant and k = reaction rate (k-78° C = 2.9x10
-5 s-1, as shown in Table 
5). 
By using the Gibbs equation, the values for the ∆H≠ and ∆S≠ were used to calculate the ∆G≠rac 
at –78 ºC = ~10 kcal mol–1, which is in line with Hoffman’s results108–110. In addition to 
providing thermodynamic parameters for racemisation (Table 6), these studies also showed 
that racemisation of Li‐122 at −78 °C occurred over an extended period of time, as expected. 
 
Chart 2: Eyring plot for the racemisation of Li-122 with 1.2 eq. of TMEDA in TBME. 
 





















Table 6: Activation parameters for enantiomerisation for thiobenzoate 122. 
ΔHǂ (kcal/mol) 12.51 ± 0.62  
ΔSǂ (cal/mol•K) 14.30 ± 3.05  
ΔGǂ (kcal/mol) 195 (–78 oC) 9.71 ± 0.86 
 203 (–70 oC) 9.60 ± 0.88 
 208 (–65 oC) 9.50 ± 0.89 


























Scheme 63: Lithiation-electrophile trapping of thiobenzoates for the synthesis of enantioenriched tertiary 
thiols. 
 
In conclusion, we have found α-S lithiated secondary dialkyl thiobenzoates, previously 
believed to be configurationally unstable, can both be generated and trapped with electrophiles 
with high enantiospecificity. The combination of non-coordinating solvents together with short 
reaction times and the use of reactive electrophiles to ensure immediate trapping of the 
organolithium species are crucial in achieving high enantioenrichment. The subsequent 
trapping of the tertiary organolithium intermediates with electrophiles proceeded with excellent 
enantioselectivity, enabling the synthesis of highly enantioenriched tertiary thiol derivatives. 
Subsequently, the tertiary thiol can be accessed through the reduction of the thiobenzoate group 
using LiAlH4 (Scheme 63). Furthermore, this methodology has been applied to cyclic natural 
products, such as cholesterol and (‒)-menthol. Similarly, it has been used on the cyclohexyl 
substrate reported by Beak and co-workers to showcase the performance advance, by showing 
that the previously inaccessible cis-isomer can be synthesised using the conditions reported 
herein.  Finally, we have reported a kinetic study into the configurational stability of the Li-
122, to establish an Eyring Plot and calculate parameters for the barrier to racemisation.  
 
Overall, these conditions provide a new class of organolithium reagents for asymmetric 








Previous advances in carbon-carbon bond formation have waranted the Nobel Prize in 
Chemistry, such as in 2010, when the prize was awarded for the development of transition 
metal catalysed sp2-sp2 carbon-carbon coupling reactions.112 Even with such breakthroughs, a 
persistent challenge encountered in synthetic organic chemistry concerns the ability to control 
stereochemistry of C–C bond formation.111 To this extent, lithiation-borylation methodology 
provides a versatile option for coupling two building blocks to generate enantioenriched 
products under stereocontrol.113–116 
 
Scheme 64: Brown enantioselective hydroboration of z-alkenes. 
 
Pioneering work by H. C. Brown showcased organoboron reagents as candidates for highly 
stereoselective processes and as synthetic alternatives to analogous enzymatic reactions.117–119 
For example, the enantioselective hydroboration of an unhindered cis-alkene, but-2-ene, using 
a naturally occurring (+)-α-pinene derivative to give diisopinocampheylborane 169 (Scheme 
64). The subsequent boronic ester intermediate 170 was oxidised to give enantioenriched 
alcohol 171 in high e.e.118,120–122 More recently the versatility of organoboron reagents in 
asymmetric synthesis has led to significant development of synthetic organic chemistry 
utilising this functional group.  
 
The vacant p-orbital on the boron atom of a boronic ester allows for addition of a nucleophile 
which results in the formation of a boronate complex (scheme 65). This species can undergo a 




the boron atom to an adjacent carbon atom, simultaneously expelling a leaving group. This 
produces a homologue of the starting boronic ester.123–126  
 
Scheme 65: 1,2-metallate rearrangement of boron-ate complexes. 
 
The migration requires the σCB bond to align anti-periplanar to the σ*C-LG. As a consequence, 
this stereoelectronic requirement results in stereoinversion of the carbon centre.127 The 1,2-
migration requires the leaving group and boron atom to have a geminal relationship, as shown 
in Scheme 66. The stereospecific nature of the concerted mechanism enables this chemistry to 
produce stereocentres with high stereofidelity.127 
 
Scheme 66: The orbital alignment required to facilitate 1,2-migration. 
 
The migratory carbon substituent required in this process can be introduced through a metal 
carbenoid128,129 bearing a leaving group. A carbenoid is a carbene-like compound that displays 
both nucleophilic and electrophilic character.130,131 Carbenoids can be prepared in a chiral and 
non-racemic manner by careful choice of leaving group (LG), making these class of 
compounds useful for the stereoselective homologation of organoboron compounds, by either 






Figure 5: Comparison of carbenoids to carbenes. 
2.1.1. Substrate Controlled Homologation of Boronic Esters 
 
The substrate controlled stereoselective homologation requires the boronic ester to bear a chiral 
diol ligand 172. This imparts a diastereoselective 1,2-migration, thus controlling the 
stereochemical outcome of the homologated product. As shown in Scheme 67, 
dichloromethyllithium is a useful reagent for homologation. This achiral carbenoid possesses 
two chloride leaving groups, allowing the product to partake in further homologations. 
However, the intermediate boronate complex 173 has two ways in which it can migrate (there 
are two identical leaving groups) and without direction product 174 would be formed as a 1:1 
mixture of diastereoisomers. Use of a chiral and non-racemic diol on boron directs the 
migration affording diastereomerically enriched product 174. A limitation of this methodology 
is the requirement for changing the chiral diol if the opposite boron ester isomer is desired. 
This reduces the practicality of this method for introducing multiple stereocentres through 
sequential homologation. 
 
Scheme 67: Substrate-controlled boronic ester homologation for stereoselective homologation. 
 
The use of chiral boronic esters for substrate-controlled homologation of boronic esters was 
first developed by Matteson and co-workers in the 1980’s.132 Here they showed that boronic 
esters 172 bearing a C2-symmetrical chiral diol ligand reacted with dichloromethyllithium to 
furnish boronate complex 173 (Scheme 68). The boronate complex 173 underwent 1,2-




this protocol required the addition of a Lewis acid, ZnCl2. The authors suggested that this 
helped to sequester free chloride ions and prevent erosion of diastereoselectivity.133134 
Subsequent, ab initio calculations reported by Midland and co-workers were used to explain 
the stereoselectivities observed in this reaction, which gives 174.135 It was found that the lowest 
energy transition state (giving 175), required the ZnCl2 to complex to the least sterically 
hindered boronate oxygen atom, with the free chloride sitting in an anti-configuration to the 
zinc atom.135 However, further studies by Aggarwal and co-workers suggested that the 
preferential hydrogen bonding of the chelated ZnCl2 with the hydrogen atom on 
dichloromethyllithium, rather than the chlorine atom, reduced the steric clash and promoted 
diastereoselective 1,2-migration to give 174.136  
 
Scheme 68: Role of ZnCl2 in controlling diastereoselectivity of Matteson-type homologation. 
 
Successive treatment of α-chloroboronic ester 174 with carbon nucleophiles furnished boronate 
complex 177 (Scheme 69). This underwent stereospecific 1,2-migration to access secondary 
boronic ester 178 and enantioenriched secondary alcohol 179 post oxidation. In addition, a 
range of heteroatom nucleophiles were also tolerated in this methodology, including, azide, 





Scheme 69: Homologation and oxidation of α-chloro boronic esters. 
 
This iterative homologation methodology allowed for the incorporation of adjacent 
stereocentres (highlighted yellow), as later shown by Matteson and co-workers, in the total 
synthesis of natural products (Figure 6), such as, insect pheromone japonilure137 180, exo-
brevicomin138 181 and stegobinone133,139 182. 
 
Figure 6: Examples of total syntheses achieved using Matteson homologations. 
 
The total syntheses reported also highlight the limitation of this methodology, such that if the 
opposite boronic ester stereoisomer were required then the chiral diol on the boronic ester 
would need to be exchanged for its enantiomer. This need for transesterification increases the 
reaction step count. Bearing this mind, Matteson developed methods to cleave boronic ester 
diol groups, through transesterification with diethanolamine140, TAPS (3-
{[tris(hydroxymethyl)methyl]amino}propanesulfonic acid)139 or pentaerythritol139. However, 
these interconversions require two steps, with an associated decrease in reaction yield. For 
example, the transesterification of boronic ester 172 with pentaerythritol, generated boronic 






Scheme 70: Exchanging boronic ester diol group (pentaerythritol). 
 
Though the Matteson protocol is excellent for the synthesis of secondary boronic esters, it 
displays poor diastereoselectivity when attempting to synthesise tertiary boronic esters. The 
unpredictable reactivity encountered renders it difficult to establish stereochemical outcomes 
when using various tertiary boronic ester derivatives.141 
 
2.1.2. Reagent Controlled Homologation of Boronic Esters 
 
Reagent control of stereochemistry is a complementary strategy to the substrate-controlled, 
stereoselective homologation of boronic esters. This method requires synthesis of 
stereochemically defined and configurationally stable chiral carbenoid bearing a suitable 
leaving group for the migration step. The reaction of such a chiral carbenoid with a boronic 
ester furnishes a boronate complex with predefined stereochemistry, such that the subsequent 
stereospecific 1,2-migration transfers the stereochemical information set by the carbenoid to 
the homologated product. If both enantiomers of the carbenoid can be synthesised, both 
enantiomers of homologated product can be accessed, without alteration to the ligand on the 
boronic ester. For this reason, the reagent-controlled approach to stereoselective boronic ester 
homologation is considered the more versatile synthetic option, when compared to substrate-
controlled homologation.124 
 
Given the limitations of Matteson’s homologation using substrate control of stereochemistry 
outlined above, a more synthetically efficient route would use reagent-controlled homologation 
(Scheme 71). This can be achieved by using nucleophilic chiral carbenoid reagents, which are 








Scheme 71: A reagent-controlled approach to boronic ester homologation. 
2.1.2.1. Boronic ester homologation of α-Chloro Carbenoids 
 
Scheme 72: Sulfoxide ligand exchange for electrophile trapping. 
 
Hoffman and co-workers utilised α-chlorosulfoxides 185 (Scheme 72) as precursors to 
configurationally stable α-chloro chiral magnesium carbenoids 186.142,143 The stereospecific 
sulfoxide-magnesium exchange of optically pure sulfoxide 185 with EtMgBr generates chiral 
organomagnesium reagent 186 and by-product 187. This reagent 186 was then trapped by 
benzaldehyde to give chlorohydrin 188, which was converted to an epoxide 189 to determine 
the e.e. (93%). The high level of stereocontrol in this reaction were achieved due to the α-chloro 




trapping with α-aminomethylbenzotriazole, gave 190 in high e.r. with retention of 
stereochemistry.  The α-chloro organolithium species are less configurationally stable than 
their magnesium counterparts, with full racemisation at after 15 mins at −50 °C.144  
 
Subsequently, Blakemore and co-workers reported the use of α-chloro carbenoids 186/191 as 
reagents for the stereoselective homologation of boronic esters.145 The boronic ester products 
192 obtained from these reactions were oxidised in situ to give secondary alcohols 193 in 




Scheme 73: The asymmetric homologation of α-chloro sulfoxides with boronic esters. 
 
The poor selectivity was attributed to epimerisation of the enantiopure α-chloro Grignard 
following sulfoxide ligand exchange. At this stage, the authors explored α-chloro alkyllithium 
reagents, generated through sulfoxide-lithium exchange. However, these reagents were 
difficult to synthetically exploit due to configurational lability issues encountered at −78 °C.  
 
Blakemore and co-workers overcame these issues through in situ generation of the chiral 
carbenoids which were successfully reacted with a range pinacol or neopentylglycol boronic 
esters (Bneo) to give secondary boronic esters. These were oxidised in situ to afford the 
secondary alcohols in significantly higher e.r.146 The improvement in e.r. was attributed to 
higher reactivity of the configurationally labile α-chloro alkyllithium reagents, which led to 
faster trapping of the boronic ester than when using α-chloro Grignard reagents.  
 
Blakemore’s reagent-controlled methodology overcomes the ligand exchanges issues apparent 




protocol, hence this methodology is generally limited to primary alkyl sulfoxides. Blakemore-
type homologations were used to synthesise all 4 stereoisomers of 195, which were isolated as 
single enantiomers, through using either enantiomer of the sulfoxide precursor in an iterative 
manner with boronic ester 194, in moderate diastereoselectivity (Scheme 74).146,147 
 
Scheme 74: α-chloro organolithium reagents in the homologation of boronic esters. 
 
 
2.1.2.2. Borane Homologation using Sulfur Ylides 
 
The homologation of boranes using semi-stabilised sulfur ylides were first reported by 
Aggarwal and co-workers (Scheme 75). The authors had previously reported using sulfonium 
ylides 196 for the synthesis of enantioenriched epoxides, cyclopropanes and aziridines.148 
 





Here, aryl sulfonium salts 196 have been used to generate semi-stabilised sulfur ylides in situ, 
using a hindered base (LiHMDS). These highly reactive species act as carbenoids and undergo 
similar homologations with trialkyl or triaryl boranes 197, in which the sulfide group is 
displaced. The homologated boranes 198 were isolated as oxidised alcohols 199 or amine 200, 
for ease of handling, in good yield.  
 
This methodology was translated to the stereoselective variant by using chiral sulfonium salts 
201, which underwent homologation with a range of organoboranes at a given temperature (5 
°C or -78 °C to improve product e.r.) to provide the corresponding secondary alcohols and 
amines in good yield and high enantioselectivity (Scheme 76). This methodology allowed for 
the synthesis of either enantiomer of organoborane homologated product, as both enantiomers 
of sulfonium salt 201 could be readily prepared. 
 
The high stereoselectivities achieved in this methodology are attributed to the conformational 
bias present in the sulfur ylide, which forces the aromatic group away from the bridging 
methylene (scheme 76, 201). This renders the process selective, as reaction with the 
organoborane can only proceed on the less hindered face 203 (Si face) of the sulfur ylide, thus 
generating the boron ate complex 204 in very high diastereoselectivity.116,149 The subsequent 
stereospecific 1,2-migration of the boron ate complex means that the homologated product 205 






Scheme 76: Origin of stereoselectivity in homologation of boranes with sulfur ylides. 
In this methodology, the 1,2-migration of non-symmetrical organoboranes is dependent upon 
the migratory aptitude of that substituent, thus reducing the functional groups that can be used 
in this iterative homologation.127 Furthermore, an aryl substituent had to be present on the semi-
stabilised ylide as non-stabilised alkyl or silyl-substituted ylides gave poor enantioselectivities. 
To overcome the selectivity over which group migrates, boronic esters were utilised in place 
of boranes, however boronic esters are unreactive to sulfur ylides, due to difficulties associated 
with the 1,2-migration of the boronate complexes, and therefore not applicable to this 
methodology. 
 
2.2.1.3. Hoppe’s Primary Lithiated Carbamates 
 
Hoppe and co-workers reported the enantioselective deprotonation of primary O-alkyl 
carbamates 206 (Scheme 77), using a stoichiometric chiral and non-racemic diamine [(−)-
sparteine) 210 and sBuLi to generate lithiated carbamates Li-(−)-sp-207. These could be 
trapped with a range of electrophiles (E-X) to give products 208 in high yields and high e.r. 





If TMEDA 209 is used in place of (−)-sparteine 210, then the racemic product is achieved 
through this protocol. Hoppe and co-workers used three types of carbamate groups (Scheme 
77): diisopropyl carbamate (Cb) and oxazolidine carbamates (Cbx and Cby). The diisopropyl 
carbamate can be reduced to the corresponding alcohol in the presence of LiAlH4 and 
oxazolidine carbamates can be removed by acid/base hydrolysis, to give the corresponding 
secondary alcohol.   
 
The carbamate electron-withdrawing group enables α-deprotonation by initially forming a pre-
lithiation complexation, followed by deprotonation.151,152 The rate of (irreversible) 
deprotonation of pro-S is fifty fold greater than pro-R, giving rise to Li-(−)-sp-207 with high 
selectivity.153 This is an example of kinetic control. Li-(−)-sp-207 shows high chemical and 
configurational stability in diethyl ether at −78 °C. The presence of bulky, hindered substituents 
on the carbamate nitrogen prevents the organolithium undergoing nucleophilic addition to the 
amide.151 
 
Scheme 77: Lithiation of primary alkyl carbamates and trapping with electrophiles. 
 
The deprotonation of 206 is dependent on solvent, whereby stereoselective lithiation of primary 
O-alkyl carbamates under same conditions in Et2O, occurs with a higher degree of selectivity 




cation over (−)-sparteine, and as a result, 6.0 equivalents of (−)-sparteine with respect to the 
organolithium base are required for reactions that use THF as solvent. 
 
At present, both enantiomers of sparteine are commercially available, however (−)-sparteine 
210 is typically more expensive, but (+)-sparteine 213 can also be synthesised.155 However, 
(+)-sparteine 213 was more difficult to obtain than (−)-sparteine at the time of Hoppe’s work. 
Hoppe used only (−)-sparteine 210, as this was a cheaper, readily available natural product, 
isolated from Lupin seeds.151 The O’Brien group developed (+)-sparteine surrogate 212, which 
could be obtained from (−)-cytisine 211 in 3 steps (Scheme 78). This surrogate induces the 
opposite enantioselectivity to (−)-sparteine 210 with products usually obtained in high 
stereoselectivity.156,157 
 
Scheme 78: O'Brien's (+)-sparteine surrogate 212 synthesis. 
 
2.1.2.4. Lithiation-Electrophile Trapping of Primary Benzylic Carbamates  
 
Hoppe and co-workers also explored the lithiation of O-benzyl carbamates 214, which could 
be generated by using sBuLi/TMEDA (Scheme 79), in which the presence of an aromatic ring 
stabilises the carbanion, by promoting solvent-separated ion pair formation.150 The choice of 
solvent also influences the stereoselectivity of secondary benzylic carbamates. For the scope 
of this reaction, it was found that Et2O results in a tighter ion pair between the lithium cation 





Scheme 79: Lithiation-electrophile trapping of secondary benzyl carbamates. 
 
The stereochemical outcome of the trapping of Li-TMEDA-215 is electrophile dependant, such 
that electrophiles that co-ordinate to the lithium cation react with retention of stereochemistry 
216, whereas electrophiles without coordinating groups reacting with inversion (alkyl halides, 
stannanes, silyl electrophiles 217).158 
 
Lithiated secondary benzylic carbamates undergo partial planarization of the carbanion by 
delocalisation into the adjacent benzene π-system, which increases the electron density on the 
carbanion back face and so encourages antarafacial approach (Scheme 80), therefore non-
coordinating electrophiles (e.g. ethyl bromide) react with inversion to avoid the steric 
interaction with the Li•TMEDA diethyl ether complex. On the other hand, electrophiles which 
possess coordinating groups (e.g. methyl acetate) react with retention of configuration as pre-
coordination to the lithium complex, delivers the electrophile suprafacially.  
 




2.1.2.5. Lithiation-Borylation of α-Boryl Carbamates  
 
Homologation of α-boryl carbamates by Hoppe provided an alternate two-step procedure to the 
existing Matteson homologation methodology.159,160 The lithiation of N,N-
diisopropylcarbamate 218 with sBuLi/(−)-sparteine, electrophilic trapping of the carbenoid 
with B(OiPr)3 and transesterification with pinacol, gave α-boryl carbamate 219 (Scheme 81).  
 
Scheme 81: Two-pot lithiation-borylation reaction of primary O-alkyl carbamates. 
 
α-Boryl carbamate 219 could then undergo addition from a suitable Grignard reagent at low 
temperatures. This affords boronate complex 220, which, upon heating, undergoes a 1,2-
migration to give secondary boronic ester 221. Subsequent stereoretentive oxidation of the 
boronic ester gave the corresponding secondary alcohol 222 in high yield and e.e. The use of 
excess Grignard was essential for 1,2-migration to occur, as the Mg salts act as Lewis acids 
and coordinate to the carbamate leaving group to aid 1,2-migration. 
 
In 2006, Kocienski and co-workers reported a one-pot variant of this reaction, which tolerated 
homologation of the boronic ester with a lithiated carbamate (Scheme 82).161 Here aryl boronic 




subsequent homologation product isolated upon migration. However, due to slow and 
inefficient 1,2-migration of the boronate complex, the diethyl ether used for the reaction was 
exchanged for higher boiling DME and a Lewis acid (MgBr2) was added to the reaction 
mixture, after which the mixture was heated under reflux. These modified conditions gave the 
secondary alcohol 225, after oxidation of the boronic ester, in good yield and excellent e.r. 
 
 
















2.1.2.6. One-Pot Homologation of Boranes and Boronic Esters 
 
Kocienski’s one pot procedure was further developed by Aggarwal and co-workers, showing 
that Hoppe-type O-alkyl carbamates Li•(−)-sp-226 could be reacted with both boranes and 
boronic esters, in good yields and high e.r. with retention of stereochemistry (Scheme 83).162  
 
Scheme 83: Aggarwal synthesis of enantioenriched secondary alcohol 229. 
 
The homologated organoboron products 227 and 228 were isolated as the corresponding 
secondary alcohols 228 in high e.r. after oxidation. The 1,2-migration of boronic ester ‘ate’ 
complexes were slower than that of analogous borane ‘ate’ complexes and required the addition 
of MgBr2/Et2O and heating under reflux for 12 hrs, whereas boranes underwent migration upon 
warming to RT. 
Aggarwal and co-workers showed that primary O-alkyl carbamates could be used in an iterative 
fashion to generate adjacent stereocentres (Scheme 84) by using (−)-sparteine (sp) or O’Brien’s 
(+)-sparteine surrogate (sps).162 Lithiation of carbamate 230 with sBuLi in the presence of (−)-
sp gave lithiated intermediate (R)-Li•231, which was trapped with EtBpin to give boronic ester 
(S)-232 in good yield and 98:2 er. Next, (S)-232, was reacted with either lithiated carbamate 
(S)- Li•233 or (R)-Li•234, to access, after boronic ester oxidation (NaOH, H2O2), alcohols 
(S,R)-235 (82% yield, 96:4 d.r., >98:2 e.r.) and (S,S)-236 82% yield, 96:4 d.r., >98:2 e.r.). 




(+)-sps gave lithiated intermediate (S)-Li•237, which was trapped with EtBpin to give boronic 
ester (R)-238 in good yield and 97:3 e.r. Finally, (R)-238, was reacted with either lithiated 
carbamate (R)-Li•239 or (S)- Li•240, to  access, after in situ oxidation, alcohols (R,S)-241 (63% 




Scheme 84: Aggarwal synthesis of enantioenriched secondary alcohols. 
The stereochemical outcome of the reaction (high e.r. and d.r.), suggested that the second 
homologation is independent of the stereochemistry of the boronic ester employed, making this 
a powerful tool for the instalment of consecutive stereocentres as desired. This methodology 
was further exemplified in the total synthesis of Pharaoh’s ant pheromone (+)-faranal 243 
(Figure 7), introducing the two highlighted stereocentres.163 
 




2.1.2.7. Lithiation-Borylation of Secondary Benzylic Carbamates  
 
Subsequently, Aggarwal and co-workers incorporated secondary benzylic carbamates into 
lithiation-borylation methodology to access enantioenriched tertiary alcohols, post oxidation 
(Scheme 85).164 Though literature for the asymmetric synthesis of secondary alcohols165,166 is 
abundant with examples, the synthesis of tertiary alcohols (quaternary stereocentres) is 
comparatively underdeveloped, typically relying upon nucleophilic addition to ketones with 
asymmetric induction using chiral ligands.28,167,168  
 
Scheme 85: Lithiation–borylation of secondary benzylic carbamates for the synthesis of tertiary alcohols. 
Adapting Hoppe’s electrophile dependent retention or inversion of stereochemistry of 
secondary benzylic carbamates, the use of boranes (inversion, antarafacial addition) and 
boronic esters (retention, suprafacial addition) allowed the group to access either enantiomer 
of product from the same carbamate. The reaction can tolerate a broad substrate scope, reacting 
with alkyl, vinyl, allyl and electron-rich/ deficient aryl/heteroaromatic boronic esters.164  
 
However, when sterically hindered, electron-deficient secondary carbamates such as 
pchlorophenyl (98:2 e.r.) were used in the homologation of boronic esters, product e.r. (4:96 
e.r.) was lower than expected. This erosion of e.r. was studied using a method developed in the 
Aggarwal group termed the two-electrophile test,169 to account for the fate of competing 
reaction pathways that could affect the product e.r. Here it was seen that increasing equivalents 
of boronic ester in the reaction with lithiated carbamate Li-244 gave product 246 in high e.r. 
This suggested that boronate complex formation was reversible at −78 °C, with the lithiated 




is warmed to higher temperatures to promote 1,2-migration of the boronate complex, the 
unreacted lithiated carbamate Li-244a epimerises before recombining with the boronic ester. 
This results in a product 246a with lower e.r. (Scheme 86).170  
 
Scheme 86: Epimerisation of boronate complex through dissociative pathway. 
 
Early attempts worked by adding an additional, more reactive electrophile (allyl bromide) to 
the reaction mixture after boronate complex formation. This would out compete the boronic 
ester to react with any dissociated lithiated carbamate Li-244  ̧thus prevent it from recombining 
with the ester after epimerisation. Though the addition of allyl bromide helped to improve 
stereoselectivity, the yield of product was lower, as expected. Instead, the addition of Lewis 
acid MgBr2 in MeOH, known to promote 1,2-migration, restored stereoselectivity and gave 
product in high yields. The presence of MeOH also quenches any unreacted or dissociated 
lithiated carbamate 247 and generates product 246 in high enantiomeric excess.  
 
A different strategy to overcome this stereoselectivity issue observed with electron-deficient 
carbamates 248 was to use neopentyl glycol boronic esters, which can give the analogous 
boronic esters (Bneo) 249 in similar high yields and stereoselectivities (Scheme 87). A 
disadvantage of this is that neopentyl boronic esters are less stable than the pinacol counterparts 
and as such are usually unstable to silica gel chromatography and under air. In addition, there 
was erosion of product e.r. when hindered substrates 250 were utilised, due to reversible ate 






Scheme 87: Neopentyl glycol boronic esters in homologation of tertiary carbamates. 
 
2.1.2.8. Lithiation−Borylation with Benzoate Esters 
 
Lithiation-borylation of carbamates provides access to either enantiomer of homologated 
boronic ester by using either a borane or boronic ester substrate. However, the 1,2-metallate 
rearrangement of boronate complexes derived from pinacol boronic esters and lithiated 
carbamates can be slow and inefficient, particularly when using methyl or phenyl boronic 
esters, and therefore require Lewis acids (MgBr2) to promote this reaction pathway.
171 
However, the addition of Lewis acid does not provide a general solution to all substrates. As a 
result, strategies using alternative leaving groups have been explored.  
 
Beak and co-workers initially showed that primary 2,4,6-triisopropyl benzoates could be 
deprotonated with TMEDA/sBuLi to access the configurationally stable lithiated benzoate.172–
175 Subsequently, in 2010, Aggarwal reported the first stereoselective lithiation of primary 
2,4,6-triisopropyl benzoates 253, using (−)-sparteine/sBuLi. These lithiated benzoates were 
successfully used in the homologation of boronic esters to access secondary alcohols 252 in 
higher yields and similar (ca. 95:5 for a benzoate and 97:3 for the corresponding carbamate) 
e.r. to the analogous carbamates 251 (Table 7). The superior leaving group potential of the 




shorter reflux times were required for the benzoate 1,2-migration (2 hrs) in comparison to 
carbamate 1,2-migration (16 hrs). 
This methodology works well for primary and secondary benzylic benzoates and carbamates. 
However, non-activated, secondary dialkyl benzoates/carbamates are difficult to use in this 
methodology, with previous work from Beak175 and Hoppe150, reporting difficulty in 
abstraction of the α-oxy proton.  
It should be noted that although Matteson homologations can also produce enantioenriched 
tertiary alcohols, these reactions suffer from poor and difficult to predict selectivity.141 
 
Table 7: Carbamates in the lithiation-borylation of boronic esters. Conditions: A: MgBr2Et2O (2.0 eq.), 16 hrs 












1-Bpin Yield (%) e.r. Conditions 
1 Me 50 95:5 A 
2 cPr 71 98:2 B 
3 (CH2)2COO
tBu 35 93:7 A 
4 (CH2)2CN 0 N.A. A 
5 Ph 88 99:1 A 
 R
1-Bpin Yield (%) e.r. Conditions 
1 Me 76 96:4 C 
2 cPr 86 96:4 C 
3 (CH2)2COO
tBu 63 96:4 B 
4 (CH2)2CN 46 97:3 B 




In 2012, Aggarwal and co-workers reported the synthesis of enantioenriched tertiary boronic 
esters using lithiation/borylation of enantioenriched secondary alkyl benzoates (Scheme 88).169 
This feat was achieved by performing the lithiation of enantioenriched benzoate 254 with s-
BuLi (1.6 eq.) and an excess of TMEDA (6.0 eq.) in CPME as the solvent at −60 ˚C. The 
enantioenriched lithiated benzoate was reacted with a broad range of neopentyl glycol boronic 
esters in good yield and complete enantiospecificity to produce tertiary boronic esters 255. 
These can be oxidised to the corresponding enantioenriched tertiary alcohols 256. The 
analogous dialkyl carbamates were trialled in a lithiation-deuteration under optimised 
conditions however; they demonstrated low recovery (49%) of material with low deuterium 
incorporation (10%).  
 
Scheme 88: Lithiation−borylation of dialkyl benzoates.  
 
The Aggarwal protocols for lithiation-borylation have been successfully applied to ‘assembly 
line’ synthesis, in which up to 10 iterative homologations are used to introduce 10 adjacent 
methyl stereocentres,176 with control over the absolute and relative stereochemistry of the 




kalkitoxin177 and (+)- hydroxyphthioceranic acid177 (Figure 8), were synthesised through this 
synthetic approach. 
 
Figure 8: (+)-Kalkitoxin and (+)-Hydroxyphthioceranic acid with coloured highlights indicating the carbon 
centres introduced through lithiation–borylation reactions. 
















2.1.3. Boronic Ester Functional Group Interconversion 
 
In the homologation methodology discussed so far, the boronic esters have been used to create 
carbon-carbon bonds through means of a boronate complex undergoing 1,2-migration.178,179 
 
Figure 9: Examples of boronic ester transformations 257. 
Typically, the boronic ester moiety is retained as a functional handle to undergo subsequent 
homologations. However, the boron atom can be interconverted to various other functional 
groups, further expanding the use and application of this chemistry.178 Beyond the scope of this 
report, the boronic ester transformations are highlighted in Figure 9, and are grouped by 
modification. Boronic ester 257 could undergo further lithiation-borylation type reactions, 
either through Aggarwal or Matteson type reactions133. Similarly, the boronic ester can be 
exchanged for a heteroatom, giving access to alcohols, secondary amines, or halides (F180, 
Cl171, Br171 or I171). Furthermore, the boronic ester can be exchanged for a hydrogen atom 
through protodeboronation.181,182 There are also additional carbon-carbon bond forming 
processes available. The boronic ester can be converted to an alkene via Zweifel 
olefination,183184 terminal alkyne,185 ketone169 or fluoromethyl/ gem-difluoromethyl186 group. 




protocols and transition metal-free routes.187 Most boronic ester/borane transformations are 
stereospecific and therefore retain the stereocentre installed through lithiation–borylation (or 
any other boron installation) methodologies. 
 
The 1,2-metallate rearrangement observed in boron-ate complexes can be used to explain many 






















2.1.4. In-situ Spectroscopy in Lithiation-Borylation 
 
Traditionally, infrared spectroscopy (IR) provides an analytical method to assess chemical 
molecules, by exposing the chemical to IR radiation, which is absorbed by the chemical.188 
This absorption information is then presented as an IR spectrum, which shows the absorption 
“fingerprint”, bespoke to each molecule, in a range that spans from 4000-400 cm-1. By a 
chemical entity absorbing IR radiation, the bonding and even structure can be elucidated. 
 
The bond vibration frequency (ν) at temperature T, is proportional to the square root of the 
bond strength and inversely proportional to the root mass of the atom (equation below). 
Therefore, higher order of bonding, (i.e.) single → double → triple, will increase bonding 
strength and therefore result in a higher wavenumber. Finally, higher reduced masses will 








IR spectroscopy is only possible if the molecule produces a change in dipole moment upon IR 
absorption. Typically bonds such as carbonyl (C=O), which possess a strong dipole 
(electronegativity difference between O and C atoms) produce very strong IR signals.  
 
In situ IR spectroscopy allows real-time monitoring of a reaction mixture using IR 
spectroscopy, through the means of a probe placed in the reaction mixture.189 An IR spectrum 
can be produced periodically throughout the course of the reaction, thus providing a depiction 
of any changes that may occur to the molecule.  
 
As lithiation–borylation makes use of carbamate and benzoate directing groups, the bond order 
of the carbonyl in these groups can be followed throughout the reaction using in situ IR 
Where:  
ν = wavenumber/ vibration frequency (cm-1);  
k = (rate constant);  
F = bond strength; 




spectroscopy. As the carbonyl is involved in the lithiation by coordination to lithium, the bond 
order reflects the reaction coordinate. The carbonyl group of the carbamate appears at ~1700 
cm1 and the benzoate at ~1730 cm-1 (Scheme 89). After addition of the organolithium, the 
lithiation of the carbamate (~1620 cm-1) and benzoate (~1630 cm-1) are observed. In slower 
lithiations, a pre-coordination complex (~1680 cm-1 for carbamate and ~1700 cm-1 for 
benzoate), in which the lithium and carbonyl form a complex before deprotonation has 
occurred, can also be seen.190 Next, boronic ester addition, forms a boronate complex (~1640 
cm-1 for carbamate and ~1680 cm-1 benzoate) (Scheme 89). All reported wavenumber values 
were obtained from by Mykura et. al.191 The by-product of the benzoate 1,2 migration is lithium 
benzoate, LiOTIB, which appears at ~1580 cm-1. These changes in the above wavenumbers 
can be followed through the course of the reaction through a live trace. In situ IR spectroscopy 
is well suited for lithiation–borylation as the intermediates are only stable at cryogenic 
temperatures and are not air stable. As boronate complexes are typically air stable (and due to 
a large difference in chemical shift between boronic esters and boronate complexes) this step 










2.1.5. 1,1-Disubstituted Cyclobutanes 
 
Cyclobutane derivatives are highly strained, small-ring systems found in biologically active 
natural products and pharmaceutical treatments.192–196 Many of the natural products are found 
to possess antibacterial, anti-cancer and antimicrobial properties.  
 
Given these attributes, cyclobutane motifs have attracted interest from the pharmaceutical 
industry, to deviate from “flatland” (flatland is the region of chemical space occupied by sp2 
rich pharmaceuticals) and explore sp3/3D molecules to help produce more efficacious 
treatments.4,5 Cyclobutane derivatives address many of these issues, providing a sp3 scaffold 
that is rigid, with spatially defined arrangement of substituents197–199, which can be classed as 
privileged structural bioisostere to aromatic rings in structure-based drug design.200–204  
 
 
Figure 10: Cyclobutane containing natural products and bioactive molecules. 
 
As shown in Figure 10, a range of natural and synthetic cyclobutane motifs have been isolated 
or synthesised. 1,1-Disubstituted cyclobutanes are also commonly seen in natural sources 
(quaternary centre) (black circle). (±)-Pentacycloanammoxic acid 258, a fatty acid found in 




molecule contains an unusual [5]-ladderane motif.205 Similarly, 261, was isolated from the 
leaves and fruits of Egyptian Schinus mole and S. terebinthifolius, found to be an effective 
inhibitor of breast and brain cancer cell lines.206 Other synthetic molecules containing the 
cyclobutane motif include the anti-viral agent, lobucavir 259, produced by Bristol-Myers 
Squibb. 260 is a voltage gated sodium blocker, useful for treating cardiac arrhythmia.207 
Finally, GABA analogue208 262, for Parkinson’s and epilepsy and guanylate cyclase activator 
263 provide additional examples of cyclobutane-containing derivatives in biologically active 
molecules.    
 
 




Figure 11: Cyclobutane bond angles. 
 
Unlike acyclic nbutane, which adopts a sp3 tetrahedral geometry and C-C bond angles of 
109.5°, cyclobutane has a smaller internal C-C bond angle (88.5°), this ~29° deviation in bond 
angle leads to Baeyer ring strain, making the cyclobutyl core less stable than higher order 
cycloalkanes (Figure 11).209–211 As a result of the ring strain a part of the molecule is rotated 
out of the plane by 26°, resulting in the “butterfly” conformation. The ring strain makes 
cyclobutane motifs ideal for ring-opening reactions. A key feature of cyclic compounds is that 
deprotonation becomes progressively easier with decreasing ring size due to the increasing 





2.1.5.2. Synthesis of 1,1-Disubstituted Cyclobutanes Through Functionalisation 
 
 
As cyclobutanes are of interest in both natural product synthesis and medicinal chemistry,214 
there have been numerous methods developed for their preparation.215–218 Most (non-
functionalising219) methods are focussed on the construction of cyclobutane cores. These 
include [2+2] cycloadditions,220–230 α-alkylation of cyclobutanones,231 ring-expansion of 
cyclopropanes232 and cyclisations (such as, boryl carbanions233), and 1,4-radical addition-polar 
cyclisation234 (Figure 12).  
 
Figure 12: Synthetic routes to access cyclobutanes. 
 
It could be envisaged a simple route to furnish 1,1-disubstituted cyclobutanes would be the 
reaction of Grignard reagents or organolithiums (nucleophilic addition) with cyclobutanone 
264, to give the corresponding racemic tertiary alcohol 264 (Scheme 90, Route A). The scope 
of R groups introduced in this manner would be limited, due to compatibility issues with 





Scheme 90: Simple 1,1-disubstituted cyclobutanes. 
 
Alternatively, in a reversal of reactivity (Route B), a functional handle 266 could activate 
lithiation-electrophile trapping of cyclobutyl derivatives to give a functionalised disubstituted 
products 267. A recent publication from Xu and co-workers,235 reported the synthesis of 
cyclobutanecarboxamide 270, using an adapted procedure for the preparation of 
cyclopropanecarboxamide homologues (Scheme 91).236  
 
    
Scheme 91: Lithiation of cyclobutanecarboxylic acid 268. 
 
Here, cyclobutanecarboxylic acid 268, was deprotonated with LDA and then alkylated with 
benzyl bromide. The subsequent conversion of the carboxylic acid 269 to the corresponding 
amide, gave cyclobutanecarboxamide 270 in 80 % yield over two steps.  
 
Most recently, Hartwig and co-workers237 reported a palladium-catalysed α-arylation of simple 
cyclobutyl esters 271 (Scheme 92), expanding upon existing Negishi cross-coupling of 






Scheme 92: Palladium-catalysed α-arylation of cyclobutyl esters. 
 
The reaction scope is broad, with > 25 examples, consisting of electron rich and deficient aryl 
groups including heterocyclic substituents, with reported yields of 272 ranging 50-100%. 




2.1.5.3. Studies into the Lithiation of Cycloalkanes 
 
In 1985, Gadwood and co-workers reported the successful lithiation of cyclopropyl 2,4,6-
triisopropylbenzoate 276, derived from cyclopropanol 275, using sBuLi (2.5 eq.), TMEDA (5.8 
eq.) at –78 °C for 6 hrs in THF (Scheme 93).241 Prior to this study, only various dipole-
stabilised (α-alkoxyalkyl)lithiums had been generated via deprotonation of alkyl ethers. As 
expected, the presence of ring strain on cyclopropane renders the α-proton more acidic than in 
the acyclic secondary dialkyl benzoate due to the increased s-character of the C−H bond. The 
lithiation-deuteration of 277 afforded deuterated product 278 in 92% (90% D-incorporation by 
NMR, D2O quench). In addition, trapping with trimethylsilyl chloride afforded 279 in 68% 
yield. However, reaction with cyclohexanone failed to afford 280, even when the reaction was 
warmed to RT. The authors suggested steric hindrance was an issue when using cyclohexanone 
as an electrophile, similarly, quenching of organolithium 277 by α-proton transfer from the 







Scheme 93: Lithiation of cyclopropyl 2,4,6-triisopropylbenzoate 276. 
 
 
2.1.5.4. Lithiation-Borylation of Cycloalkanes 
 
Previous literature reports from Danheiser,242 showed that lithiation-borylation of substituted 
α-dibromo-cyclopropane 281 in the presence of catechol borane to give cyclopropyl boronic 
ester 282 after 1,2-migration of the hydride substituent (Scheme 94). This reaction benefits 
from having a good bromide leaving group.  
 
 
Scheme 94: Lithiation-borylation of α-dibromo-cyclopropane 281. 
 
Related studies on  lithiation-borylation of cyclopropyl 2,4,6-triisopropylbenzoate 283 were 
conducted by Daniel Blair243 (Scheme 95). Although benzoate 283 deprotonation was facile, 




obtained) subsequent reaction of lithiated benzoate 284 with pinacol borane failed to give the 
desired product 287. It was suggested that the strained cyclopropyl ring, prevented the boronate 
complex 285 from forming the required anti-periplanar configuration required for 1,2-
migration. Instead the boronic ester oxygen was found to migrate, giving only O-migration116 
product 286 (which was identified by 11B NMR) after 18 hrs at RT. 
 
 
Scheme 95: Lithiation-borylation of cyclopropyl 2,4,6-triisopropylbenzoate 283. 
 
Daniel Blair also studied the lithiation–deuteration of cyclohexyl benzoates 288 and 289. Given 
the larger ring size, this cyclic derivative would suffer from lower acidity than cyclopropyl 
benzoates. Indeed, this reaction proved challenging. Even after 8 hrs of lithiation, less than 
25% D-incorporation was observed in products cis-290 and trans-291 (Scheme 96). These 
results are in accordance with the lithiation of secondary benzoates, which displayed poor 





Scheme 96: Lithiation of cyclohexyl 2,4,6-triisopropylbenzoate 288/289. 
 
A formal lithiation for cyclobutane 2,4,6-triisopropyl benzoate has not been reported to date 
nor has this motif been studied in lithiation-borylation methodology. The above results, 
indicate that the success of cycloalkyl benzoates in lithiation-borylation, is a fine balance 
between ring size and ring strain (Figure 13). As the ring size increases, the benzoate is more 
difficult to deprotonate. However as the ring size decreases, ring strain prevents the boronate 
complex from occupying the required anti-periplanar configuration to undergo 1,2-migration 
and furnish product.  
 
 
Figure 13: Comparison of hydrocarbon. 
 
The limited methods for the preparation of cyclobutanes with versatile functional groups 






2.2. Previous Work  
 
The work completed in the previous work section of this thesis was carried out by Eugenia Luc 
and Rory Mykura.245 The work disclosed here includes the synthesis of cyclobutyl benzoate, 
which has been used as test substrate for boronic ester homologations in the substrate scope. 
There is also inclusion of in-situ IR spectroscopy traces to summarise this aspect of the work. 
All tables and diagrams discussed in the previous work have been adapted/ reproduced from 
Eugenia Luc’s Masters thesis.245  
 
2.2.1. Synthesis of Cyclobutyl Benzoate via Cyclobutylbromide  
 
 
Scheme 97: Proposed route to the synthesis of cyclobutyl 2,4,6-triisopropylbenzoate 292. 
 
Initial attempts to synthesise benzoate 292 utilised SN2 displacement of cyclobutylbromide by 
the hindered benzoate nucleophile, which is generated by base in-situ deprotonation of 2,4,6-
triisopropylbenzoic acid (TIBOH) as shown in Scheme 97. Whilst this gave the desired 
product, a competing side-reaction, giving the ring contraction cyclopropyl methyl benzoate 




The formation of benzoate 293 side-reaction is possible due to equilibrating non-classical 
cationic intermediates, as reported by Robert and co-workers in their isotopic labelling 
experiments.246 The rearrangement is thought to arise due to formation of an equilibrating non-
classical bicyclobutonium ion intermediate, as shown in scheme 97.247,248 The subsequent 
trapping of the more stable cationic species with the benzoate nucleophile gives the ring 
contracted side product. This competing side pathway takes place via SN1 mechanism. 
 
Due to the difficulties in purification and separating the side product from the desired product, 
attempts were made to eliminate the side product formation, however, these were also 
unsuccessful. Therefore, the cyclobutyl benzoate substrate, containing a small percentage of 
side-product 293 (~10%) was used without further purification and the side-product did not 
interfere with the lithiation-borylation reaction.  
 
Attempts by Eugenia Luc to access the cyclobutyl benzoate through the reaction between the 
acyl chloride and cyclobutanol, did not yield desired product. Therefore, Eugenia Luc explore 
the Mitsunobu reaction as a potential route. Initial attempts to synthesise desired benzoate 292 
were performed in DMA at 120 ˚C, resulting in a 1.00:0.38 ratio of 292:293 (Table 8, entry 1). 
Repeating the same reaction at RT improved ratios in favour of desired benzoate 292 1.00:0.26, 
(entry 2). This would suggest heating the reaction mixture favours SN1 over SN2, hence the 
larger ratio of side product 293 in entry 1. Using apolar toluene, entry 3, improved the ratio to 
1.00:0.18 of 292:293. Further study of solvent effect on ratio, showed that THF was optimum 











Table 8: Optimisation of Mitsunobu esterification for the synthesis of cyclobutyl benzoate 292. 
 
Entry Solvent T/ °C t / hrs 292:293a) Yieldb) % 292:293a) 
1 DMA 120 5 1.00:0.38 - - 
2 DMA RT 16 1.00:0.26 39 1.00:0.27 
3 PhMe 50 16 1.00:0.21 43 1.00:0.18 
4 THF RT 16 - 68 1.00:0.07 
a) Crude ratio of benzoates 292:293 via 1H NMR. b) Yield of isolated benzoate 292.  
 
 
2.2.2. Optimising Lithiation-Borylation Conditions 
 
To accelerate the development of conditions for the lithiation-borylation reaction, in-situ IR 
spectroscopy was utilised to study the formation and depletion of intermediates throughout the 
reaction. In-situ IR spectroscopy is a powerful tool that can help determine optimal reagent 
stoichiometries, reaction times and stability of intermediates. 
When initially screening conditions, Eugenia Luc used 2-phenylethyl-1-boronic acid pinacol 
ester 294, an air-stable primary boronic acid as the substrate for lithiation–borylation due to its 








2.2.3. In-situ IR Spectroscopy of the Lithiation–Borylation of Cyclobutyl 
Benzoate  
 
The lithiation-borylation of cyclobutyl 2,4,6-triisopropylbenzoate 292, was investigated by 
Eugenia Luc using in-situ IR spectroscopy and reported in a graph as a function of absorbance 
(a.u.) against time (mins) (Figure 14).  
 
Benzoate 292 was converted to lithiated species 295, after addition of sBuLi, with maximum 
lithiation at ~21 mins. The addition of sBuLi results in dilution of the reaction mixture, as 
shown in Figure 14, which accounts for the concentration of benzoate 292 falling to less than 
zero absorbance. Similarly, the dilution effects also contribute to the initial sharp decrease in 
the benzoate 292 concentration.  
 
The lithiation of cyclobutyl benzoate 292  ̧showed that the lithiated species 295 is chemically 
unstable under the reaction conditions over time through generation of lithium 2,4,6-
triisopropylbenzoate species (green line). Upon addition of boronic ester 294 at ~ 51mins, the 
lithiated species 295 was rapidly consumed to give boronate complex 296.  
 
The lithiation-borylation of cyclobutyl benzoate 292 was a promising result and provided a 
starting point for the optimisation of reaction conditions to synthesise the desired product. The 
fast rate of lithiation (~9 minutes) is due to the increased s-character of the C-H bond of the 4 
membered ring in comparison to acyclic secondary TIB esters which require >2hrs to achieve 
30% deprotonation at -60 ˚C and a large equivalent of TMEDA.169 The lithiated benzoate 
species 295 is chemically unstable with about 15% decomposition being observed over 50 
minutes. Using this information, Eugenia optimised the 1,2 borylation step and reagent 




















































2.2.4. Optimised Lithiation–Borylation Conditions for Cyclobutyl Benzoate 
 
 
Scheme 98: Optimised lithiation–borylation conditions. 
 
By using a combination of techniques, such as in-situ IR spectroscopy, complete lithiation had 
been achieved after 9 minutes, with the species stable for an additional 25 minutes. After 
boronic ester addition, a solvent exchange to CHCl3 was carried out and the reaction heated to 
60 °C to promote 1,2-migration, with reactions complete after 4 hours of heating (Scheme 98). 
Finally, workup was performed by simply filtering the crude reaction through a short silica 














2.3. Project Aims 
 
Having established optimised conditions for the lithiation-borylation of cyclobutyl 2,4,6-
triisopropyl benzoate 292, using in-situ IR spectroscopy, it is imperative to develop a substrate 
scope for this methodology for the synthesis of 1,1-disubstituted cyclobutanes. 
 
A range of primary, secondary, tertiary and sp2-hybridised (aryl and alkenyl) boronic esters 
was to be tested in this methodology. In addition, enantioenriched boronic esters and natural 
product boronic ester derivatives (cholesterol and lithocholic acid) can also be tested in this 
methodology to show broader application. Furthermore, boronic ester functional group 
interconversions of a homologated product from this methodology can used to emphasise the 
potential of the products obtained from this protocol.  
 
Finally, in-situ IR spectroscopic methods will be used to establish lithiation–borylation 
conditions for other small-ring systems, such as, substituted cyclobutyl rings, oxetane and 















2.4. Results and Discussion 
 
2.4.1. Collaboration Disclaimer 
 
Parts of this project/chapter contain work that has been completed in collaboration with Rory 
Mykura (RM), Eugenia Luc (EL), Jack Rogers (JR) and Ellie Stammers (ES), which formed 
the basis for a publication249. In the substrate scope, work contribution from myself have been 
highlighted with my initials (PS). The remaining substrates were produced by the above 
collaborators and it has been included to provide a complete story for this chapter. However, 
the Experimental Chapter includes information only of the products that PS synthesised.  
 
2.4.2. Substrate Scope of Lithiation-Borylation 
 
Having optimised lithiation-borylation conditions using 2-phenylethyl-1-boronic acid pinacol 
ester 294, the generality of the reaction was explored by performing a substrate scope using a 
range of boronic esters. Primary, secondary, tertiary, sp2 and enantioenriched boronic esters 
were tested and moderate to good yields were achieved. 
 
2.4.2.1 Primary Boronic Esters 
 
As shown in Scheme 99, the standard substrate, phenylethyl-1-boronic acid pinacol ester 294, 
gave 297 in 60% yield. The use of linear primary boronic ester substrates bearing tert-butyl 
ester 301 and nitrile 300 functional groups were tolerated in this reaction. The yield for nitrile 
300 is given as a 1H NMR yield (using dibromomethane as an internal standard), due to the 






Scheme 99: Range of primary boronic esters synthesised. 
 
The azide functional group for substrate 298, was the only poorly tolerated substrate, possibly 
due to addition of the organolithium to the azide. The presence of a para-methoxy benzyl group 
was well tolerated 299 (69%). The subjection of trans-3-fluoro-cyclobutylbenzoate 302 to the 
optimized conditions gave 303 in 62% yield and high d.r. (starting from a single 
diastereoisomers of the TIB ester), demonstrating that the presence of a fluorine atom on the 
cyclobutyl ring does not affect the reaction pathway. The scope of the reaction was also 
successfully expanded to biologically relevant compounds such as lithocholic acid derivative 
304 (63%), which was synthesized in-house from TBS protected lithocholic acid by 









Scheme 100: Range of secondary boronic esters synthesised. 
 
Expanding boronic ester scope to include secondary boronic esters gave poor to good yields 
(Scheme 100, 16-65%). Cyclohexyl boronic ester gave compound 305 in 60% yield. However, 
increasing the steric bulk on the cyclohexyl ring moiety, when using a menthol derived boronic 
acid pinacol ester (Bpin), failed to give the desired product. This is a consequence of the vicinal 
isopropyl group on the cyclohexyl ring, which hinders the borylation, as no boronate complex 
was observed (11B NMR). Using the less sterically hindered neopentyl boronic ester analogue 
(Bneo) gave 306 in 58% yield. 
The use of a phenyl cyclopropyl boronic ester gave compound 307. However, using nitrile 
containing secondary dialkyl boronic ester gave the desired product (compound 310) in poor 




opposed to any incompatibility with the nitrile group, as the reaction worked well when using 
primary propanenitrile boronic acid pinacol ester (300, 69%). As the less sterically hindered 
Bneo group has been shown in previous attempts to facilitate reactions that were poor yielding 
or non-occurring when using Bpin analogues, perhaps the yield of this reaction could be 
improved by using the Bneo group.  
 
A similar steric congestion was observed in the synthesis of enantioenriched boronic ester 309, 
which gave the desired product in 54% yield, albeit lower than less challenging secondary 
boronic esters. In comparison to compound 310, it is evident the replacement of a one bulky 
alkyl group with a simple methyl group afforded reduced steric congestion, which reflects on 
the better yield. These observations demonstrate the sensitivity of the hindered secondary 
lithiated species to the steric environment of the pertinent boronic ester, whether during 
borylation or 1,2-migration. 
 
The presence of heterocyclic ring systems was well tolerated in the lithiation borylation of the 
cyclobutyl benzoate, especially given the presence of an adjacent bulky Boc protecting group 
on the ring nitrogen for two examples. The 2-substituted NBoc pyrrolidine (compound 308) 
was obtained in 42% yield, similarly the 4-substitued NBoc piperidine derivative (compound 
311) was also obtained in good yield (48%).  
 
However, when 1-Boc-piperidine-3-boronic acid pinacol ester was utilised (to synthesis 
compound 312), desired product was obtained in 31% yield (Table 9, entry 1). It was noted in 
entry 1 that the 1,2-migration step had not reached completion (boronate still present by 11B 
NMR); this was reflected in the starting boronic ester recovered (36%). A subsequent reaction 
(entry 2) was left for a longer duration (48 hrs) at standard conditions, with 11B NMR taken 
every ~16 hrs (3 NMR’s taken over 48 hrs) which indicated that no further 1,2-migration 
occurred after 32 hrs. Using this reaction time, a better yield was obtained (42%), with a lower 
starting boronic ester recovery (25%). The improved yield is a consequence of heating the 
reaction for a longer period, which indicates that the 1,2-migration is slow and requires a 
prolonged reaction time under standard conditions. Consequently, the solvent was exchanged 
for a higher boiling solvent, such as toluene (entry 3) during the 1,2-migration step instead of 
chloroform. This reaction mixture was heated to 110 ̊ C. This gave a 4% increase in yield (46%) 




4); a Lewis-acid known to promote 1,2-migration was utilized. However, after 16 hours, the 
reaction gave a 46% isolated yield. Depending on the chemist’s requirements, either entry 3, 
which uses toluene at reflux, or entry 4, requiring preparation and addition of fresh 
MgBr2•Et2O, can be used to prepare this boronic ester in moderate yield.  
 
Table 9: Reaction conditions tested in the lithiation-borylation of compound 312. 
 







1 Standarda) 16 31 36 
2 Standarda) 48 42 25 
3 Et2O →Toluene 48 46 22 
4 MgBr2•Et2O 16 46 25 
  Conditions: a) standard: TMEDA/sBuLi (1.3 eq.) in Et2O at -78 ˚C, 20 mins. Then R-Bpin (1.5 eq.) at -78 ˚C for 30 
mins. Warm, solvent exchange to CHCl3 and reflux (4 hrs). 
 
1-Phenylethyl boronic acid pinacol ester product (pre-oxidation 313), presented problems with 
isolation and purification under standard conditions during lithiation-borylation. After 
promising NMR yields, the product and starting boronic ester could not be separated. To 
overcome purification issues, the crude reaction mixture was oxidized with H2O2/NaOH, to 
convert the boronic ester to alcohol 313, which was isolated in 18% yield. This yield did not 




IR spectroscopy (Figure 15). It was found that the reaction had undergone complete lithiation 
and subsequent borylation but failed to undergo 1,2-migration. Further studies helped to 
elucidate and improve reaction conditions for compound 313 (Table 10). 
 





Isolated Yield (%) 
1 Standarda) 16 18 
2 Et2O →Toluene 20 58 (rac)/56 (e.e) 
3 MgBr2•Et2O 16 0 
  Conditions: a) standard: TMEDA/sBuLi (1.3 eq.) in Et2O at -78 ˚C, 20 mins. Then R-Bpin (1.5 eq.) at -78 ˚C for 30 

















Entry 1 (Table 10), shows the reaction under standard conditions. Interestingly, solvent 
exchange to toluene (instead of chloroform, entry 2) provided a better yield after 20 hours (58 
% (rac)/56 % (e.e.). Finally, Lewis-acid MgBr2·Et2O (entry 3) was also tested. Unfortunately, 
after peroxide oxidation, no product was obtained but 1-phenylethan-1-ol (21%) was isolated, 
from oxidation of the starting boronic ester. The synthesis of compound 313 also confirmed 
the enantiospecificity of the 1,2-migration process, compound 313 was analysed by 
supercritical fluid chromatography (SFC) to show 96:4 e.r. (starting boronic ester >95:5 e.r.). 
This result indicates that the reaction occurs with high (essentially complete) stereospecificity 
(100% e.s.). 
 
Finally, the methodology was tested on a derivative of cholesterol pending an alcohol moiety 
that was TBS protected, where the secondary boronic ester was installed through hydroboration 
(314) as shown in Scheme 101. 
 
 
Scheme 101: Failed attempts to synthesis cholesterol derived products. 
 
As shown in Table 11, all attempts to synthesise compound cholesterol derivatives 316, were 




product 306, the substituted cyclohexane motif presents too much steric hinderance to allow 
addition to the boronic ester from the lithiated cyclobutyl TIB ester. However, the lack of result 
even swapping to the Bneo demonstrates the sheer size of the cholesterol moiety most likely 
shields the boronic ester from reacting with the lithiated species.  
 
 
Table 11: Reaction conditions tested in the lithiation-borylation of compound 315. 
Reaction 
Entry 





ester re-isolated (%) 
1 Bpin 314 Standarda) 16 0 72 
2 Bpin 314 Et2O 
→Toluene 
48 0 65 
3 Bpin 314 MgBr2•Et2O 16 0 68 
4 Bneo 315 Standarda) 16 0 49 
  Conditions: a) standard: TMEDA/sBuLi (1.3 eq.) in Et2O at -78 ˚C, 20 mins. Then R-Bpin (1.5 eq.) at -78 ˚C for 30 
mins. Warm, solvent exchange to CHCl3 and reflux (4 hrs). 
 
Entry 1, using standard conditions, only gave starting materials back, even though boronate 
complex was visible by 11B NMR (5 ppm). Comparatively, a larger signal for unreacted boronic 
ester was also present on the 11B NMR. It was thought at this point that two problems were 
causing this reaction to fail. Firstly, the sterically encumbered boronic ester may not be 
completely reacting with the lithiated species (as seen by the 11B NMR). Secondly, the boronate 
complex is sterically congested around the boron atom, restricting access to the required anti-
periplanar conformation for 1,2-migration, such that migration is not feasible. This could lead 
to decomposition or reversal of the boronate complex to regenerate starting boronic ester 314. 
It was proposed that exchanging solvent to a higher boiling point solvent (entry 2) would force 
the small portion of boronate complex to undergo 1,2-migration, however solvent exchange 
did not help. Similarly, using Lewis-acid (entry 3) also failed to give desired product, and only 
starting materials were recovered. Finally, analogous boronic ester 315, with a less sterically 
bulky neopentyl glycol ligand (in comparison to pinacol) on boron was investigated (entry 4). 
This would potentially aid boronate complex formation given the reduced steric hinderance 




also failed to produce any desired product. At this stage, the cholesterol derivative was 
abandoned, and attention directed to other types of boronic esters. 
 
 
2.4.2.3. Tertiary Boronic Esters  
 
This work on tertiary boronic esters was completed by Jack Rogers & Rory Mykura. The use 
of tertiary boronic ester demonstrated the limitations of lithiation-borylation on small rings. 
Here, tbutyl boronic acid pinacol ester was used to synthesize compound 317 (Figure 16), 
however, the first attempt proved unsuccessful with starting cyclobutyl benzoate 292 recovered 
(90%). The lack of borylation could be attributed to the bulky tBu group rendering the 
borylation step reversible and so lithiated TIB-ester complex is reobtained. Upon work-up this 
would return starting cyclobutyl benzoate 292.  
 
Figure 16: Tertiary boronic esters tested using optimised conditions. 
 
To test this hypothesis, the reaction was repeated and monitored using in-situ IR spectroscopy 
(Figure 17). The lithiated species did not react with tbutyl pinacol boronic acid pinacol ester 
when this was added to the reaction mixture at -78 °C. This can be attributed to the steric bulk 
of the tBu group, which hinders the boronic ester from reaction to form boronate complex. An 






Figure 17: In-situ IR spectroscopy study into the synthesis of compound 317. 
 
In a final attempt, the pinacol group was exchanged for Bneo to increase the reactivity of the 
boronic ester, which should facilitate the borylation step to take place giving product 318. 
However, though boronate complex was observed by 11B NMR, no borylation product was 
obtained from the reaction. This would suggest again the bulky tbutyl group on the boronic 
ester was too large to generate a boronate complex that can undergo 1,2-migration, most likely 
due to competing reversibility, leading to recovered cyclobutyl benzoate 292 (90%).  
 












2.4.2.4. sp2 Boronic Esters 
 
 
Scheme 102: sp2 boronic esters tested using optimised conditions. 
A range of alkenyl, aryl, heteroaromatic boronic esters were tested with good yields obtained 
(43-67%) as shown in Scheme 102. Reaction of phenyl Bpin gave the product 319 in good 
yields (64%). Subsequent, addition of electron withdrawing groups on the aryl ring (Cl, 320 
and CF3, 322) did not hinder reaction. Similarly, the electron donating group such as p-methoxy 
group was also tolerated (321). However, the p-methoxy boronic ester product, had to be 
oxidised to the corresponding alcohol 321, due to issues with separating the boronic ester 
starting material from the desired product during purification by column chromatography. In 
addition, compound 323 was synthesised from 2-benzofuran Bpin (375) in 53% yield and 
compound 324 from NBoc protected indole pinacol boronic ester in 67% yield. The use of 




A range of alkenyl boronic esters were used successfully, where mono-substituted alkenes with 
alkyl (compound 326) and styrenyl groups (compound 327) tolerated. Furthermore, 
substitution at the α-position of the olefin was also tolerated 328.  However, like previous 
boronic esters synthesised, the crude reaction for boronic ester derivative of compound 328 
was difficult to purify, due to co-elution of the starting boronic ester. A mixture of H2O2/ NaOH 
was used to oxidise the boronic ester to the analogous alcohol. However, compound 328 was 
found to be incompatible with these conditions and so milder oxidation conditions using 
NaBO3.4H2O were used. The poor isolated yield is a result of oxidation, rather than poor 
borylation reaction yield, as the 1H NMR prior to oxidation (88%) was better than the isolated 
yield (49%). 
  
2.4.3. Boronic Ester Functionalisation Group Interconversions 
 
Scheme 103: Functional group interconversions of 311. 
 
To illustrate the synthetic utility of the reaction products, tertiary boronic ester 311 was 
subjected to several boronic ester functional group interconversions, which proceeded with 
excellent yields (Scheme 103). Oxidation of boronic ester products to their respective alcohols 
has previously been described (for example compound 303 or 313). However, additional 




329, 80%), along with an alkynylation with vinyl carbamate (381), to give compound 332 
(83%) in excellent yield were also demonstrated.251 In addition, Matteson homologation252 
provided the methylene homologated primary boronic ester, compound 330, in good yield and 
amination253 and Boc protection, compound 331, installed a protected tertiary amine in 
moderate yield (55%).  
 
Some functional group interconversion reactions failed to give desired products as shown in 
Scheme 104. The first functional group interconversion was attempted by radical addition to 
strained σ-bonds, as reported by Aggarwal and co-workers for other molecules, to produce 
compound 333.254 Here bicyclo[1.1.0]butyl (BCB) sulfoxide undergoes sulfoxide-lithium 
exchange, followed by addition of boronic ester starting material 311, to give a boronate 
complex. Visible light irradiation (blue LED) in the presence of CF3I•2DMSO, generates an 
electron deficient •CF3 radical, which can add the strained central σ-bond of the BCB boronate 
complex. Subsequent one-electron oxidation of this radical to a carbocation triggers 1,2-
metalate migration to give 1,3-cylobutyl cyclobutane boronic ester (333). The literature 
published by our group on this methodology, has an example of a 1,1-cyclobuty-substituted 
1,3 cyclobutane254. 
 
Scheme 104: Failed functional group interconversions. 
 
However, noticeably, the reported yield (41%) for this reaction is lower than that of other 
substrates reported (typical yields reported 60-90%). The literature example possesses a methyl 
group, whereas the failed reaction features a larger piperidine group, this suggests that the 




After not obtaining compound 333, an alternate route, to access 1,3 cyclobutyl cyclobutane 
boronic esters, was attempted using C–C σ-bond carbopalladation, using a protocol published 
by Aggarwal and co-workers255, which would have given compound 334. Here, an aryl 
palladium(II) complex undergoes addition to the strained BCB boronate complex derived from 
boronic ester 311 to access cyclobutyl derivatives. However, this reaction also failed to give 
desired compound 334. Again, the steric congestion expected at the boron atom centre, could 
explain why this reaction failed to give any desired product. At this stage, further attempts to 





2.4.4. Expanding Methodology to Complex Cyclobutyl-Containing Motifs 
 
2.4.4.1. 2-Methylcyclobutyl 2,4,6-triisopropylbenzoate 
 
(±)-2-Methylcyclobutyl-1-ol (335) was subjected to Mitsunobu esterification, to produce 
compound 336, as shown in Scheme 105. Though the reaction profile, by TLC was clean, 
purification of the reaction mixture indicated that the reaction had not yielded desired product 
336. Instead, the cyclopropane ester 337 was obtained in excellent yield (70%). This side-
reaction was also an issue when conducting the Mitsunobu reaction on cyclobutanol, where 









However, the Mitsunobu reaction of 2-methylcyclobutanol gave no desired product as 
described above. This can be attributed to the formation of a non-classical cyclobutonium ion 
intermediate 339 from 338 (Scheme 106) which for 2-methylcyclobutanol, is now stabilised 
by the adjacent methyl group. This leads to the formation of a more stable secondary 
cyclopropylcarbocation 340 (as opposed to the primary carbocation for cyclobutanol, § 2.2.1.). 













Scheme 107: Synthesis and lithiation-borylation of tert-butyl 6-hydroxy-2-azaspiro[3.3]heptane-2-carboxylate 
342. 
 
The second cyclobutyl core to be tested, contained a 2-azaspiro[3.3]heptane motif. The desired 
benzoate (compound 342) was synthesised via Mitsunobu esterification of 341, as shown in 
Scheme 107. Subsequent lithiation-borylation, under standard conditions, using 2-phenylethyl 




Instead, starting benzoate 342 (80%) and 2-phenylethyl boronic acid pinacol ester 294 (66%) 
were recovered. The large recovery of starting benzoate 342 suggested lithiation was not taking 
place, so to better understand the reaction profile in-situ IR spectroscopy was used.  
 




During the in-situ spectroscopy study, a probe is inserted into the reaction vessel, such that the 
tip of the probe contacts the surface of the reaction solvent. It is crucial that the reaction mixture 
is homogenous, otherwise the IR study will not be accurate. When attempting to dissolve 
benzoate 342, in Et2O at -78 ˚C the benzoate was found to precipitate onto the surface of the 
probe, ruining the experiment. To overcome this, THF (0.22 mL) was added in addition to the 
reaction solvent (Et2O). Subsequent lithiation of compound 342 was attempted using sBuLi 
(1.3 eq.), TMEDA (1.3 eq.) in Et2O/THF (0.22 mL) (0.2 M) at -60 °C (cryostat).  
 
The in-situ IR spectroscopy study, as shown in Figure 18, showed that the reaction profile for 
this substrate was complex. The first addition of sBuLi to the reaction caused a drop in the IR 
signal for both ROTIBC=O = 1730 cm
-1 and NBocC=O = 1708 cm
-1, due to dilution effects in the 



















Figure 18: Lithiation-borylation in-situ IR spectroscopy study of tert-butyl 6-((2,4,6-triisopropylbenzoyl)oxy)-2-
azaspiro[3.3]heptane-2-carboxylate 342. Reagents: sBuLi (1.3 eq.) x3, TMEDA (1.3 eq.) Et2O/THF (0.2 M) at -60 
°C (cryostat).  
Though a new signal (1666 cm-1) appeared, this was not characteristic of organolithium 
formation (normally seen in the range of 1600-1650 cm-1), which suggested lithiation had not 
occurred. The signal seen at 1666cm-1, could be because of a co-ordination complex forming 
between the sBuLi and NBoc group, that could be preventing lithiation. So, after 30 minutes at 
-60 ˚C, another 1.3 equivalents of sBuLi were added, to promote lithiation. Again, there was a 
drop in signal, due to solvent dilution effects, however, there was no sign of lithiation having 
taken place. A final, additional equivalents of sBuLi was added after 15 minutes, there was no 
observable lithiation by in-situ IR spectroscopy. The reaction mixture was left to stir at -60 ˚C 
for ~ 30 minutes, after which TMSCl (4.5 eq.) was added to trap any lithiated species to enable 
column chromatography isolation.  
 
However, TLC confirmed that the major constituents in the reaction mixture were still the two 
starting materials (benzoate and boronic ester), and no trimethylsilyl-containing products were 
obtained. A total of 3.9 equivalents of sBuLi was added, however no lithiation occurred, as 
suggested above. Thus, this molecule is inert to lithiation, potentially due to coordination of 






























Scheme 108: Mitsunobu esterification of tert-butyl ((1R,3R)-3-hydroxycyclobutyl)(methyl)carbamate 344. 
 
Commercially available trans-tert-butyl (3-hydroxycyclobutyl)(methyl)carbamate 344 (97:3 
d.r. trans:cis), from which the desired benzoate 345 was synthesised via Mitsunobu 
esterification, as shown in Scheme 108, in 65% yield and isolated >99:1 d.r. Next, the core’s 
lithiation-borylation prospect was directly tested using in-situ IR spectroscopy. 
2.4.4.5. In-situ IR Spectroscopy Studies into the Lithiation-Borylation of (1s,3s)-3-((tert-
butoxycarbonyl)(methyl)amino)cyclobutyl 2,4,6-triisopropylbenzoate  
 
Due to complexity of the lithiation-borylation methodology, it was decided that a simple 
lithiation-electrophile trap would be conducted initially, which would be monitored via in-situ 
IR spectroscopy. The electrophiles used in the reaction were TMSCl (3.0 eq., large excess), 
followed by MeOD (3.0 eq., large excess).  Due to the steric congestion around the cyclobutyl 
ring in compound 345, TMSCl might fail to react with the lithiated species. However, adding 
MeOD, would ensure the lithiated species are quenched, with D-incorporation. The crude 
reaction mixture can be evaluated by 1H NMR. Similarly, the tri-methyl groups on the TMS 
group, are distinctly up-field due to the presence of the silicon heteroatom. 
 
The appending N-methyl carbamate would also provide insight into OTIB vs N(Me)Boc CH 
lithiations, since azetidine NBoc substrates were found to be resistant to α-lithiation with 
sBuLi/TMEDA.256 Reaction conditions were adapted from the attempted lithiation-borylation 
of azaspiro 342 reaction (-60 ˚C), due to similar solubility issues of 345 at -78 °C, therefore the 
solvent used was a mixture of Et2O/THF (0.2 M). As shown in Figure 19, addition of sBuLi 
(1.3 eq.) to the cooled benzoate 345 (ROTIBC=O = 1731 cm
-1 and NBocC=O = 1700 cm




~24 min, showed the signal attributed to NBoc group drop to the baseline, whilst the signal 
attributed to the OTIB group did not change in intensity. In addition, a signal at 1731 cm-1 had 
now appeared and continued to increase. This combination would suggest lithiation adjacent 
to nitrogen. After 10 mins (t= ~36 mins) another 1.3 equivalents of sBuLi was added to the 
reaction, to see if this would affect the lithiation profile, however, only dilution effects were 
observed. Over the following 20 minutes, no change in the intensity of any signals was 
observed, suggesting the lithiated species generated were chemically stable. TMSCl (3.0 eq.) 
was added to the reaction mixture to quench the reaction (t = ~56 mins). The addition saw 
immediate decrease in the population of lithiated species (1731 cm-1), similarly the NBocC=O = 
1700 cm-1, which had disappeared had now returned. After 5 min, MeOD (3.0 eq.) was added 
to the reaction mixture to quench any unreacted lithiated species. A total of 2.6 eq. sBuLi was 
added to the reaction mixture followed by 3.0 eq. TMSCl and MeOD, however no ring-lithiated 
derived products (345a/b) were obtained from this reaction. The crude reaction mixture was 
filtered using a short silica plug and submitted for NMR. However, 1H NMR, showed no TMS 
incorporated on the cyclobutyl ring CH adjacent to the N(Me)Boc group. However, the N-
methyl singlet (CH3N) (3H, 2.86 ppm) had now become a singlet (2H, 2.66 ppm). Similarly, 
there was an upfield methyl signal that would suggest TMS incorporated (9H, 0.00 ppm). 
Subsequent TLC analysis showed two spots (eluted 10% EtOAc/pentane), the lower of which 
was the starting benzoate 345. Isolation of the top spot (50% yield), followed by NMR 
spectroscopy and mass spectroscopy analysis, confirmed compound 348, where lithiation has 
taken place on the N-methyl group followed by electrophile trapping (TMS) as shown in 






Figure 19: Lithiation-borylation in-situ IR spectrsoscopy study of (1s,3s)-3-((tert-
butoxycarbonyl)(methyl)amino)cyclobutyl 2,4,6-triisopropylbenzoate 345. Reagents: sBuLi (1.3 eq.) x2, TMEDA 
(1.3 eq.) in THF/Et2O (0.3 M) at -60 °C (cryostat). 
 
The presence of bulky substituents on the cyclobutane ring (NBoc and OTIB), increases steric 
bulky around the ring (346) and hinders ring deprotonation of 344. The side reaction is 
promoted by the presence of the NBoc carbamate group, which can form a 5-bond co-
ordination complex with the lithiated species (347), as shown in scheme 109. Furthermore, the 
stability of primary carbanion over the secondary carbanion, may provide an electronic 
argument for the selective deprotonation of the methyl group to give product 348. No other 
products were isolated from this reaction. As a result, this reaction shows the difficulty in 
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Scheme 109: Proposed cause of side reaction in lithiation-electrophile trapping study of (1s,3s)-3-((tert-
butoxycarbonyl)(methyl)amino)cyclobutyl 2,4,6-triisopropylbenzoate 344. 
 
 
2.4.5. Expanding Methodology to Heterocyclic Analogues 
 
To expand upon the methodology established for cyclobutyl benzoates, our attention turned to 
heterocycle analogues of cyclobutane, such as oxetanes and azetidines. As demonstrated in the 
cyclobutyl benzoate chemistry, this area of small ring lithiation is under-studied. Therefore, 
this work would provide insight into a) the lithiation properties and stabilities of 3-substituted 
oxetane and azetidine substrates and b) develop conditions for the novel lithiation-borylation 
chemistry of these heterocycles, to explore new chemical space.  
 
2.4.5.1. Synthesis of Oxetan-3-Benzoate 
 
There have been some literature reports into the lithiation-electrophile trapping of 2-substituted 




provide suitable activation and stability of the lithiated intermediate to facilitate the reaction. 
However, the lithiation of 3-subsituted oxetane has not been reported.   
 
 
Scheme 110: Mitsunobu esterification of oxetan-3-ol. 
 
Oxetan-3-ol was subjected to Mitsunobu esterification, using standard conditions applied to 
cyclobutanol (Scheme 110). The reaction produced desired benzoate 349 in 57% yield after 
column chromatography. No side products were observed in the reaction, thus demonstrating 
the oxetane’s preference to not undergo the rearrangement process (as seen in cyclobutyl 
benzoate derivatives). 
 
2.4.5.2. Lithiation-deuteration study of Oxetan-3-Benzoate 
 
Having successfully synthesised benzoate 349, the substrate was initially subjected to in-situ 
IR spectroscopy monitored using conditions derived from the lithiation-borylation reactions of 
cyclobutyl benzoate 292 (§ 2.4.5.4), however this attempt was unsuccessful. Therefore, the 
whole process was simplified by attempting to first establish lithiation conditions for the 
substrate. For this purpose, lithiation-deuteration studies were undertaken, where the model 
substrate was lithiated with sBuLi (1.2 eq.)/ TMEDA (1.2 eq.) for 1, 2, 5, 10 and 20 minutes at 
-78 ˚C, after which MeOD (2.0 eq.) was added to the reaction mixture to quench any potential 
lithiated species 351 to give product 350 (Scheme 111). Subsequent, 1H NMR (with 1.0 
equivalents of 1,3,5-trimethoxybenzene, TMB) would allow for an 1H NMR yield to be 
calculated. This simple exercise would confirm if lithiation occurred, and if so, where. If the 
desired lithiation-deuteration occurred, then the oxetane ring CH signal which appears at 5.68 






Scheme 111: Lithiation-deuteration study of oxetan-3-benzoate 349. 
 
As shown in Table 12 lithiation of oxetan-3-benzoate 349 is rapid, with full lithiation observed 
within 1 min. Unfortunately, the lithiated species generated is not chemically stable and 
decomposes over time. As shown in Chart 3, the decay of lithiated 351 gives a half-life (t½) for 
this species of ~13 min.    
 
Table 12: Lithiation-deuteration results for benzoate 349. 
Time 
(t/mins) 
% D-incorporation (1H 
NMR) 




1 100 98 97 
2 100 97 95 
5 100 91 89 
10 100 60 55 









Chart 3: Lifetime of lithiated oxetan-3-benzoate 351. 
 
 
Though the lithiated species 351 is chemically unstable, the fast and quantitative lithiation 
could be beneficial if the species is immediately trapped with a boronic ester. There is also the 
potential to try the carbamate derivative of oxetane 352, however, compared to the rapid 
lithiation observed for benzoate 349, analogous carbamates are typically slower to deprotonate. 
However, we did not undertake these studies at this time (Scheme 112). 
 
 
Scheme 112: Lithiation of oxetan-3-carbamate 352. 
 
2.4.5.3. Lithiation-Borylation of Oxetan-3-Benzoate 
 
Studies into the lithiation-borylation of 349 was also explored, as shown in Scheme 113, in this 
reaction 1.0 eq. benzoate 349, 1.2 eq. TMEDA/ sBuLi in diethyl ether (1 mL, 0.35 M) were 
used for the lithiation reaction at -78 ˚C for 2 mins, after which boronic ester phenylethyl 
boronic acid pinacol ester 294 (1.2 eq.) in diethyl ether (0.5 mL) was added to the reaction 
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mixture and left to stir at -78 ˚C for 30 min. The first reaction mixture i) was left to reflux in 
diethyl ether, whereas ii) was exchanged for chloroform and then refluxed.  Both reactions 
were refluxed for 7 and 5 hours respectively with monitoring via 11B NMR to assess boronate 
complex consumption. 
 
Scheme 113: Initial attempt at lithiation borylation of 349. 
 
Subsequent, 1H NMR of both crude reaction mixtures (TMB internal standard), showed a 
messy reaction profile, with no signals matching that of desired product 354. Purification of 
both reaction mixtures confirmed that no product had been generated, however starting boronic 
ester 294 was recovered from both mixtures, 63% and 55%, respectively for i) and ii).   
Though benzoate 349 has been shown to undergo lithiation and trapping with MeOD, the 
reaction outcome from the above study does not show successful lithiation-borylation. 11B 
NMR had shown a signal corresponding to a boronate complex at 5 ppm, which was consumed 
over time (11B NMR taken every 2 hr) giving rise to a boronic ester signal at 34 ppm. This 
demonstrated that boronate complex has been consumed. The two obvious pathways for the 
consumption of boronate complex are 1,2-migration (desired) and reversal of the boronate 
complex back to the lithiated species and starting boronic ester. To confirm that the lithiated 









2.4.5.4. In-situ IR Spectroscopy Studies into the Borylation of Oxetan-3-Benzoate 
 
 
Figure 20: Lithiation-borylation of oxetan-3-benzoate 349 using in-situ IR spectroscopy. 
 
For the lithiation-borylation of benzoate 349, in-situ IR spectrsoscopy was conducted at the 
same conditions as the optimised conditions for the cyclobutyl benzoate 292 substrate, no 
solvent exchange was made (Figure 20). The lithiation of 349 is rapid (yellow line, OTIBCO= 
1729 cm-1) with full consumption of starting benzoate 349 within 1 min, giving rise to lithiated 
species 351 (orange line, LiTIBCO= 1651 cm
-1), which was left to stir at -78 ˚C for 15 mins. 
This time was chosen due to the previously established t½= ~13 mins. The in-situ IR 
spectroscopy study confirmed the chemical instability of lithiated species derived from 349, 
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gives rise to boronate complex 355 (blue line, B-ate-CO= 1672 cm
-1) and lithiated species 351 
are consumed as the signal declines. The reaction sample was refluxed and left to stir for 7 hrs, 
with no solvent exchange. The 1,2 migration was monitored with 11B NMR, as shown in Table 
13. 
Table 13: 11B NMR 355:294 ratio from lithiation-borylation of 349. 
Entry Time (hrs) after reflux 
started 
Boronate (355): Boronic 
ester (294) ratio 
1 3 50:50 
2 6 6:94 
3 7 0:100 
 
However, 1H NMR (with TMB as internal standard) of the crude reaction mixture sample 
showed a similar trace to that obtained from the initial test reaction, TLC also verified that 
starting boronic ester 294 (49% isolated yield) and starting benzoate 349 (15% isolated yield), 
were the only materials present in the crude. At this point it was clear that though unstable, the 
lithiated intermediate was reacting with the boronic ester and forming a boronate complex 355. 
However, the fate of the boronate complex was uncertain. It could be possible that the boronate 
complex, unable to undergo 1,2-migration may revert to starting boronic ester 294 and lithiated 
benzoate 351. The lithiated benzoate would decompose in time, leaving the boronic ester, as 
the only recovered product from the reaction. To address the fate of the 1,2-migration step a 










2.4.5.5. Two-Electrophile Test on Oxetan-3-Benzoate 
 
 
Scheme 114: Two-electrophile test for oxetanyl benzoate 349. 
 
The two-electrophile test is a one pot multi-component reaction (Scheme 115).170 Benzoate 
349, TMEDA and diethyl ether were added to the flask, which is cooled to -78 ˚C. After the 
addition of sBuLi, the reaction is stirred for 2 min at -78 ˚C. After which the boronic ester 294 
was added to the reaction mixture followed by a further 15 mins of stirring at -78 ˚C. The 
literature example leaves the reaction mixture to stir for 30 mins, however given the short 
lifetime of the lithiated species the borylation time had to be shortened. Next, allyl bromide 
(first electrophile) was added to the reaction mixture and stirred for 15 mins at -78 ˚C. The 
purpose of this electrophile is to trap unreacted lithiated benzoate 351 to give allylation product 
356. Finally, D2O (the second electrophile) was added to the reaction mixture, with a further 
15 mins of stirring at -78 ˚C. The D2O will lead to the formation of D-incorporated benzoate 
350, should the boronate complex 355 be reversible and revert to lithiated benzoate 351. This 
renders the two-electrophile test a powerful tool for identifying issues with the reactivity of 
351 (k1 and k4), the boronate step (k2) and reversibility of borylation (k-1 and k3). 
 
From this experiment, it is conclusive that the lithiated species 351 reacts with boronic ester 
294 to form boronate complex 355. As no allylated product 356 was obtained from this 
experiment, it also confirms that within 15 minutes of reaction time all the lithiated benzoate 
351 has been consumed. However, failure to obtain the desired boronic ester 354 (k2), suggests 
that there is an issue with the 1,2-migration step. Post-reaction recovery gave only D-
incorporated benzoate 350 (51%) (k3) and starting boronic ester 294 (60%), therefore verifying 






Scheme 115: Two-electrophile test reaction pathways for benzoate 349. 
 
Interestingly, changing from cyclobutane to oxetane renders boronate complex formation 
reversible. This could be due to inductive effects of the oxygen in the ring which makes the 
lithiated oxetane more stable. No further studies were conducted on the lithiation-borylation of 
oxetane benzoate 349. 
 
2.4.5.6. Synthesis of Azetidine Benzoate 
 
There have been literature reports into the lithiation-electrophile trapping of the 2-position of 
N-thiopivaloyl/ tertbutoxythiocarbonyl-azetidines (Scheme 116), where a range of 
electrophiles were tolerated.260,261 The ring-lithiation of the 2-positions of azetidines does not 
occur when a Boc group is used.260 Neither the study into the lithiation of 3-subsituted azetidine 








Scheme 116: Synthesis of azetidine benzoate 358 via Mitsunobu esterification. 
 
Azetidine benzoate 358 was synthesised via Mitsunobu esterification in 57% yield from the 
corresponding alcohol 357, in which the TIBOH was the limiting reagent. As shown by 
Hodgson et. al.260, the lithiation of N-Boc azetidine 2-position 362 was unsuccessful (Scheme 
117) and therefore lithiated species 363 was not observed. Instead, it was found that ring-
lithiation 360 was only possible when using thiopivaloyl protecting group (Botc) 359, which 
gave various 2-substituted products upon reacting with suitable electrophiles 361. Thus the 











2.4.5.7. In-situ IR Spectroscopy Study of Azetidine Benzoate 
 
Having successfully, synthesised compound 358, focus turned to evaluation of lithiation-
borylation parameters for 358, by in-situ IR spectroscopy study of the benzoate. For this 
reaction (Figure 21), 1.0 eq. azetidine benzoate 358, 1.2 eq. TMEDA/ sBuLi in diethyl ether (1 
mL, 0.35 M) were used for lithiation at -78 ˚C for 12 mins (length of time determined by 
monitoring changes to IR spectra over time), after which boronic ester 294 (1.2 eq.) in diethyl 
ether (0.5 mL) was added to the reaction mixture and left to stir at -78 ˚C for 15 mins. The 
reaction mixture was left to reflux in Et2O for 7 hours and then the reaction mixture analysed 
by 11B NMR and subsequent isolation of reaction species. However, the reaction failed to give 
































Boc at 1710 cm-1 LiOTIB at 1607 cm-1 C=C at 1659 cm-1
New NBoc at 1691 cm-1 TIB at 1734 cm-1





As shown by the red (ROTIBC=O = 1734 cm
-1) and black (NBocC=O = 1710 cm
-1) traces, 
addition of sBuLi to the reaction mixture at 7.37 mins results in a decrease in intensity for both 
IR signals, though this could be a result of solvent dilution effects, as observed previously in 
other in-situ IR spectroscopy studies. The presence of lithiated benzoate (light grey trace) 
(LiOTIBC=O = 1607 cm
-1) however, suggests that 358 is undergoing a side-reaction, in which 
the OTIB group is being eliminated from azetidine benzoate 365 to give azetidene 366 (Scheme 
118). This type of reaction has been observed by Hodgson et. al., where they report the 
elimination of the methoxy group in tert-Butyl 3-methoxyazetidine-1-carboxylate 367, via a 
lithiation-elimination pathway 368 to 366.256 Then 366 can undergo an additional lithiation in 
the presence of excess sBuLi to give 369, which can be trapped through deuteration (MeOD) 
to give 370. In a similar manner, it is proposed that a formal lithiation of 358 occurs followed 
by elimination of the OTIB group.  
 
It is also important to note that no pre-lithiation complex between the NBoc group and sBuLi/ 
TMEDA was observed (~1675 cm-1) in the reaction before the elimination reaction occurred. 
There was also no evidence of ring lithiation at α-CH-OTIB (~1640 cm-1). The reaction was 
left to stir at -78 ˚C for 15 mins, however the profile of the reaction IR did not change over this 
period. Subsequently, boronic ester 294 was added to the reaction mixture and left to stir at -78 
˚C for 30 mins. The addition of boronic ester showed a further drop in signal intensity, however, 
the uniformity of the change suggests this could be a result of dilution effects. This was 
confirmed to be the case when no desired products or side-products with boronic ester 
incorporation were obtained after crude 1H NMR of the reaction mixture. Instead, only the 
starting boronic ester 294 was observed in 73% NMR yield (TMB internal standard). There 
were also NMR signals present in the crude composition that suggested side-product 366 had 






Scheme 118: Proposed lithiation-deuteration mechanism of azetidine benzoate 358. 
 
 
2.4.5.8. Lithiation-Deuteration Study of Azetidine Benzoate 
 
Having failed to obtain desired azetidine boronic ester 364, further studies were taken to 
understand the lithiation profile of this substrate. Although it was suspected that lithiation was 
not taking place, lithiation-deuteration study was conducted (Scheme 119), to elucidate any 
side-product pathways occurring. Furthermore, the addition of MeOD would act to trap any 
lithiated 369, which is formed due to the unsaturated and more strained 2-azetidene, undergoing 
lithiation as shown in Scheme 118. The crude reaction mixture was filtered through a small 
plug of silica (to remove salts), concentrated, and submitted for 1H NMR analysis with internal 
standard (TMB). The results from the NMR would help to determine the ratio of 





Scheme 119: Proposed lithiation-deuteration study of azetidine benzoate 358. 
 
The deuteration study confirmed the proposed reaction pathway, whereby no ring lithiation-
deuterations products were obtained (371). Similarly, 366 was also not present from crude 
NMR comparisons with literature, suggesting that 366 is short lived in the presence of sBuLi. 
The only products obtained from the reaction are 370 (30%) and starting benzoate 358 (15%). 
As this side-pathway is the only reaction taking place in this reaction, this would suggest that 
azetidine benzoate 358 is not a suitable substrate for lithiation-borylation. For this reason, 










A range of suitable cyclobutyl-containing substrates were synthesised to explore the lithiation-
borylation pathway. The Mitsunobu esterification of cyclobutanol to synthesise 292 was 
difficult due to partial rearrangement of cyclobutanol, giving an inseparable, 
cyclopropylmethyl 2,4,6-triisopropylbenzoate 293. However, to our advantage, 
cyclopropylmethyl 2,4,6-triisopropylbenzoate 293  ̧ did not affect the lithiation-borylation 
reaction outcome. Subsequently, we have shown cyclobutyl 2,4,6-triisopropylbenzoate 292, 
undergoes rapid lithiation and reaction with boronic esters. 
 
 
Scheme 120: Optimised Mitsunobu esterification of cyclobutyl 2,4,6-triisopropylbenzoate 292. 
 
The lithiation–borylation methodology for cyclobutane benzoates has been established 
(Scheme 121) and the methodology has been successfully tested against a range of boronic 
ester substrates, as shown in Figure 22. The scope explored demonstrates that this methodology 
is applicable to a range of substrates, provides an additional tool to the well-established 
lithiation-borylation methodologies and allows access to 1,1-disubstituted cyclobutyl boronic 
esters. 
 
Scheme 121: Methodology for lithiation borylation of cyclobenzoate 292. 
 
Furthermore, boronic ester 311 was successfully reacted in functional group interconversions, 









A range of modified cyclobutyl motifs have been test against the established methodology, 
though the reaction outcomes have been unsuccessful with no lithiation-borylation observed. 
Subsequent, in-situ IR spectroscopy studies allowed an in depth understanding of the difficulty 
in performing the methodology with these benzoates (Figure 23). Here it was shown that 
benzoate 335 could not be synthesised by Mitsunobu due to competing ring rearrangement 
which gave only the cyclopropyl benzoate 337. Similarly, 342 failed to undergo lithiation under 
tested conditions and 344 underwent lithiation and electrophile trapping (TMSCl), at the NMe 
group instead of the ring CH. 
 
Figure 23: Failed benzoate motifs. 
 
Finally, oxetane benzoate 349 and azetidine benzoate 358 were also synthesised via Mitsunobu 
esterification (Figure 24). 
 
Figure 24: Study into the lithiation-borylation of oxetane benzoate 349 and azetidine benzoate 358. 
 
However, these small-ring molecules proved challenging in lithiation-borylation methodology. 




chemically unstable and degraded over time. The subsequent trapping of the species was also 
achieved using test boronic ester 294, however a two-electrophile test confirmed the boronate 
complex to be reversible. Similarly, the studies into the lithiation-borylation of azetidine 
benzoate 358, were also difficult, due to a competing side reaction, whereby substrate 358, was 
undergoing E2 elimination, with loss of OTIB, to generate the unsaturated azetidene 366. Then 
azetidene 366, can undergo lithiation in the presence of sBuLi to give azetidene 369 
intermediate, which have been shown to undergo electrophile trapping to give 370 in previous 
literature reports.256 However, the side-reaction means that 358 is not suitable for this 





3. Experimental  
Parts of the experiemental have been adapted from the following articles: 
Pulis, A. P.; Varela, A.; Citti, C.; Songara, P.; Leonori, D.; Aggarwal, V. K., Angew. Chem. Int. Ed. 
2017, 56, 10835. 
& 
Mykura, R. C.; Songara, P.; Luc, E.; Rogers, J.; Stammers, E.; Aggarwal, V. K., Angew. Chem. Int. 
Ed. 2021, Article ASAP. DOI: 10.1002/ange.202101374 (accessed 05-03-2021) 
3.1. General Information 
 
Anhydrous solvents were either dried using an Anhydrous Engineering alumina column drying 
system (THF, toluene, CH2Cl2) or obtained as Acroseal bottles and used directly. All other 
employed solvents were reagent grade solvents and were used directly. Petroleum ether refers 
to the fraction collected between 40 – 60 °C. Reactions requiring anhydrous conditions (where 
specified) were conducted under a N2 / Argon atmosphere using standard Schlenk techniques 
unless otherwise stated. All reagents were purchased from commercial sources and used as 
received, unless otherwise stated. Flash column chromatography was carried out using Aldrich 
silica gel (40-63 μm) or on a Biotage isolera one machine (following λall) using the column 
and gradient specified (CV = column volumes). Reactions were monitored by thin-layer 
chromatography (TLC) when practical, using Merck Kieselgel 60 F254 fluorescent treated 
silica which was visualized under UV light (254 nm) or by staining with an aqueous basic 
potassium permanganate or p-anisaldehyde solution or ninhydrin as stated. 1H NMR spectra 
were recorded using either Jeol ECS/ECZ 400 MHz, Bruker 101 MHz, Bruker Cryo 500 MHz, 
or Varian VNMR (400 MHz or 500 MHz) spectrometers. Chemical shifts (δ) are given in parts 
per million (ppm) and coupling constants (J) are given in Hertz (Hz) and reported to the nearest 
0.1 Hz. 13C NMR spectra were recorded using either Jeol ECS/ECZ 400 MHz Varian VNMR 
400 (101 MHz or 126 MHz), Bruker 101 MHz or Bruker Cryo 500 (126 Hz) spectrometers. 
NMR assignments for all compounds reported were determined using a combination of 1H 
NMR, 13C NMR, Heteronuclear Single Quantum Coherence (HSQC), Heteronuclear Multiple 
Bond Correlation (HMBC), DEPT-135 and NOE (where applicable). High resolution mass 
spectra (HRMS) were recorded on a Bruker Daltonics Apex IV by Electrospray Ionisation 





selected absorption maxima (νmax) are reported in wavenumbers (cm
-1). Melting points were 
recorded in degrees Celsius (°C) using a Stuart SMP30 melting point apparatus. Optical 
rotations ([α]D T) were measured on a Bellingham & Stanley Ltd. ADP 220 polarimeter. 
ADP220 polarimeter and is quoted in (° mL)(g dm)-1. Chiral HPLC was performed on a HP 
Agilent 1100 with an isocratic gradient and a specified column eluting iPrOH/hexane at a given 
temperature, monitoring by DAD (Diode Array Detector). 
 
3.2. Chapter 1 
3.2.1. Synthesis of Starting Materials 
 
2,4,6-Triisopropylbenzothioic S-acid (123)  
Route 1: TIBCl – Acyl chloride thiolation 
 
NOTE: Exclusion of oxygen from the reaction mixture and crude product at all staged is crucial 
to avoid significant formation of the corresponding disulfide of 124.  
 
A suspension of NaS2 (3.29 g, 42.2 mmol) and 2,4,6-triisopropylbenzoyl chloride (5.62 g, 
21.1 mmol) in THF (45 mL) was heated at reflux overnight (~16 hrs) under a N2 atmosphere. 
The reaction was allowed to reach ambient temperature and the reaction vessel was connected 
to a gas trap containing 6 M NaOH(aq.). A long needle attached to a N2 line was inserted through 
a septa of the reaction vessel. The reaction vessel was placed under a positive pressure of N2 
(through the long needle) to create a steady stream of bubbles through the NaOH trap. The 
needle attached to the N2 line was positioned below the level of the solvent to create a steady 
stream of N2 bubbles though the reaction mixture. The reaction was quenched with the slow 
addition of 2 M HCl in Et2O (55 mL) (see Figure 25, below). The reaction was stirred for 1 hr 
while N2 was bubbled through the reaction mixture. The solvent was then removed in vacuo. 





transferred via cannula onto a silica pad under N2 and the filtrate collected into a pre-weighed 
Schlenk flask (see Figure 25, below). The reaction flask was washed with a mixture of pentane 
and Et2O (1:1 v.v, 2 × 50 mL), transferring the washings onto the silica filter cake and 
collecting the filtrate into the same Schlenk flask as before. The solvent was removed in vacuo 
to give thiobenzoic acid 123 (5.01 g, 89%) as a pale green solid that contained approximately 
5 mol% of the corresponding disulfide 124. Thioic acid 123 was stored under N2 to prevent 
disulfide formation.  
 
Thioacid (123)  
1H NMR (400 MHz, CDCl3):  = 7.02 (2H, s, H4), 3.16 (2H, hept., J = 7.0 Hz, H6), 2.90 (1H, 
hept., J = 7.0 Hz, H2), 1.27 (12H, d, J = 7.0 Hz, H7), 1.26 (6H, d, J = 7.0 Hz, H1) ppm;  
13C NMR (101 MHz, CDCl3):  = 196.8 (C9), 150.7 (C3), 143.5 (C5), 137.1 (C8), 121.2 (C4), 
34.4 (C2), 30.8 (C6), 24.3 (C7), 23.9 (C1) ppm; 
IR (νmax/ cm
-1, neat): 2961, 2929, 2869, 1682, 1669, 1604, 1458, 947, 825; 
HRMS (ESI) calc. for [C16H24OS + H]




1H NMR (400 MHz, CDCl3):  = 7.08 (4H, s, H4), 3.21 (4H, hept., J = 7.0 Hz, H6), 2.94 (2H, 
hept., J = 7.0 Hz, H2), 1.27-1.37 (36H, m, H1/H7) ppm; 
13C NMR (101 MHz, CDCl3):  = 192.4 (C9), 151.5 (C3), 145.6 (C5), 133.1 (C8), 121.3 (C4), 
34.5 (C2), 30.7 (C6), 24.4 (C7), 23.9 (C1) ppm;  
IR (νmax/ cm
-1, neat): 2962, 2929, 2870, 1717, 1603, 1462, 865; 
HRMS (ESI) calc. for [C32H46O2S2 + Na]







Figure 25: Apparatus and set up for workup during the synthesis of thio acid 122. A: during HCl quench. B: for 
filtration through silica gel. 
 
Route 2 – Lawesson’s reagent route 
Using a modified procedure reported by Danishefsky et al.1, a large flame-dried microwave 
vial (fitted with a suba seal) and a flame-dried round-bottom flask were both purged with N2 
gas. Then, the round-bottom flask was charged with 2,4,6-triisopropylbenzoic acid (TIBOH) 
(1.00 g, 4.00 mmol, 1.00 eq.), Lawesson’s reagent (1.63 g, 2.20 mmol, 0.55 eq.) and CH2Cl2 
(10 mL) followed by stirring at RT for 1 min to dissolve the suspension. The solution was then 
transferred to the microwave vial by syringe. Next, the suba seal, whilst under positive N2 
pressure was rapidly replaced with a microwave vial cap and crimped immediately. The sample 
was irradiated with a microwave irradiator for 15 mins at 80 ˚C. The resultant solution was 
cooled to RT and then the solution was transferred via cannula onto a silica pad under N2 and 
the filtrate collected into a pre-weighed Schenk flask (see Figure 25). The reaction flask was 
washed with a mixture of pentane and Et2O (1:1 v.v, 2 × 15 mL), transferring the washings 
onto the silica filter cake and collecting in the same Schlenk flask. The solvent was removed 
in vacuo to give thiobenzoic acid 123 (880 mg, 83%) as a pale green solid. 
 











Following a modified procedure from Titu and Chadha262, to a stirred solution of (E)-4-
phenylbut-3-en-2-one (20.0 g, 0.137 mol) in MeOH (50 mL) at 0 °C (salt/ice bath) under a N2 
atmosphere was added NaBH4 (5.67 g, 0.150 mol) portionwise at such a rate that the internal 
temperature did not rise above 10 °C. After stirring for 45 mins, crushed ice (10 g) was added 
followed by the slow addition of saturated NH4Cl(aq.) (25 mL) and the mixture stirred at ambient 
temperature. Once effervescence had ceased, the mixture was extracted with Et2O (4 × 70 mL), 
the combined organic phases were washed with brine, dried over MgSO4 and the solvent 
removed in vacuo. The crude material was purified by flash column chromatography (25% 
EtOAc/petrol) to give alcohol 132 (18.6 g, 92%) as a colourless oil.  
Rf = 0.20 (15% EtOAc/petrol); 
1H NMR (400 MHz, CDCl3):  = 7.41-7.37 (2H, m, H2), 7.35-7.30 (2H, m, H3), 7.25 (1H, 
m, H1), 6.59 (1H, d, J = 15.9 Hz, H5), 6.28 (1H, dd, J = 15.9, 6.3 Hz, H6), 4.50 (1H, dq, J = 
6.3, 6.3 Hz, H7), 1.76 (1H, br. s, H9), 1.39 (3H, d, J = 6.3 Hz, H8) ppm; 
13C NMR (101 MHz, CDCl3):  = 136.6 (C4), 133.5 (C5), 129.3 (C2), 128.5 (C3), 127.6 
(C1), 126.4 (C6), 68.9 (C7), 23.4 (C8) ppm. 
 












Route 1: Noyori Catalyst (98:2 e.r.) 
(S,E)-4-phenylbut-3-en-2-ol (132)  
 
 
Following a procedure from Noyori et al.,264 to a solution of (S,E)-4-phenylbut-3-en-2-ol (11.0 
g, 68.4 mmol) and potassium carbonate (18 mg, 0.10 mmol%) in iPrOH (20 mL) at ambient 
temperature was added RuCl2[(R)-DM-BINAP][(R)-DAIPEN] (16 mg, 0.10 mol%). The 
reaction flask was transferred to an autoclave, purged with N2, and then pressurised with 
hydrogen gas (50 bars). The reaction mixture was left to stir at ambient temperature for 48 hrs. 
Subsequent GCMS analysis of the reaction mixture showed quantitative conversion of starting 
material to product. The reaction mixture was filtered through Celite ® and the filter cake 
washed with CH2Cl2 after which the solvent was removed in vacuo. Next, the material was 
purified by flash column chromatography (CH2Cl2). The solvent was removed in vacuo to give 
a pale-yellow oil (11.1 g, 98%, 98:2 e.r.).  
Rf = 0.30 (CH2Cl2); 
1H NMR (400 MHz, CDCl3):  = 7.41-7.36 (2H, m, H2), 7.35-7.28 (2H, m, H3), 7.27-7.20 
(1H, m, H1), 6.56 (1H, d, J = 16.0 Hz, H5), 6.26 (1H, dd, J = 16.0, 6.3 Hz, H6), 4.50 (1H, dq, 
J = 6.3, 6.2 Hz, H7), 1.75 (1H, br. s, H9), 1.38 (3H, d, J = 6.2 Hz, H8) ppm; 
13C NMR (101 MHz, CDCl3):  = 136.8 (C4), 133.7 (C5), 129.5 (C2), 128.7 (C3), 127.8 
(C1), 126.6 (C6), 69.1 (C7), 23.5 (C8) ppm; 
IR (νmax/ cm
-1, neat): 3329, 2971, 2869, 1449, 1056, 965. 
 









Route 2: Novozyme enzymatic resolution (>99:1 e.r.) 





To a stirred mixture of allylic alcohol (19.8 g, 6.75 mmol), and freshly activated crushed 4Å 
molecular sieves (50% wt. of alcohol, 9.90 g) in pentane (60 mL) at ambient temperature, was 
sequentially added vinyl acetate (3.11 mL, 33.7 mmol) and Novozyme 435 (lipase acrylic resin 
from Candida antarctica, 1.52 g), filtering the reaction at 49% conversion after 7 hrs, followed 
by flash column chromatography (25% EtOAc/petrol) gave enantiopure (S,E)-132 (449 mg, 
45%, >99:1 e.r.) as a colourless liquid and (R,E)-133 (642 mg, 50%, 95:5 e.r.)* as a pale yellow 
liquid.  
Alcohol (132)  
Chiral HPLC (IB, 4% iPrOH/hexane) TR = 27.60 mins.  
[𝛂]𝐃
22 ‒33.4 (c 1.02, CHCl3), Lit. +33.2 for (R) (c 1.02 CHCl3, >99:1).
262  
 
Spectral data were in accordance with the literature reported racemic alcohol.  
Acetate (133)  
Rf = 0.71 (25% EtOAc/petrol); 
1H NMR (400 MHz, CDCl3):  = 7.41-7.37 (2H, m, H2), 7.35-7.30 (2H, m, H3), 7.25 (1H, m, 
H1), 6.61 (1H, dd, J = 15.9, 1.2 Hz, H5), 6.20 (1H, dd, J = 15.9, 6.6 Hz, H6), 5.54 (1H, dqd, J 
= 6.6, 6.4, 1.2 Hz, H7), 2.09 (3H, s, H10), 1.42 (3H, d, J = 6.4 Hz, H8) ppm;  
13C NMR (101 MHz, CDCl3):  = 170.3 (C9), 136.3 (C4), 131.5 (C5), 128.8 (C3), 128.5 (C3), 
127.9 (C1), 126.5 (C6), 71.0 (C7), 21.4 (C10), 20.4 (C8) ppm; 
IR (νmax/ cm
-1, neat): 2981, 1732 (C=Oacetate), 1370, 1233, 1040.  
 






Route 1 – Hydrogenation of vinylbenzene 
 
 
To a solution of (S,E)-4-phenylbut-3-en-2-ol (10.0 g, 82.9 mmol, >99:1 e.r.) in MeOH (70 mL) 
under a N2 atmosphere, was added 10% Pd on carbon (10% wt., 813 mg). The N2 atmosphere 
was flushed out with a hydrogen balloon and the mixture was stirred at ambient temperature 
and pressure for 16 hrs. The reaction mixture was filtered through a pad of Celite ® and the 
filter cake washed with Et2O (50 mL). After removal of the solvent under reduced pressure, 
the residue was purified by flash column chromatography (30% Et2O/pentane) to give (S)-4-
phenylbutan-2-ol 121 (11.1 g, 92%, 99:1 e.r.) as a colourless liquid.  
Route 2 – Epoxide ring opening 
Benzylmagnesium chloride (1 M in Et2O, 28 mL, 28 mmol, 2.0, eq.) was added dropwise to a 
solution of (S)-2-methyloxirane (813 mg, 14 mmol, 1.0 eq.) and CuI (2.6 g, 14 mmol, 1.0 eq.) 
in THF (14 mL) at −78 °C. The reaction was quenched after 2 hrs through addition of sat. 
NH4Cl (50 mL) and the aqueous phase extracted with Et2O (3 × 50 mL). The organics were 
combined, dried (MgSO4) and concentrated under reduced pressure to give an oil. 
Subsequently, purification by column chromatography (30% Et2O/pentane) gave (S)-4-
phenylbutan-2-ol 121 as an amorphous white solid (1.87 g, 89%, >99:1 e.r.).  
Rf = 0.30 (20% EtOAc/PE);  
1H NMR (400 MHz, CDCl3):  = 7.29 (2H, m, H2), 7.23-7.19 (3H, m, H1/H3), 3.84 (1H, br. 
sext., J = 6.2 Hz, H7), 2.82-2.64 (2H, m, H5), 1.86-1.72 (2H, m, H6), 1.36 (1H, s, H9), 1.24 
(3H, d, J = 6.2 Hz, H8) ppm;  
13C NMR (101 MHz, CDCl3):  = 142.0 (C4), 128.4 (C2), 128.3 (C3), 125.8 (C1), 67.5 (C7), 
40.8 (C5), 32.1 (C6), 23.6 (C8) ppm; 
[𝛂]𝐃
25 +14.8 (c 1.0, CHCl3).  
 










(S)-2-Methyl-3-phenylpropan-1-ol 134 was isolated from the epoxide ring opening reaction as 
a colourless oil (126mg, 6%). 
Rf = 0.18 (25% EtOAc/PE);  
1H NMR (400 MHz, CDCl3):  = 7.28 (2H, m, H2), 7.21-7.17 (3H, m, H1/H3), 3.54 (1H, dd, 
J = 10.5, 6.0 Hz, H7a), 3.47 (1H, dd, J = 10.5, 7.5 Hz, H7b), 2.75 (1H, dd, J = 13.5, 6.0 Hz, 
H5a), 2.42 (1H, dd, J = 13.5, 8.0 Hz, H5b), 1.95 (1H, m, H6), 1.36 (1H, br. s, H9), 0.91 (3H, 
d, J = 6.5 Hz, H8) ppm;  
13C NMR (101 MHz, CDCl3):  = 140.6 (C4), 129.2 (C2), 128.3 (C3), 125.8 (C1), 67.5 (C7), 
39.8 (C5), 37.7 (C6), 16.8 (C8) ppm. 
 
Spectral data were in accordance with the literature.267 
 
 
3.2.1.1 General Procedure for the Synthesis of S-Thiobenzoates from Secondary Alcohols 
(GP1)  
 
DIAD (325 µL, 1.65 mmol, 1.10 eq.) was added dropwise over 5 mins to a stirred solution of 
PPh3 (472 mg, 1.80 mmol, 1.20 eq.) in THF (8 mL) at 0 °C (ice) under a N2 atmosphere. After 
stirring for 20 mins at 0 °C a solution of alcohol (1.80 mmol, 1.20 eq.) and 2,4,6-
triisopropylbenzothioic S-acid (476 mg, 1.50 mmol; ca. 10 mol% of 2,4,6-triisopropylbenzoic 
dithioperoxyanhydride, 1.00 eq.) in THF (3 mL) was added and the mixture stirred at 0 °C for 
2-5 hrs. The volatiles were removed in vacuo and the residue was triturated with pentane (20 
mL). The white suspension was filtered and the filter cake washed with pentane (3 × 20 mL). 
The solvent was removed in vacuo and the residue purified by flash column chromatography 





(R)-S-(4-Phenylbutan-2-yl) 2,4,6-triisopropylbenzothioate (122) 
 
Following GP1 using (S)-4-phenylbutan-2-ol (3.11 g, 20.7 mmol, >99:1 e.r.) gave (R)-S-
thiobenzoate 122 (4.67 g, 63%, >99:1 e.r.) as a viscous colourless oil and O-thiobenzoate 122a 
(1.34 g, 18%) as a yellow oil.  
S-thiobenzoate 122:  
Rf = 0.28 (30% toluene/pentane);  
1H NMR (400 MHz, CDCl3):  = 7.35-7.29 (2H, m, H2), 7.25-7.20 (3H, m, H1/H3), 7.03 (2H, 
s, H14), 3.85 (1H, app. br. sext., J = 7.0 Hz, H7), 3.13-2.72 (5H, m, H5/H12/H16), 2.00 (2H, 
m, H6), 1.48 (3H, d, J = 7.0 Hz, H8), 1.27 (18H, br. d, J = 7.0 Hz, H13/H17) ppm; 
13C NMR (101 MHz, CDCl3):  = 198.1 (C9), 150.3 (C15), 144.4 (C11), 141.6 (C4), 135.8 
(C10), 128.5 (C2), 128.4 (C3), 126.0 (C1), 121.0 (C14), 40.1 (C7), 38.1 (C5), 34.4 (C16), 33.4 
(C6), 30.6 (C12), 24.5 (br. s, C13), 23.9 (C17), 21.5 (C8) ppm; 
IR (νmax/ cm
-1, neat): 2960, 2927, 2868, 1675 (C=OTIB), 1657, 1456, 1206, 895, 698; 
Elemental analysis: calc. for C26H36OS: C, 78.73; H, 9.15. Found: C, 78.25; H, 9.00;  
HRMS (CI) calc. for [C26H36OS + H]
+ 397.2565. Found 397.2569; 
LRMS (CI): 397.3, 231.2 (basepeak); 
[𝜶]𝑫
25 −22.0 (c 3.0, CHCl3);  












Rf = 0.65 (30% toluene/pentane);  
1H NMR (400 MHz, CDCl3):  = 7.35-7.29 (2H, m, H2), 7.25-7.20 (3H, m, H1/H3), 7.02 (1H, 
s H14), 7.01 (1H, s, H14), 5.90 (1H, app. br. sext., J = 6.2 Hz, H7), 3.13 (1H, hept., J = 7.0 Hz, 
H12 or H12”), 3.01 (1H, hept., J = 7.0 Hz, H12 or H12”), 2.90 (1H, hept., J = 7.0 Hz, H16), 
2.85-2.67 (2H, m, H5), 2.26-2.16 (1H, m, H6), 2.06-1.96 (1H, m, H6), 1.49 (3H, d, J = 6.2 Hz, 
H8), 1.23-1.30 (18H, m, H13/H17) ppm; 
13C NMR (101 MHz, CDCl3):  = 218.9 (C9), 149.0 (C15), 143.4 (C11), 143.3 (C11), 141.3 
(C4), 138.8 (C10), 128.5 (C2), 128.3 (C3), 126.0 (C1), 121.03 (C14), 120.98 (C14), 78.6 (C9), 
37.3 (C6), 34.3 (C16), 31.7 (C5), 30.8 (C12 or C12”), 30.4 (C12 or C12”), 24.5 (C13), 24.4 






-1, neat):  2959, 2927, 2868, 1605, 1457, 1223, 696;  
HRMS (CI) calc. for [C26H36OS + H]
+ 397.2565. Found 397.2551;  
LRMS (CI): 397.3, 265.2 (basepeak), 231.2; 
[𝜶]𝑫
25 +9.8 (c 3.06, CHCl3). 
 
S-((cis)-4-(tert-Butyl)cyclohexyl) 2,4,6-triisopropylbenzothioate (104) 
 
 
Following GP1 using trans-4-tert-butylcyclohexanol (344 mg, 2.20 mmol, >20:1 trans:cis, 
obtained after flash column chromatography of commercially available cis/trans mixture) gave 
cis-thiobenzoate 104 (523 mg, 64%, >20:1 cis:trans) as an amorphous solid. 
Rf = 0.31 (20% toluene/pentane);  
1H NMR (400 MHz, CDCl3):  = 7.01 (2H, s, H12), 4.22 (1H, br. m, H6), 3.01 (2H, hept., J = 
7.0 Hz, H10), 2.90 (1H, hept., J = 7.0 Hz, H14), 2.04 (2H, br. d, J = 13.9 Hz, H5a), 1.83 (2H, 
tt, J = 13.9, 3.6 Hz, H5b), 1.71 (2H, br. d, J = 12.7 Hz, H4a), 1.26 (18H, br. d, J = 7.0 Hz, 
H11/H15), 1.29-1.17 (2H, m, H4b), 1.05 (1H, tt, J = 12.0, 3.0 Hz, H3), 0.85 (9H, s, H1) ppm. 
Many of the small vicinal couplings on the 6-membered ring were not resolved and gave broad 
lines; 
13C NMR (101 MHz, CDCl3):  = 197.9 (C7), 150.2 (C13), 144.4 (C9), 136.1 (C8), 121.0 
(C12), 47.8 (C6), 42.3 (C3), 34.4 (C14), 32.5 (C2), 31.9 (C5), 30.6 (C10), 27.3 (C1), 24.4 (br. 
s, C11), 23.9 (C15), 23.3 (C4) ppm; 
M.P: 89-91°C (EtOAc); 
IR (νmax/ cm
-1, neat): 2957, 2863, 1674 (C=OTIB), 1362, 899; 
HRMS (ESI) calc. for [C26H42OS+Na]
+ 425.2849. Found 425.2869; 
[𝛂]𝐃










Following GP1 using cholesterol (1.00 g, 2.59 mmol) gave thiobenzoate 143 (540 mg, 32%) 
as a white foam. 
Rf = 0.45 (20% toluene/pentane); 
1H NMR (400 MHz, CDCl3): δ = 6.97 (2H, s, H2), 5.35-5.26 (1H, m, H9), 4.21 (1H, pent., J 
= 3.0 Hz, H6), 2.99 (2H, m), 2.85 (2H, m), 2.25 (1H, m), 2.09 (2H, m), 1.99 (2H, m), 1.83 (2H, 
m), 1.72 (1H, m), 1.53 (4H, m), 1.34 (4H, m), 1.24 (20H, m), 1.11 (4H, m), 1.03 (3H, s), 0.99 
(3H, m), 0.92 (3H, d, J = 6.7 Hz), 0.87 (6H, dd, J = 6.7, 1.6 Hz), 0.67 (3H, s) ppm; 
13C NMR (101 MHz, CDCl3): δ = 198.2 (C5), 150.2 (C1), 144.4 (C3), 139.0 (C8), 136.1 (C4), 
122.8 (C9), 121.0 (C2), 56.7 (CH), 56.1 (CH), 50.2 (CH), 43.9 (C6), 42.2 (4º C), 39.7 (CH2), 
39.5 (CH2), 37.6 (CH2), 37.2 (CH2), 36.2 (CH2), 35.8 (CH2), 35.7 (4º C), 34.4 (CH), 31.9 (CH2), 
31.7 (CH), 30.6 (2 x CH), 28.2 (CH2), 28.0 (CH), 27.3 (CH2), 24.4 (4 x CH3), 24.0 (2 x CH3), 
23.8 (CH3), 22.8 (CH3), 22.6 (CH3), 20.7 (CH2), 19.3 (CH3), 18.7 (CH3), 11.9 (CH3) ppm; 
IR (νmax/ cm
-1, neat): 2958, 1676 (C=OTIB), 1460, 1206, 896; 
HRMS (ESI) calc. for [C43H68OS + Na]
+ 655.4883. Found 655.4853; 
[𝛂]𝐃











S-((1S,2S,5R)-2-isopropyl-5-methylcyclohexyl) 2,4,6-triisopropylbenzothioate (144) 
 
Following GP1 using (‒)-menthol (338 mg, 2.16 mmol) gave thiobenzoate 144 (108 mg, 15%, 
>20:1 cis:trans) as an amorphous solid.  
Rf = 0.45 (20% toluene/pentane); 
1H NMR (400 MHz, CDCl3): δ = 7.00 (2H, s, H17), 4.34 (1H, br. s, H5), 3.01 (2H, hept., J = 
7.0 Hz, H15), 2.89 (1H, hept., J = 7.0 Hz, H19), 2.03 (1H, br. d, J = 13.8 Hz, H3), 1.86 (1H, 
m, H7), 1.78-1.64 (2H, m, H4/H8), 1.55-1.37 (2H, m, H2/H3), 1.25 (18H, br. d, J = 7.0 Hz, 
H16/H20), 1.22 (1H, m, H6), 1.00-0.87 (2H, m, H4/H7), 0.97 (3H, br. d, J = 6.6 Hz, H11a), 
0.92 (3H, br. d, J = 6.6 Hz, H11b), 0.91(3H, br. d, J = 6.2 Hz, H1) ppm. Many of the small 
vicinal couplings on the 6-membered ring were not resolved and gave broad lines;  
13C NMR (101 MHz, CDCl3): δ = 197.8 (C12), 150.4 (C18), 144.5 (C14), 136.5 (C13), 121.1 
(C17), 47.7 (C6), 46.0 (C5), 42.1 (C3), 35.2 (C4), 34.6 (C19), 31.0 (C2), 30.8 (C15), 28.4 (C8), 
28.0 (C7), 24.5 (br. s, C16), 24.1 (C20), 22.3 (C1), 21.2 (C11), 20.7 (C11) ppm;  
HRMS (ESI) calc. for [C26H42OS + Na]
+, 425.2953. Found, 425.2945; 
IR (νmax/cm
−1, neat): 2956, 2860, 1675 (C=OTIB), 1366, 898; 
[𝜶]𝐃










3.2.2. Lithiation and Electrophilic Trapping of Dialkyl S-Thiobenzoates 
 
3.2.2.1. General Procedure for Lithiation/Electrophilic Trapping of Dialkyl S-Thiobenzoates 
(GP2)  
sBuLi (1.3 M in hexane, 1.20 eq., 230 µL, 0.30 mmol) was added dropwise over 2 mins to a 
vigorously stirred solution (without splashing) of S-thiobenzoate 122 (1.00 eq., 0.250 mmol) 
and TMEDA (1.20 eq., 0.30 mmol, 35 µL) in anhydrous TBME (1.5 mL) at –78 °C under a N2 
atmosphere. After the specified time, a solution of the electrophile (2.00 eq., 0.50 mmol) in 
TBME (0.25 mL) was added dropwise over 2 mins. The reaction mixture was stirred at –78 °C 
for 1 hr and then the cooling bath was removed. The reaction was allowed to reach RT and was 
quenched with H2O (2 mL) or sat. NH4Cl(aq) (2 mL). The phases were separated and the 
aqueous phase was extracted with Et2O (4 × 15 mL). The combined organic phases were 
washed with brine and dried over MgSO4. The solvent was removed in vacuo and the crude 
material purified by flash chromatography to give pure S-benzothioate. 
 
 (R)-2-methyl-4-phenyl-2-((2,4,6-triisopropylbenzoyl)thio)butanoate (150) 
 
Following a GP2 using (R)-S-benzothioate 122 (41 mg, 0.12 mmol, >99:1 e.r.) and methyl 
chloroformate (57 µL, 0.74 mmol) and purification by flash chromatography (5% 
Et2O/pentane) gave thiobenzoate 150 (42 mg, 88%, 96:4 e.r.) as a colourless oil.  
Rf = 0.42 (5% Et2O/pentane);  
1H NMR (400 MHz, CDCl3):  = 7.29 (2H, m, H2), 7.22-7.15 (3H, m, H1/H3), 7.00 (2H, s, 
H14), 3.79 (3H, s, H19), 3.11 (2H, hept., J = 7.0 Hz, H12), 2.89 (1H, hept., J = 7.0 Hz, H16), 
2.75 (1H, ddd, J = 13.5, 10.2, 7.1 Hz, H5a), 2.67 (1H, ddd, J = 13.5, 10.2, 6.9 Hz, H5b), 2.25 





13C NMR (101 MHz, CDCl3):  = 197.1 (C9), 173.5 (C18), 150.8 (C15), 144.9 (C11), 141.0 
(C4), 134.5 (C10), 128.5 (C2), 128.3 (C3), 126.1 (C1), 121.0 (C14), 55.9 (C19), 52.7 (C7), 
39.9 (C6), 34.4 (C16), 31.2 (C5), 30.3 (C12), 24.4 (br. s, C13) 23.9 (C17), 23.5 (C8) ppm;  
IR (νmax/cm
−1, neat): 1739 (C=Oester), 1678 (C=OTIB), 1459;  
HRMS (ESI) calc. for [C28H38O3S + Na]
+ 477.2434. Found 477.2441;  
[𝛂]𝐃
22 + 11 (c 1.0, CHCl3); 



















Following a GP2 using (R)-S-benzothioate 122 (99 mg, 0.25 mmol, >99:1 e.r.) and benzyl 
isocyanate (62 µL, 0.50 mmol) and purification by flash chromatography (5% Et2O/pentane) 
gave thiobenzoate 151 (67 mg, 70 %, 96:4 e.r.) as a white solid.  
Rf = 0.42 (5% Et2O/pentane); 
1H NMR (400 MHz, CDCl3):  = 7.41-7.35 (5H, m, H22/H23/H24), 7.31 – 7.26 (3H, m, 
H1/H3), 7.22 – 7.14 (2H, m, H2), 6.97 (2H, s, H14), 4.53 (1H, d, J = 1.7 Hz, H20a), 4.51 (1H, 
d, J = 1.7 Hz, H20b), 2.89 (3H, hept., J = 7.0 Hz, H12/H16), 2.78 (1H, m, H5a), 2.68 (1H, m, 
H5b), 2.37 – 2.28 (2H, m, H6), 1.83 (3H, s, H8), 1.24 (6H, d, J = 7.0 Hz, H17), 1.17 (12H, d, J 
= 7.0 Hz, H13) ppm; 
13C NMR (101 MHz, CDCl3):  = 198.2 (C9), 172.3 (C18), 151.1 (C15), 144.6 (C11), 141.0 
(C4), 138.1 (C21), 134.4 (C10), 128.8 (C23), 128.5 (C2), 128.4 (C3), 127.9 (C22), 127.5 (C24), 
126.1 (C1), 121.1 (C14), 57.7 (C7), 44.4 (C20), 40.3 (C6), 34.4 (C12), 31.1 (C5), 30.7 (C16), 
24.2 (br. s, C13), 23.9 (C17), 22.7 (C8) ppm; 
IR (νmax/cm
−1, neat): 3346 (NH), 1674 (C=OTIB), 1650 (C=OCONH); 
HRMS (ESI) calc. for [C34H43NO2S + Na]
+ 552.2901. Found 552.2907;  
[𝛂]𝐃
22 + 6 (c 1.0, CHCl3); 























Following GP2 using (R)-S-benzothioate 122 (50 mg, 0.13 mmol, >99:1 e.r.) and 4-
bromophenyl isocyanate (99 mg, 0.50 mmol) and purification by flash chromatography (2% 
Et2O/pentane) gave thiobenzoate 152 (60 mg, 80%, 98:2 e.r.) as a white solid.  
Rf = 0.40 (2% Et2O/pentane);  
1H NMR (400 MHz, CDCl3):  = 9.18 (1H, s, H19), 7.51-7.43 (4H, m, H21/H22), 7.33 – 7.27 
(2H, m, H2), 7.24 – 7.18 (3H, m, H1/H3), 7.00 (2H, s, H14), 2.89 (3H, hept., J = 7.0 Hz. 
H12/H16), 2.78 (1H, m, H5a), 2.68 (1H, m, H5b), 2.37 – 2.28 (2H, m, H6), 1.83 (3H, s, H8), 
1.24 (6H, d, J = 7.0 Hz, H17), 1.17 (12H, d, J = 7.0 Hz, H13) ppm; 
13C NMR (101 MHz, CDCl3):  = 198.2 (C9), 172.3 (C18), 151.1 (C15), 144.6 (C11), 141.0 
(C4), 138.1 (C20), 134.4 (C10), 132.2 (C22), 128.5 (C2), 128.4 (C3), 126.1 (C1), 121.4 (C21), 
121.1 (C14), 116.9 (C23), 57.7 (C7), 40.3 (C6), 34.4 (C16), 31.1 (C5), 30.7 (C12), 24.7 (br. s, 
C13), 23.9 (C17), 22.4 (C8) ppm;  
IR (νmax/cm
−1, neat): 3346 (NH), 1674 (C=OTIB), 1650 (C=OCONH); 
HRMS (EI) calc. for [C33H40NO2BrS]
+ 593.1963. Found 593.1971; 
[𝛂]𝐃
22 + 5 (c 1.0, CHCl3); 








(R)-S-(2-methyl-1-oxo-4-phenylbutan-2-yl) 2,4,6-triisopropylbenzothioate (153) 
 
Following a GP2 using (R)-S-benzothioate 122 (99 mg, 0.25 mmol, >99:1 e.r.) and N,N-
dimethyl formamide (39 μl, 0.50 mmol) and purification by flash chromatography (5% 
Et2O/pentane) gave thiobenzoate 153 (76 mg, 72%, 94:6 e.r.) as an oil.  
Rf = 0.27 (5% Et2O/pentane);  
1H NMR (400 MHz, CDCl3):  = 9.69 (1H, s, H19), 7.33-7.27 (2H, m, H2),  7.24-7.15 (3H, 
m, H1/H3), 7.01 (2H, s, H14), 3.05 (2H, hept., J = 7.0 Hz, H12), 2.89 (1H, hept., J = 7.0 Hz, 
H16), 2.77 (1H, app. td, J = 12.5, 5.3 Hz, H5a), 2.69 (1H, app. td, J = 12.5, 5.3 Hz, H5b), 2.25 
(1H, ddd, J = 14.3, 12.5, 5.3 Hz, H6a), 2.14 (1H, ddd, J = 14.3, 12.5, 5.3 Hz, H6b), 1.64 (3H, 
s, H8), 1.25 (18H, br. d., J = 7.0 Hz, H13/H17) ppm; 
13C NMR (101 MHz, CDCl3):  = 198.4 (C18), 197.1 (C9), 151.2 (C15), 144.8 (C11) 141.0 
(C4), 128.7 (C2), 128.4 (C3), 126.5 (C1), 121.3 (C14), 60.7 (C7), 36.7 (C6), 34.6 (C16), 30.9 






−1, neat): 1727 (C=OALD), 1675 (C=OTIB), 1654, 1456; 
HRMS (EI) calc. for [C27H36O2S + Na]
+ 447.2328. Found 447.2327; 
[𝛂]𝐃
22 + 11.3 (c 1.0, CHCl3); 








Following a GP2 using (R)-S-benzothioate 122 (99 mg, 0.25 mmol, >99:1 e.r.) and 
benzaldehyde (50 µL, 0.50 mmol) and purification by flash chromatography (10% 
EtOAc/petroleum ether) gave thiobenzoate 154 (80 mg, 64 %, 1:1.5 d.r.) as an oil. Further 
purification by preparative HPLC (5% EtOAc/hexane) gave diastereomer A (22 mg, 23%, 98:2 






Diastereomer A:  
Rf = 0.34 (10% EtOAc/petroleum ether); 
1H NMR (400 MHz, CDCl3):  = 7.43 (2H, m, H2), 7.36 – 7.25 (5H, m, H20/H21/H22), 7.22 
– 7.15 (3H, m, H1/H3), 7.01 (2H, s, H14), 5.30 (1H, br. d, J = 4.0 Hz, H23), 3.87 (1H, br. d, J 
= 4.0 Hz, H18), 3.16 (2H, hept., J = 7.0 Hz, H12), 3.00-2.85 (2H, m, H5a/H16), 2.81-2.65 
(2H, m, H5b/H6a), 1.97 (1H, app. td, J = 11.4, 3.3 Hz, H6b), 1.36 (3H, s, H8), 1.28 (6H, d, J 
= 7.0 Hz, H17), 1.25 (12H, d, J = 7.0 Hz, H13) ppm; 
13C NMR (101 MHz, CDCl3):  = 200.8 (C9), 150.9 (C15), 144.7 (C11), 141.8 (C4), 139.9 
(C19), 135.2 (C10), 128.6 (C21), 128.5 (C2), 128.2 (C3), 128.0 (C20), 127.9 (C22), 126.1 
(C1), 121.3 (C14), 78.8 (C18), 64.0 (C7), 38.5 (C6), 34.5 (C16), 31.5 (C5), 31.0 (C12), 24.8 
(br. s, C13), 24.0 (C17), 19.8 (C8) ppm; 
IR (νmax/cm
−1, neat): 3400 (OH), 1679 (C=OTIB), 1649, 1454; 
HRMS (ESI) calc. for [C33H42O2S + Na]
+  525.2798. Found 525.2792; 
[𝛂]𝐃
22 + 3 (c 0.5, CHCl3); 









Diastereomer B:  
Rf = 0.34 (10% EtOAc/petroleum ether); 
1H NMR (400 MHz, CDCl3):  = 7.44 (2H, m, H2), 7.36 – 7.28 (5H, m, H20/H21/H22), 7.22 
– 7.12 (3H, m, H1/H3), 7.02 (2H, s, H14), 5.29 (1H, br. d, J = 3.7 Hz, H23), 4.04 (1H, br. d, J 
= 3.7 Hz, H18), 3.15 (2H, hept., J = 7.0 Hz, H12), 2.90 (1H, hept., J = 7.0 Hz, H16), 2.83 (1H, 
app. td, J = 12.8, 4.4 Hz, H5), 2.70 (1H, td, J = 12.8, 5.2 Hz, H5), 2.30 (1H, app. td, J = 12.8, 
4.4 Hz, H6), 1.95 (1H, app. td, J = 13.0, 5.2 Hz, H6), 1.66 (3H, s, H8), 1.30 (6H, d, J = 7.0 Hz, 
H17), 1.26 (12H, d, J = 7.0 Hz, H13)  ppm; 
13C NMR (101 MHz, CDCl3):  = 201.2 (C9), 150.9 (C15), 144.7 (C11), 141.7 (C4), 140.1 
(C19), 135.3 (C10), 128.6 (C21), 128.5 (C2), 128.2 (C3), 128.0 (C20), 127.8 (C22), 126.2 (C1), 
121.2 (C14), 80.3 (C18), 63.3 (C7), 36.5 (C6), 34.5 (C16), 31.1 (C5), 31.1 (C12), 24.6 (br. s, 
C13), 24.0 (C17), 22.3 (C8) ppm; 
IR (νmax/cm
−1, neat): 3388 (OH), 1671 (C=OTIB), 1454; 
[𝜶]𝑫
22 + 2 (c 0.5, CHCl3); 












Following a GP2 using (R)-S-benzothioate 122 (99 mg, 0.25 mmol, >99:1 e.r.) and iso-
butyraldehyde (46 µL, 0.5 mmol) and purification by flash chromatography (5% Et2O/pentane) 
gave thiobenzoate 155 (30 mg, 40%, 98:2 e.r., 5:1 d.r.) as an oil.  
Major diastereomer:  
Rf = 0.21 (5% Et2O/pentane);  
1H NMR (400 MHz, CDCl3):  = 7.31 (2H, m, H2), 7.25-7.18 (3H, m, H1/H3), 6.98 (2H, s, 
H14), 4.80 (1H, d, J = 3.2 Hz, H18), 3.49 (1H, br. s, H21), 3.08 (2H, hept., J = 7.0 Hz, H12, 
2.93 – 2.74 (3H, m, H16, H5), 2.41 (1H, ddd, J = 14.0, 10.8, 6.0 Hz, H6), 2.31 (1H, ddd, J 
=14.0, 10.8, 6.8 Hz, H6), 2.05 (1H, hd, J = 6.8, 3.2 Hz, H19), 1.49 (3H, s, H8), 1.25 (18H, d, J 
= 7.0 Hz, H13/H17), 1.10 (3H, d, J = 6.8 Hz, H20), 1.05 (3H, d, J = 6.8 Hz, H20) ppm;  
13C NMR (101 MHz, CDCl3):   = 201.1 (C9), 150.8 (C15), 144.7 (C11), 142.0 (C4), 135.18 
(C10), 128.6 (C2), 128.5 (C3), 126.0 (C1), 121.2 (C14), 81.0 (C18), 64.0 (C7), 39.8 (C19), 
34.5 (C6), 31.2 (C16), 30.8 (C5), 24.7 (br. s, C13), 24.0 (C17), 23.5 (C20), 21.9 (C20), 17.7 
(C8) ppm; 
IR (νmax/cm
−1, neat): 3350 (OH), 1672 (C=OTIB), 1638, 1459;  
HRMS (ESI) calc. for [C30H44O2S + Na]
+  491.2941. Found 491.2939.  
[𝛂]𝐃
22 + 4 (c 0.5, CHCl3); 
Chiral HPLC (IB with guard, 0.5% iPrOH/hexane, 0.5 mL/min, RT) TR = 19.3 mins (minor), 

















(R)-S-(4-phenyl-2-(trimethylsilyl)butan-2-yl) 2,4,6-triisopropylbenzothioate (156) 
  
Following GP2 using (R)-S-benzothioate 122 (99 mg, 0.25 mmol, >99:1 e.r.) and 
trimethylsilyl chloride (60 µL, 0.50 mmol) and purification by flash chromatography (10% 
toluene/pentane) gave thiobenzoate 156 (80 mg, 68%, 60:40 e.r.) as an oil.  
Rf = 0.36 (10% toluene/pentane);  
1H NMR (101 MHz, CDCl3):  =  7.32 (2H, m, H2), 7.25 – 7.19 (3H, m, H1/H3), 7.00 (2H, s, 
H15), 3.23 (2H, hept., J = 7.0 Hz, H13), 2.99 – 2.78 (3H, m, H5/H17), 2.33 (2H, m, H6), 1.70 









































(3H, s, H8), 1.33 (6H, d, J = 7.0 Hz, H18), 1.25 (12H, d, J = 7.0 Hz, H14), 0.16 (9H, s, H9) 
ppm; 
13C NMR (101 MHz, CDCl3):  = 199.5 (C10), 150.3 (C16), 144.6 (C12), 142.7 (C4), 136.6 
(C11), 128.5 (C2), 125.9 (C3) 121.1 (C1), 43.0 (C7), 38.9 (C6), 34.5 (C17), 32.6 (C5), 30.7 
(C13), 24.5 (br. s, C14) 24.0 (C18), 21.1 (C8), ‒2.78 (C9) ppm; 
IR (νmax/cm
−1, neat): 1672 (C=OTIB), 1653, 1459;  
HRMS (ESI) calc. for [C29H44OSSi + Na]
+  491.2762. Found 491.2762;  














(R)-S-(4-Phenyl-2-(tributylstannyl)butan-2-yl) 2,4,6-triisopropylbenzothioate (157) 
 
Following GP2 using (R)-S-benzothioate 122 (30 mg, 0.076 mmol, >99:1 e.r.) and tributyltin 
chloride (62 µL, 0.15 mmol) and purification by flash chromatography (2% toluene/pentane) 
gave thiobenzoate 157 (40 mg, 77%, 67:33 e.r.) as an oil.  
Rf = 0.52 (5% toluene/pentane);  
1H NMR (400 MHz, CDCl3):  = 7.30 (2H, m, H2), 7.23 – 7.16 (3H, m, H1/H3), 7.00 (2H, s, 
H15), 3.14 (2H, hept., J = 7.0 Hz, H13), 2.93-2.80 (2H, m, H5/H17), 2.65 (1H, td, J = 13.2, 4.5 
Hz, H5), 2.41 (1H, td, J = 13.7, 4.5 Hz, H6), 2.23 (1H, td, J = 13.2, 4.5 Hz, H6), 1.79 (3H, s, 
H8), 1.56 (6H, m, H20), 1.36 (6H, m, H22) 1.24 (18H, br. d, J = 7.0 Hz, H14/H18), 1.06 (6H, 
m, H19), 0.92 (9H, t, J = 7.2 Hz, H22) ppm;  
13C NMR (101 MHz, CDCl3):  = 200.8 (C10), 150.2 (C16), 144.6 (C12), 142.1 (C4), 135.2 
(C11), 128.4 (C2), 128.3 (C3), 125.9 (C1), 121.0 (C15), 42.9 (C6), 42.8 (C7), 34.1 (C5), 33.5 
(C17), 30.5 (C13), 25.9 (C8), 24.4 (C14), 23.9 (C18), -7.59 (C19) ppm; 
IR (νmax/cm
−1, neat): 2957, 1673 (C=OTIB), 1646, 1459, 901;  
HRMS (ESI) calc. for [C38H62OSSn + Na]
+ 709.3442. Found 709.3411; 
[𝛂]𝐃
22 + 2 (c 0.5, CHCl3); 
Chiral HPLC (IA, 0.1% iPrOH/hexane, 0.5 mL/min, 0 °C) TR = 22.40 mins (major), 24.15 
mins (minor). Absolute stereochemistry determined after tin-lithium exchange (nBuLi, 
TMEDA, TBME, – 60 °C) and MeOD quench, followed by comparison of the Chiral HPLC 








(S)-S-(4-phenyl-2-(trimethylstannyl)butan-2-yl) 2,4,6-triisopropylbenzothioate (158) 
 
Following GP2 using (R)-S-benzothioate 122 (99 mg, 0.25 mmol, >99:1 e.r.) and trimethyltin 
chloride (57 µL, 0.50 mmol) and purification by flash chromatography (2% toluene/pentane) 
gave thiobenzoate 158 (120 mg, 88%, 82:18 e.r.) as a white solid.  
Rf = 0.44 (2% toluene/pentane);  
1H NMR (400 MHz, CDCl3):  = 7.29 (2H, m, H2), 7.22 – 7.15 (3H, m, H1/H3), 6.99 (2H, s, 
H15), 3.08 (2H, hept., J = 7.0 Hz, H13), 2.88 (1H, hept., J = 7.0 Hz, H17), 2.81 (1H, m, H5), 
2.66 (1H, m, H5), 2.19 (2H, dd, J = 9.8, 7.6 Hz, H6), 1.65 (3H, s, H8), 1.25 (18H, br. d, J = 7.0 
Hz, H14/H18), 0.28 (9H, s, H8) ppm;  
13C NMR (101 MHz, CDCl3):  = 200.8 (C10), 150.4 (C16), 144.7 (C12), 142.0 (C4), 135.2 
(C11), 128.4 (C2), 128.3 (C3), 125.9 (C1), 121.0 (C15), 42.8 (C6), 40.7 (C7), 34.4 (C5), 33.5 
(C17), 30.5 (C13), 25.9 (C8), 24.4 (C14), 23.9 (C18), -7.59 (C9) ppm; 
IR (νmax/cm
−1, neat): 1673 (C=OTIB), 1654, 1460;  
HRMS (ESI) calc. for [C17H24OSSn + Na]
+ 583.2031. Found 583.2028; 
[𝛂]𝐃
22 + 6 (c 1.0, CHCl3); 
Chiral HPLC (IB with guard, 0.1% iPrOH/hexane, 0.1 mL/min, 0 °C) TR = 36.9 mins (major), 
39.7 mins (minor). Absolute stereochemistry determined after tin-lithium exchange (nBuLi, 
TMEDA, TBME, – 60 °C) and MeOD quench, followed by comparison of the Chiral HPLC 









(R)-2-methyl-4-phenyl-2-((2,4,6-triisopropylbenzoyl)thio)butanoic acid (159) 
 
Following a GP2 using (R)-S-benzothioate 122 (99 mg, 0.25 mmol, >99:1 e.r.) and dry ice 
(passed over dry MgSO4) and purification by flash chromatography (5% Et2O/pentane) gave 
thiobenzoate 159 (94 mg, 85 %, > 97:3 e.r.) as an oil.  
Rf = 0.20 (1% MeOH/CH2Cl2);  
1H NMR (400 MHz, CDCl3):  = 7.24 (2H, m, H2), 7.20-7.13 (3H, m, H1/H3), 7.01 (2H, s, 
H14), 3.13 (2H, m, H12), 2.91(1H, hept., J = 7.0 Hz, H16), 2.75 (2H, m, H5), 2.29 (2H, m, H6) 
1.84 (3H, s, H8), 1.24 (18H, br. d., J = 7.0 Hz, H13/H17) ppm;  
13C NMR (101 MHz, CDCl3):  = 197.6 (C9), 178.8 (C18), 151.2 (C15), 144.8 (C11), 141.0 
(C4), 134.1 (C10), 128.7 (C2), 128.4 (C3), 126.5 (C1), 121.3 (C14), 60.7 (C7), 36.7 (C6), 34.6 






−1, neat): 2971, 1719 (C=OCOOH), 1675 (C=OTIB), 1656, 1461;  
HRMS (ESI) calc. for [C27H36O3S + Na]
+  463.2277. Found 463.2272; 
[𝛂]𝐃
22 + 13.5 (c 1.0, CHCl3); 
Chiral SFC (Chiracel IA, 4% iPrOH/hexane (1:1, v:v), 4mL/min, 125 bar, 40 ºC) TR = 5.08 















(R)-S-(3-methyl-1-phenylhex-5-en-3-yl) 2,4,6-triisopropylbenzothioate (160) 
 
Following GP2 using (R)-S-benzothioate 122 (99 mg, 0.25 mmol, >99:1 e.r.) and allyl bromide 
(61 mg, 43 µL, 0.50 mmol) and purification by flash chromatography (5% toluene/pentane) 
gave thiobenzoate 160 (64 mg, 59%, 51:49 e.r.) as an oil.  
Rf = 0.42 (5% toluene/pentane);  
1H NMR (400 MHz, CDCl3):  = 7.29 (2H, m, H2), 7.23 – 7.17 (3H, m, H1/H3),  6.99 (2H, s, 
H17), 5.92 (1H, ddt, J = 17.2, 10.1, 7.2 Hz, H10), 5.22 – 5.13 (2H, m, H11), 3.14 (2H, hept., J 
= 7.0 Hz, H15), 2.94 – 2.65 (5H, m, H5/H9/H19), 2.29 (1H, ddd, J = 14.1, 12.1, 5.5 Hz, H6), 
2.08 (1H, ddd, J = 14.1, 12.1, 5.5 Hz, H6), 1.57 (3H, s, H8), 1.34 – 1.23 (18H, d, J = 7.0, 
H16/H20) ppm; 
13C NMR (101 MHz, CDCl3):  = 198.7 (C12), 150.3 (C18), 144.5 (C14), 142.0 (C4), 133.6 
(C10), 128.4 (C2), 128.3 (C3), 125.9 (C1), 121.0 (C17), 118.4 (C11), 56.0 (C7), 43.7 (C9), 
41.1 (C5), 34.4 (C19), 31.2 (C6), 30.5 (C15), 24.7 (br. s, C16), 23.9 (C20), 19.9 (C8) ppm; 
IR (νmax/cm
−1, neat): 1675 (C=OTIB), 1645, 1460;  
HRMS (ESI) calc. for [C23H36O3S + Na]
+  459.2691. Found 459.2686; 
[𝛂]𝐃
22 0 (c 1.0, CHCl3); 
Chiral HPLC (IC with guard, 0.1% iPrOH/hexane, 0.15 mL/min, RT) TR = 53.1 mins (minor), 




































Following GP2 using (S)-S-benzothioate 143 (200 mg, 0.31 mmol) and methyl chloroformate 
(48.0 µL, 0.62 mmol) and purification by flash chromatography (4% toluene/pentane) gave 
(R)-S-thiobenzoate 165 (173 mg, 81%) as a white foam. 
Rf = 0.35 (5% Et2O/pentane); 
1H NMR (400 MHz, CDCl3): δ = 6.97 (2H, s, H2), 5.37 (1H, m, H9), 3.78 (3H, s, H14), 3.06 
(2H, m, H10), 3.00 (1H, m, H7ax.), 2.87 (1H, hept., J = 6.5 Hz, H11), 2.60 (1H, dd, J = 14.6, 
2.1 Hz, Hz, H7eq.), 2.22 (1H, m, H12ax.), 2.14 (1H, m, H12eq.), 2.02 (2H, m), 1.81 (2H, m), 1.57 
(2H, m), 1.47 (5H, m), 1.34 (4H, m), 1.24 (20H, m), 1.12 (4H, m), 1.04 (3H, s, H15), 0.99 (2H, 
m), 0.92 (3H, m), 0.87 (6H, dd, J = 6.5, 1.7 Hz), 0.68 (3H, s) ppm;  
13C NMR (101 MHz, CDCl3): δ = 197.2 (C5), 174.1 (C13), 150.6 (C1), 144.9 (C3), 138.0 (C8), 
134.8 (C4), 120.9 (C9), 120.8 (C2), 59.2 (C6), 56.7 (CH), 56.0 (CH), 52.6 (C14), 50.2 (CH), 
42.2 (4º C), 39.5 (CH2), 39.1 (C7), 36.6 (C16), 36.2 (CH2), 35.6 (CH2), 34.4 (C11), 32.0 (CH2), 
31.7 (C10), 30.2 (2 x CH2), 29.7 (CH), 28.1 (CH2), 28.0 (CH), 25.2 (4 x CH3), 24.2 (CH2), 23.9 
(2x CH3), 23.8 (CH2), 22.8 (CH3), 22.5 (CH3), 20.8 (CH2), 19.4 (C15), 18.7 (CH3), 11.8 (CH3) 
ppm;  
HRMS (ESI) calc. for [C45H70O3S + Na]
+ 713.4937. Found, 713.4920; 
IR (νmax/cm
−1, neat): 2958, 1737 (C=Oester), 1677 (C=OTIB), 1460, 1248, 987; 
[𝛂]𝐃








Following GP2 using (S)-S-benzothioate 144 (99 mg, 0.25 mmol, >20:1 d.r.) and 4-
bromophenyl isocyanate (99 mg, 0.50 mmol) and purification by flash chromatography (4% 
toluene/pentane) gave thiobenzoate 167 (78 mg, 53%, >20:1 d.r.) as an amorphous solid.  
Rf = 0.50 (4% toluene/pentane); 
1H NMR (400 MHz, CDCl3): δ = 9.07 (1H, s, H5), 7.50-7.46 (4H, m, H2/H3), 6.99 (2H, s, 
H18), 2.95 (2H, hept., J = 7.0 Hz, H16), 2.88 (1H, hept., J = 7.0 Hz, H20), 2.55 (2H, m, H8eq.), 
2.00 (2H, td, J = 13.5, 3.5 Hz, H8ax.), 1.81 (2H, m, H9eq.), 1.44 (2H, qd, J = 13.5, 3.2 Hz, H9ax.), 
1.26 (1H, m, H10), 1.24 (18H, d, J = 7.0 Hz, H17/H20), 0.89 (9H, s, H12) ppm. Some of the 
small vicinal couplings on the 6-membered ring were not resolved and gave broad lines; 
13C NMR (101 MHz, CDCl3): δ = 200.8 (C13), 171.6 (C6), 151.3 (C19), 144.7 (C15), 137.4 
(C4), 134.4 (C14), 131.9 (C2), 121.3 (C18), 121.2 (C3), 116.5 (C1), 60.4 (C7), 47.1 (C10), 
34.4 (C16), 32.5 (C11), 32.3 (C8), 30.9 (C20), 27.4 (C12), 24.7 (br. s, C21) 23.8 (C17), 22.9 
(C9) ppm;  
HRMS (ESI) calc. for [C33H46BrNO2S + Na]
+  622.3659. Found, 622.3655; 
IR (νmax/cm
−1, neat): 2956 (Ar), 2865 (Ar), 1681 (C=OCONH), 1675 (C=OTIB), 1492, 1266, 899; 
[𝛂]𝐃






3.3. Chapter 2  
3.3.1. Synthesis of Benzoate Derivatives 
 
3.3.1.1. General Procedure for the Synthesis of Benzoates from Secondary Alcohols (GP3)  
To a flame-dried flask under nitrogen was added 2,4,6-triisopropylbenzoic acid (1.00 eq.) and 
PPh3 (1.10 eq.). The flask was then treated to three vacuum N2 cycles with stirring. THF (0.66 
– 1.00 M) and alcohol (1.10 eq.) were added. The flask was cooled to 0 °C and DIAD (1.10 
eq.) was added dropwise over a period of 15 mins. After 10 mins, the reaction was warmed to 
RT and left to stir at RT for 16 hrs. The crude material was concentrated in vacuo and the 
residue was dissolved in minimal pentane (<25 mL) and stirred vigorously at RT for 10 mins. 
The resultant white precipitate was filtered and washed with pentane (<100 mL). The filtrate 
was concentrated in vacuo and purified by column chromatography (3-20% Et2O/PE) to afford 
the desired ester product. 
 
Cyclobutyl 2,4,6-triisopropylbenzoate (292) 
 
 
Following GP3 using 2,4,6-triisopropylbenzoic acid (6.26 g, 25.2 mmol, 1.00 eq.), PPh3 (7.26 
g, 27.7 mmol, 1.10 eq.), cyclobutanol (2.17 mL, 27.7 mmol, 1.10 eq.) and DIAD (5.44 mL, 
27.7 mmol, 1.10 eq.) in THF (25 mL, 1 M), followed by column chromatography purification 
(3-6% Et2O/PE) afforded a mixture of products (5.26 g, 69%, 93:7 ratio of desired benzoate 
292 to inseparable ring contracted benzoate 293). 





1H NMR (400 MHz, CDCl3): δ = 7.00 (2H, s, H9), 5.25 (1H, p, J = 7.5 Hz, H3), 2.94 – 2.82 
(3H, m, H7/H11), 2.51 – 2.40 (2H, m, H2), 2.23 – 2.11 (2H, m, H2), 1.91 – 1.80 (1H, m, H1), 
1.77 – 1.64 (1H, m, H1), 1.25 (12H, d, J = 6.8 Hz, H8), 1.24 (6H, d, J = 6.8 Hz, H12) ppm;  
13C NMR (101 MHz, CDCl3): δ = 170.3 (C4), 150.2 (C10), 144.9 (C6), 130.7 (C5), 121.0 (C9), 
69.4 (C3), 34.6 (C11), 31.5 (C7), 30.5 (C2), 24.3 (C8), 24.1 (C12), 14.1 (C1) ppm;  
HRMS (ESI) calc. for [C20H30O2 + Na]
+ 325.2143. Found, 325.2140; 
IR (νmax/cm




Oxetan-3-yl 2,4,6-triisopropylbenzoate (349) 
 
Following GP3 using 2,4,6-triisopropylbenzoic acid (6.09 g, 24.6 mmol, 1.00 eq.), PPh3 (7.08 
g, 27.1 mmol, 1.10 eq.), oxetan-3-ol (2.00 g, 27.1 mmol, 1.10 eq.) and DIAD (5.30 mL, 27.1 
mmol, 1.10 eq.) in THF (25 mL, 1 M), followed by column chromatography purification (3- 
20% Et2O/PE) afforded desired product 349 as a white solid (4.50 g, 57%). 
Rf = 0.22 (5% Et2O/pentane, p-anisaldehyde);  
1H NMR (400 MHz, CDCl3): δ = 7.06 (2H, s, H8), 5.70 (1H, tt, J = 6.4, 5.3 Hz, H2), 5.02 (2H, 
dd, J = 7.5, 6.4 Hz, H1), 4.79 (2H, dd, J = 7.5, 5.3 Hz, H1) 2.91 (1H, hept., J = 6.8 Hz, H10), 
2.90 (2H, hept., J = 6.8 Hz, H6), 1.26 (12H, d, J = 6.8 Hz, H7), 1.25 (6H, J = 6.8 Hz, H11) 
ppm; 
13C NMR (101 MHz, CDCl3): δ = 170.1 (C3), 150.7 (C9), 145.1 (C5), 129.3 (C4), 121.0 (C8), 
77.6 (C1), 68.5 (C2), 34.5 (C10), 31.6 (C6), 24.2 (C7), 24.0 (C11) ppm;  
HRMS (ESI) calc. for [C19H28O3 + Na]
+ 327.1936. Found, 327.1936; 
IR (νmax/cm
−1, neat): 2968, 2871, 1720 (C=OTIB), 1610, 1468, 1252, 1238, 1137, 1039, 974, 
843, 765; 









Following GP3 using 2,4,6-triisopropylbenzoic acid (2.60 g, 10.4 mmol, 1.00 eq.), PPh3 (3.03 
g, 11.5 mmol, 1.10 eq.), tert-butyl 3-hydroxyazetidine-1-carboxylate (2.0 g, 11.5 mmol, 1.10 
eq.) and DIAD (2.27 mL, 11.5 mmol, 1.10 eq.) in THF (25 mL, 1 M), followed by column 
chromatography purification (3-20% Et2O/PE) afforded desired product 358 as a white solid 
(2.50 g, 57%). 
Rf = 0.17 (10% Et2O/pentane, p-anisaldehyde);  
1H NMR (400 MHz, CDCl3): δ = 7.02 (2H, s, H8), 5.38 (1H, tt, J = 6.9, 4.2 Hz, H2), 4.34 (2H, 
ddd, J = 10.3, 6.9, 0.7 Hz, H1), 4.00 (2H, ddd, J = 10.3, 4.2, 0.7 Hz, H1), 2.89 (1H, hept., J = 
6.8 Hz, H11), 2.83 (2H, hept., J = 6.8 Hz, H6), 1.45 (9H, s, H14), 1.25 (12H, d, J = 6.8 Hz, 
H7), 1.24 (6H, d, J = 6.8 Hz, H11) ppm; 
13C NMR (101 MHz, CDCl3): δ = 170.3 (C3), 156.2 (C12), 150.9 (C9), 145.1 (C5), 129.4 (C4), 
121.1 (C8), 80.1 (C13), 64.0 (C2), 56.5 (br.s, C1), 34.6 (C10), 31.7 (C6), 28.5 (C14), 24.3 (C7), 
24.1 (C11) ppm;  
HRMS (ESI) calc. for [C24H37NO4 + Na]
+ 426.2620. Found, 426.2608; 
IR (νmax/cm
−1, neat): 2964, 2878, 1723 (C=OTIB), 1720 (C=Oamide), 1604, 1402, 1285, 1252, 
1133, 1108, 1073; 
















Following GP3 using 2,4,6-triisopropylbenzoic acid (633 mg, 2.55 mmol, 1.15 eq.), PPh3 (640 
mg, 2.44 mmol, 1.10 eq.), (1s,3s)-3-fluorocyclobutan-1-ol (200 mg, 2.22 mmol, 1.00 eq.)  and 
DIAD (0.48 mL, 2.44 mmol, 1.10 eq.) in THF (3.7 mL, 0.66 M), followed by column 
chromatography purification (0-10% Et2O/PE) afforded desired product 302 as a white solid 
(440 mg, 62%, >99:1 d.r.).  
Rf = 0.41 (10% Et2O/pentane, p-anisaldehyde); 
1H NMR (400 MHz, CDCl3): δ = 7.01 (2H, s, H9), 4.84 (1H dp, J = 55.7JH-F, 6.6 Hz, H1), 4.83 
(1H, pd, J = 7.1, 3.8 Hz, H3), 3.02 (2H, ddtd, J = 13.7JH-F, 10.2, 7.1, 6.6, 3.8 Hz, H2) 2.89 (1H, 
hept., J = 6.9 Hz, H11), 2.84 (2H, hept., J = 6.9 Hz, H7), 2.43 (2H, m, H2), 1.25 (12H, d, J = 
6.9 Hz, H8), 1.24 (6H, d, J = 6.9 Hz, H12) ppm; 
13C NMR (101 MHz, CDCl3): δ = 170.3 (C4), 150.6 (C10), 145.0 (C6), 130.0 (C5), 121.1 (C9), 
80.9 (d, JC-F = 211.5 Hz, C1), 60.3 (d, JC-F = 22.8 Hz, C3), 39.2 (d, JC-F = 21.2 Hz, C2), 34.6 
(C11), 31.6 (C7), 24.2 (C8), 24.1 (C12) ppm; 
19F NMR (376 MHz, CDCl3): δ = -169.6 (dtt, JH-F = 55.7, 25.1, 13.7 Hz) ppm; 
HRMS (ESI) calc. for [C20H29FO2 + Na]
+ 343.2103. Found, 343.2112; 
IR (νmax/ cm
−1, neat): 3675, 2969, 1725 (C=OTIB), 1462, 1394, 1260, 1060, 879, 748;  
M.P: 63-65 °C (EtOAc); 
[𝜶]𝑫










1-Cyclopropylethyl 2,4,6-triisopropylbenzoate (337) 
 
 
Following GP3 using 2,4,6-triisopropylbenzoic acid (663 mg, 2.67 mmol, 1.15 eq.), PPh3 (670 
mg, 2.56 mmol, 1.10 eq.), 2-methylcyclobutan-1-ol (200 mg, 2.32 mmol, 1.00 eq.) and DIAD 
(0.50 mL, 2.56 mmol, 1.10 eq.) in THF (3.52 mL, 0.66 M), followed by column 
chromatography purification (2-10% Et2O/PE) to afford the ring contracted side product 337 
as a colourless oil (515 mg, 70%).  
Rf = 0.62 (10% Et2O/pentane, p-anisaldehyde); 
1H NMR (400 MHz, CDCl3): δ = 7.00 (2H, s, H4), 4.57 (1H, dq, J = 9.1, 6.3 Hz, H14), 3.07 
(1H, hept., J = 6.8 Hz, H7), 2.94 (2H, hept., J = 6.8 Hz, H2), 1.43 (3H, d, J = 6.3 Hz, H10), 
1.08 (1H, m, H11), 0.63-0.52 (2H, m, H12/13), 0.48 (1H, m, H12), 0.31 (1H, m, H13) ppm; 
13C NMR (101 MHz, CDCl3): δ = 170.5 (C9), 150.1 (C5), 145.5 (C3), 131.2 (C8), 121.2 (C4), 
76.7 (C14), 34.6 (C7), 31.6 (C2), 24.4 (C1), 24.0 (C6), 19.9 (C10), 16.6 (C11), 4.2 (C12), 2.9 
(C13) ppm; 
HRMS (ESI) calc. for [C21H32O2 + Na]
+ 317.2475. Found, 317.2471; 
IR (νmax/cm
















Following GP3 using 2,4,6-triisopropylbenzoic acid (284 mg, 1.14 mmol, 1.15 eq.), PPh3 (287 
mg, 1.09 mmol, 1.10 eq.), tert-butyl ((1R,3R)-3-hydroxycyclobutyl)(methyl)carbamate (200 
mg, 0.99 mmol, 1.00 eq.) and DIAD (0.22 mL, 1.09 mmol, 1.10 eq.) in THF (1.50 mL, 0.66 
M), followed by column chromatography purification (2-10% Et2O/PE) to afford the desired 
product 344 colourless oil (429 mg, 65%).  
Rf = 0.40 (10% Et2O/pentane, p-anisaldehyde); 
1H NMR (400 MHz, CDCl3): δ = 7.02 (2H, s, H4), 5.28 (1H, tt, J = 7.4, 2.4 Hz, H10), 4.76 
(1H, br. s, H12), 2.90 (3H, hept., J = 6.8 Hz, H2/H6), 2.85 (3H, s, H13), 2.64 (2H, dddd, J = 
14.3, 7.4, 3.7, 2.4 Hz, H11), 2.46 (2H, ddt, J = 14.3, 8.3, 2.4, 2.4 Hz, H11), 1.45 (9H, s, H16), 
1.27 (12H, d, J = 6.8 Hz, H7), 1.25 (6H, d, J = 6.8 Hz, H1) ppm; 
13C NMR (101 MHz, CDCl3): δ = 170.6 (C9), 155.8 (C14), 150.3 (C3), 144.9 (C5), 130.3 
(C8), 120.9 (C4), 79.7 (C15), 67.7 (C10), 48.7 (br. s, C12), 35.0 (C11), 34.5 (C2), 31.5 (C6), 
29.7 (C13), 28.5 (C16), 24.2 (C7), 24.0 (C1) ppm; 
HRMS (ESI) calc. for [C26H41NO4 + Na]
+ 454.2928. Found, 454.2922; 
IR (νmax/cm
−1, neat): 2962, 1726 (C=Oester), 1697 (C=Oamide), 1461, 1364, 1251, 1148, 1077; 
[𝜶]𝑫










tert-Butyl 6-((2,4,6-triisopropylbenzoyl)oxy)-2-azaspiro[3.3]heptane-2-carboxylate (342) 
 
 
Following GP3 using 2,4,6-triisopropylbenzoic acid (200 mg, 0.81 mmol, 1.15 eq.), PPh3 (202 
mg, 0.77 mmol, 1.10 eq.), tert-butyl 6-hydroxy-2-azaspiro[3.3]heptane-2-carboxylate (150 mg, 
0.70 mmol, 1.00 eq.) and DIAD (0.15 mL, 0.77 mmol, 1.10 eq.) in THF (1.10 mL, 0.66 M), 
followed by column chromatography purification (2-10% Et2O/PE) to afford the desired 
product 342 as a colourless oil (162 mg, 52%).  
Rf = 0.16 (10% Et2O/pentane, p-anisaldehyde); 
1H NMR (400 MHz, CDCl3): δ = 7.00 (2H, s, H4), 5.16 (1H, p, J = 7.0 Hz, H10), 3.97 (2H, s, 
H13), 3.92 (2H, s, H13), 2.88 (1H, hept., J = 6.6 Hz, H2), 2.83 (2H, hept., J = 6.6 Hz, H6), 
2.73 (2H, ddd, J = 10.5, 7.0, 2.8 Hz, H11), 2.32 (2H, ddd, J = 10.5, 7.0, 2.8 Hz, H11), 1.43 
(9H, s, H16), 1.24 (12H, d, J = 6.6 Hz, H7), 1.23 (6H, d, J = 6.6 Hz, H1) ppm; 
13C NMR (101 MHz, CDCl3): δ = 170.2 (C9), 156.2 (C14), 150.4 (C3), 144.8 (C5), 130.1 
(C8), 120.9 (C4), 79.6 (C15), 64.9 (C10), 61.4 (C13), 60.6 (C13), 40.8 (C11), 34.5 (C2), 31.6 
(C12), 31.5 (C6), 28.4 (C16), 24.2 (C7), 24.0 (C1) ppm; 
HRMS (ESI) calc. for [C27H41NO4 + Na]
+ 466.2928. Found, 466.2923; 
IR (νmax/ cm
−1, neat): 3675, 2970, 2901, 1725 (C=Oester), 1699 (C=Oamide), 1404, 1259, 1101, 








3.3.2. Preparation of Boronic Ester Starting Materials 
 







2-phenethylboronic acid (10.0 g, 66.7 mmol) and pinacol (7.9 g, 66.7 mmol) and anhydrous 
MgSO4 (4.0 eq.) in Et2O (0.5 M) was stirred at RT for 16 hrs. The reaction mixture was filtered 
and concentrated in vacuo. The crude material was purified by flash column chromatography 
to give the pure boronic ester 294 as a white crystalline solid (15.4 g, 99%).  
Rf = 0.49 (10% EtOAc/PE, p-anisaldehyde); 
1H NMR (400 MHz, CDCl3): δ = 7.20-7.13 (4H, m, H2/H3), 7.07 (1H, m, H1), 2.67 (2H, t, J 





13C NMR (101 MHz, CDCl3): δ = 144.4 (C4), 128.2 (C2), 128.0 (C3), 125.5 (C1), 83.1 (C7), 
29.9 (C5), 24.8 (C8) ppm. C6 (next to B) not observed due to quadrupolar relaxation; 
11B NMR (CDCl3, 128 MHz): δ = 34.0 ppm. 
 






A mixture of 4-methoxyphenylboronic acid (3.80 g, 25 mmol, 1.00 eq.) and pinacol (2.96 g, 
25 mmol, 1.00 eq.) in Et2O (50 mL) was stirred at ambient temperature for 16 hrs. Then, flame-
dried MgSO4 (3.01 g, 25 mmol, 1.00 eq.) was added and the reaction mixture was stirred for 
an additional 1 hour. The resultant solution was then filtered under argon through a plug of 
anhydrous MgSO4 (~1 cm), the solids were washed with diethyl ether (2 × 20 mL) and 
combined filtrates were concentrated in vacuo at ambient temperature. The residue was 
subjected to Kugelrohr distillation (80→120 °C/0.1 mbar) to afford the desired product 373 
(5.26 g, 98%) as a colourless oil. 
1H NMR (400 MHz, CDCl3):  = 7.79 (2H, app. d, J = 8.9 Hz, H3), 6.89 (2H, app. d, J = 8.9 
Hz, H4), 3.81 (3H, s, H1), 1.36 (12H, s, H9) ppm;  
13C NMR (101 MHz, CDCl3):  = 162.2 (C2), 136.6 (C4), 113.3 (C3), 83.6 (C8), 55.1 (C1), 
24.9 (C9) ppm. C7 (next to boron) not observed due to quadrupolar relaxation;  
11B NMR (128 MHz, CDCl3):  = 30.0 ppm. 
 









The corresponding aryl boronic acid (1.00 g, 6.17 mmol, 1.00 eq.) and pinacol (801 mg, 6.79 
mmol, 1.10 eq.) were dissolved in anhydrous Et2O (3.0 mL, 0.50 M) under an Ar atmosphere. 
The mixture was stirred for 16 hrs at RT and concentrated under reduced pressure. The crude 
product was purified by column chromatography (3% EtOAc/pentane) to yield the desired 
product 375 (1.20 g, 80%). 
1H NMR (400 MHz, CDCl3): δ = 7.63 (1H, m, H3), 7.57 (1H, m, H4), 7.40 (1H, d, J = 1.0 Hz, 
H2), 7.34 (1H, ddd, J = 8.4, 7.2, 1.0 Hz, H1), 7.23 (1H, m, H7), 1.39 (12H, s, H10) ppm;  
13C NMR (101 MHz, CDCl3): δ = 157.6 (C5), 127.6 (C6), 126.1 (C2), 122.9 (C1), 122.0 (C4), 
119.7 (C3), 112.1 (C7), 84.8 (C9), 24.9 (C10) ppm. C8 (next to boron) not observed due to 
quadrupolar relaxation;  
11B NMR (128 MHz, CDCl3): δ = 28.0 ppm.  
 















tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrrolidine-1-carboxylate (377) 
 
N-Boc-pyrrolidine (1.00 g, 5.84 mmol, 1.00 eq.) and TMEDA (1.10 mL, 7.00 mmol, 1.20 eq.) 
were dissolved in Et2O (50 mL). The solution was cooled to –78 °C and sBuLi (1.3 M in 
hexanes, 6.00 mL, 7.00 mmol, 1.20 eq.) was added dropwise. The solution was stirred for 3 hrs 
at –78 °C, then iPrOB(pin) (1.63 g, 8.80 mmol, 1.30 eq.) was added dropwise. The solution 
was stirred for 1 hr at –78 °C, then allowed to warm up to RT slowly. Aqueous 1 M HCl (50 
mL) was added and the layers were separated. The organic layers were washed with brine 
(3 x 20 mL) and the combined aqueous layers were extracted with Et2O (3 x 50 mL). The 
organic layers were combined, dried over MgSO4 and concentrated in vacuo. The crude product 
was purified by fast column chromatography on silica gel, eluting with 15% EtOAc/PE, to give 
377 as a white solid (987 mg, 57%).  
1H NMR (500 MHz, DMSO-d6, 90°C): δ = 3.23 (1H, m, H5), 3.14 (1H, m, H4), 2.80 (1H, m, 
H4), 1.87 (2H, m, H7), 1.74 (2H, m, H6), 1.37 (9H, s, H1), 1.19 (12H, m, H9) ppm; 
13C NMR (125 MHz, DMSO-d6, 90°C): = δ 83.5 (C8), 78.5 (C2), 46.4 (C4), 28.7 (C1), 25.4 
(C7), 25.2 (C9), 24.8 (C6) ppm. C3 (C=O) peak not observed, C5 (next to B) not observed due 
to quadrupolar relaxation; 
11B NMR (96 MHz, CDCl3): δ = 33.1 ppm;  
 










tert-Butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate (378) 
 
In air, CuI (72 mg, 10 mmol%, 0.10 eq.), PPh3 (129 mg, 13 mmol%, 0.13 eq.), LiOMe (288 
mg, 7.57 mmol, 2.00 eq.) and bis(pinacolato)diboron (1.44 g, 5.68 mmol, 1.50 eq.) were added 
to a Schlenk tube equipped with a magnetic stir bar. The vessel was evacuated and filled with 
argon three times. DMF (7.5 mL) and tert-butyl 4-bromopiperidine-1-carboxylate (1.00 g, 3.78 
mmol, 1.00 eq.) were added in turn under Ar. The reaction mixture was heated at 37 °C for 24 
hrs. The reaction mixture was cooled and diluted with EtOAc (10 mL) and the resultant slurry 
was filtered through a silica pad (~2 cm) and washed with EtOAc (40 mL). The crude solution 
was concentrated in vacuo and purified by silica column chromatography (5-10% 
EtOAc/pentane), to afford the desired compound 378 (966 mg, 82%) as a clear oil. 
 
Rf = 0.50 (10% EtOAc/pentane, anisaldehyde);  
1H NMR (400 MHz, CDCl3): δ = 3.77 (2H, br. d, J = 12.8 Hz, H4), 2.91 (2H, ddd, J = 12.8, 
10.1, 3.2 Hz, H4), 1.62 (2H, dq, J = 13.2, 10.4, 3.8, 3.2 Hz, H5), 1.46 (2H, qd, J = 13.2, 10.4, 
10.1, 3.8 Hz, H5), 1.43 (9H, s, H1), 1.22 (12H, s, H8), 1.09 (1H, tt, J = 10.4, 3.8 Hz, H6) 
ppm. Many of the small vicinal couplings on the 6-membered ring were not resolved and 
gave broad lines due to rotamers about the amide ; 
13C NMR (101 MHz, CDCl3): δ = 155.0 (C3), 83.3 (C2), 79.1 (C7), 45.2 (C4), 28.6 (C1), 
27.1 (C5), 24.9 (C8), 20.1 (br. s, C6) ppm;  
 









tert-Butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate (379) 
 
tert-Butyl piperidine-1-carboxylate (2.00 g, 10.8 mmol, 1.00 eq.) and TMEDA (1.95 mL, 13.0 
mmol, 1.20 eq.) were dissolved in Et2O (100 mL). The solution was cooled to –78 °C and 
sBuLi (1.3 M in hexanes, 10.0 mL, 13.0 mmol, 1.20 eq.) was added dropwise. The solution was 
stirred for 3 hours at –78 °C, then iPrOB(pin) (2.61 g, 2.86 mL, 14.0 mmol, 1.30 eq.) was added 
dropwise. The solution was stirred for 1 hr at –78 °C, then allowed to warm up to RT slowly. 
Aqueous HCl (1 M, 150 mL) was added and the layers were separated. The organic layer was 
washed with brine (3 x 50 mL) and the combined aqueous layers were extracted with Et2O (3 
x 100 mL). The organic layers were combined, dried over MgSO4 and concentrated under 
vacuum. The crude product was purified by fast column chromatography (15% EtOAc/PE), to 
give the desired compound 379 as an oil (1.49 g, 44%).  
1H NMR (400 MHz, CDCl3): δ = 3.72 (1H, br. d, J = 12.7 Hz, H4), 2.74 (1H, td, J = 12.7, 2.9 
Hz, H4), 2.30 (1H, dd, J = 12.6, 3.2 Hz, H5), 1.81 (1H, m, H7), 1.65‐1.54 (2H, m, H6/H8), 
1.49 (9H, s, H1), 1.44 (1H, m, H6), 1.40‐1.29 (2H, m, H7/H8), 1.19 (12H, s, H10) ppm. Many 
of the small vicinal couplings on the 6-membered ring were not resolved and gave broad lines 
due to rotamers about the amide; 
13C NMR (100 MHz, CHCl3): δ = 139.8 (C3), 85.6 (C9), 79.9 (C2), 42.4 (C4), 28.4 (C1), 26.5 
(C8), 25.1 (C10), 24.9 (C6), 24.4 (C7) ppm. C5-not observed due to quadrupolar relaxation; 
11B NMR (128 MHz, CDCl3): δ = 16.0 ppm. 
 













Racemic: To a solution of [RhCl(cod)]2 (50 mg, 0.10 mmol, 0.5 mol%), dppb (104 mg, 
0.25 mmol, 1.25 mol%) and DMAP (30 mg, 0.25 mmol, 1.25 mol%) in 1,2-dichloroethane 
(21 mL) was added freshly distilled styrene (3.8 mL, 40.6 mmol, 1.00 eq.) and freshly distilled 
pinacolborane (7.1 mL, 48.7 mmol, 1.20 eq.) at RT.270 The resulting solution was stirred at RT 
for 1.5 hrs, then filtered through a plug of silica gel with Et2O (50 mL) and concentrated in 
vacuo. The crude residue was purified by column chromatography (4% Et2O/hexane) to give 
racemic boronic ester 380 as a colourless oil (7.56 g, 80%). 
(S)-enantiomer: A mixture of CuCl (6 mg, 0.06 mmol, 3 mol%), NaOtBu (12 mg, 0.12 mmol, 
6 mol%) and (R)-DTBM-SEGPHOS ® (71 mg, 0.12 mmol, 3 mol%) in anhydrous toluene (0.8 
mL) was stirred for 10 mins in a Schlenk tube under N2. Pinacolborane (0.36 mL, 2.40 mmol, 
1.20 eq.) was added to the reaction mixture and stirred for 10 mins at RT. Styrene (0.23 mL, 
2.0 mmol, 1.00 eq.) was added, and the Schlenk flask was washed with further toluene (1.2 
mL), sealed and stirred at RT, with progress monitored by TLC. The reaction mixture was 
filtered through a pad of Celite ® (~2 cm thick) and concentrated under reduced pressure. The 
product was purified by flash column chromatography (4% Et2O/hexane) to give the desired 
product 380 as a colourless oil (425 mg, 92%, >95:5 e.r.). 
Rf = 0.57 (10% Et2O/PE, p-anisaldehyde);  
1H NMR (400 MHz, CDCl3): δ = 7.28 – 7.20 (4H, m, H2/H3), 7.13 (1H, m, H1), 2.43 (1H, q, 
J = 7.5 Hz, H5), 1.33 (3H, d, J = 7.5 Hz, H6), 1.21 (6H, s, H8), 1.20 (6H, s, H8) ppm; 
13C NMR (101 MHz, CDCl3): δ = 145.1 (C4), 128.4 (C2), 127.9 (C3), 125.2 (C1), 83.4 (C7), 
24.8 (C8), 24.7 (C8), 17.2 (C6) ppm. C5 (next to boron) not observed due to quadrupolar 
relaxation. 
 






Vinyl diisopropylcarbamate (381) 
 
Following a modified procedure by Clayden et al.,274,275 nBuLi (6.00 mL, 2.5 M in hexanes, 15 
mmol) was added to THF (11 mL, 1.3 M) at RT. After 16 hrs, N,N-diisopropyl carbamoyl 
chloride (1.60 g, 10 mmol) was dissolved in DMPU (11 mL, 0.91 M) and added dropwise to a 
cooled solution (0 °C) containing the lithium ethenolate. The reaction was warmed to RT over 
4 hrs. The reaction was quenched with saturated NH4Cl and extracted with Et2O (3 x 25 mL). 
The organic layer was washed with water and dried over Na2SO4. The solvent was removed in 
vacuo and purified by flash silica chromatography (33% EtOAc/hexane) to afford the desired 
product 381 as a colourless oil (975 mg, 83%).  
Rf = 0.84 (50% EtOAc/hexane);  
1H NMR (400 MHz, CDCl3): δ = 7.26 (1H, dd, J = 14.7, 5.6 Hz, H4), 4.77 (1H, dd, J = 14.0, 
1.4 Hz, H5trans-H4), 4.43 (1H, dd, J = 6.3, 1.4 Hz, H5cis-H4), 4.07 (1H, br. s, H2), 3.86 (1H, br. s, 
H2), 1.25 (12H, d, J = 6.7 Hz, H1) ppm;  
13C NMR (101 MHz, CDCl3): δ = 152.7 (C3), 142.3 (C4), 94.5 (C5), 46.7 (C2), 45.8 (C2), 
20.4 (C1), 19.4 (C1) ppm. 
 

















Under a N2 atmosphere, TMEDA (1.30 eq.) was added to benzoate (1.00 eq.) dissolved in 
anhydrous Et2O (0.2 M) in a flame dried Schlenk tube. After cooling to −78 °C, sBuLi (1.3 
mmol mL-1 solution, 0.25 mL, 0.32 mmol, 1.30 eq.) was added dropwise and the brown/orange 
reaction mixture was left to stir for 20 mins. A solution of boronic ester (1.50 eq.) in dry Et2O 
(1.0 M), made up in a flame dried flask, was added dropwise to the reaction mixture. After 30 
mins the reaction was warmed to RT and the solvent exchanged to CHCl3 or toluene* (2.5 mL) 
by removal of Et2O under vacuum. The resultant mixture was heated to 60 °C for 16 hrs or 
until full consumption of the boronate complex was observed by 11B NMR. The crude material 
was filtered through a silica plug and washed with Et2O, concentrated in vacuo, and purified 
by flash column chromatography to afford the desired product. *All solvent exchange to 
toluene are explicitly stated, otherwise assume solvent exchange to CHCl3.  
GP5 
As per GP4 with oxidation of the boronic ester to the corresponding alcohol prior to column 
chromatography for ease of purification: 
The reaction mixture was cooled down to 0 °C and THF (0.50 mL) was added. A 2:1 NaOH (2 
M):H2O2 (33% aq.) mixture (0 °C, 1 mL) was added dropwise. The reaction was warmed to RT 
and stirred until deemed complete by TLC analysis (typically 4–16 hrs). The reaction was 
dissolved in diethyl ether (10 mL) and washed with brine (5 mL). The aqueous phase was 
extracted twice with diethyl ether (5 mL). The combined organic phases were dried over 
MgSO4 and the solvent removed in vacuo to afford the crude alcohol, which was then purified 










297 was synthesised following GP4 using cyclobutyl 2,4,6- triisopropylbenzoate (1.00 eq.) and 
4,4,5,5-tetramethyl-2-phenethyl-1,3,2-dioxaborolane 294 (70 mg, 0.30 mmol, 1.50 eq.) as the 
starting boronic ester. The crude mixture was purified using flash column chromatography (15-
30% CH2Cl2/pentane) to afford the title compound as a colourless oil (34 mg, 60%). 
Rf = 0.30 (30% CH2Cl2/pentane, p-anisaldehyde);  
1H NMR (400 MHz, CDCl3): δ = 7.31 – 7.13 (5H, m, H9/H10/H11), 2.49 (2H, m, H7), 2.16 
(2H, m, H2), 1.95 (2H, m, H1), 1.85 (2H, m, H6), 1.78 – 1.69 (2H, m, H2), 1.29 (12H, s, H5) 
ppm; 
13C NMR (101 MHz, CDCl3): δ = 143.4 (C8), 128.5 (C10), 128.4 (C9), 125.6 (C11), 83.2 (C4), 
42.2 (C6), 33.4 (C7), 30.6 (C2), 24.9 (C5), 18.4 (C1) ppm. 
 














2-(1-(4-Methoxybenzyl)cyclobutyl)-4,4,5,5-tetramethyl-1,3,2- dioxaborolane (299) 
 
299 was synthesised following GP4 using cyclobutyl 2,4,6- triisopropylbenzoate (1.00 eq.) and 
2-(4-methoxybenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 372 (74 mg, 0.30 mmol, 1.50 
eq.) as the starting boronic ester. The crude mixture was purified using flash column 
chromatography (5-10% Et2O/PE) to afford the desired compound as a colourless oil (41 mg, 
67%). 
Rf = 0.30 (10% Et2O/PE, p-anisaldehyde);  
1H NMR (400 MHz, CDCl3): δ = 7.13 – 7.07 (2H, m, H7), 6.79 – 6.75 (2H, m, H6), 3.77 (3H, 
s, H9), 2.80 (2H, s, H4), 2.13 (2H, m, H2), 1.96-1.82 (4H, m, H1/H2), 1.18 (12H, s, H11) ppm;  
13C NMR (101 MHz, CDCl3): δ = 157.8 (C8), 133.5 (C5), 130.1 (C6), 113.4 (C7), 83.2 (C10), 
55.4 (C9), 44.2 (C4), 30.4 (C2), 24.8 (C11), 18.3 (C1) ppm. C3 (next to boron) not seen due to 
quadrupolar relaxation; 
IR (νmax/cm
−1, neat): 2975, 2855, 1611, 1511, 1380, 1302, 1244, 1140, 1037, 836, 686, 631;  
HRMS (ESI) calc. for [C18H27BO3 + Na]
















303 was synthesised following GP4 using (1s,3s)-3-fluorocyclobutyl 2,4,6-
triisopropylbenzoate 302 (1.00 eq.) and 4,4,5,5-tetramethyl-2-phenethyl-1,3,2-dioxaborolane 
294 (54 mg, 0.23 mmol, 1.50 eq.) as the starting boronic ester, followed by oxidation according 
to GP5. The oxidised crude mixture was purified using flash column chromatography (0-10% 
EtOAc/pentane) to afford the desired compound as a colourless oil (19 mg, 62%). 
Rf = 0.31 (3% EtOAc/pentane, p-anisaldehyde); 
1H NMR (400 MHz, CDCl3): δ = 7.29 (2H, m, H8), 7.23-7.17 (3H, m, H7/H9), 4.75 (1H, dp, 
J = 55.8JH-F, 6.6 Hz, H1), 2.71 (2H, m, H5), 2.65 (2H, dddd, J = 13.5, 9.0JH-F, 6.6, 3.8 Hz, H2) 
2.32 (2H, dddd, J = 25.7JH-F, 13.5, 6.6, 3.8 Hz, H2), 1.81 (2H, m, H4) ppm; 
13C NMR (101 MHz, CDCl3): δ = 141.7 (C6), 128.6 (C8), 128.3 (C7), 126.0 (C9), 80.8 (d, JC-
F = 208.2 Hz, C1), 67.3 (d, JC-F = 17.9 Hz, C3), 44.8 (d, J = 19.5 Hz, C2), 42.8 (d, J = 3.4 Hz, 
C4), 30.2 (C5) ppm;  
19F NMR (376 MHz, CDCl3): δ = -171.8 (dtt, JH-F = 55.8, 25.7, 9.0 Hz) ppm; 
HRMS (ESI) calc. for [C12H15OF + Na]
+ 217.1025. Found 217.1033 
IR (νmax/ cm
−1, neat): 3403, 2987, 2938, 1454, 1274, 1261, 1143, 1028, 764, 750; 
[𝛂]𝐃












313 was synthesised following GP4 using (S)-4,4,5,5-tetramethyl-2-(1-phenylethyl)-1,3,2-
dioxaborolane 313 (70 mg, 0.30 mmol, 1.50 eq.) as the starting boronic ester. Solvent exchange 
to toluene was performed, followed by oxidation using GP5. The oxidised crude mixture was 
purified using flash column chromatography (5-10% Et2O/pentane) to afford the title 
compound as a colourless oil (19 mg, 56%, 96:4 e.r.). 
Rf = 0.20 (10% Et2O/pentane);  
1H NMR (400 MHz, CDCl3): δ = 7.35 – 7.27 (4H, m, H7/H8), 7.25 – 7.21 (1H, m, H9), 2.93 
(1H, q, J = 7.2 Hz, H4), 2.25 (1H, m, H2), 2.14 (1H, m, H2), 2.02 (1H, m, H2), 1.86 (1H, dtt, 
J = 10.5, 9.4, 4.9 Hz, H1), 1.80 – 1.71 (1H, m, H2), 1.67 – 1.51 (1H, m, H1), 1.56 (1H, br.s, 
H10), 1.32 (3H, d, J = 7.2 Hz, H5) ppm; 
13C NMR (101 MHz, CDCl3): δ = 142.7 (C6), 128.7 (C8), 128.4 (C7), 126.7 (C9), 78.1 (C3), 
47.2 (C4), 34.6 (C3), 34.3 (C2), 14.4 (C5), 12.6 (C1) ppm;  
IR (νmax/ cm
−1, neat): 2968 (br.), 1455, 1260, 1922, 799, 702; 
HRMS (ESI) calc. for [C12H16O2 + Na]
+ 199.1099. Found, 199.1090; 
[𝜶]𝑫
24 +12.2 (c 0.49, CHCl3); 
Chiral HPLC (IB with guard, 2% iPrOH/hexane, 0.7 mL/min, RT) TR = 6.01 mins (major), 













308 was synthesised following GP4 using cyclobutyl 2,4,6- triisopropylbenzoate (1.00 eq.) 
and tert-butyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole-1-carboxylate 377 
(111 mg, 0.30 mmol, 1.50 eq.) as the starting boronic ester. The crude mixture was purified 
using flash column chromatography (5-15% Et2O/PE) to afford the desired compound as a 
colourless oil (35 mg, 42%). 
Rf = 0.13 (10% Et2O/pentane); 
1H NMR (400 MHz, CDCl3): δ = 3.89 (1H, br. s, H6), 3.48 (1H, br. m, H9), 3.17 (1H, br. s, 
H9), 2.15 – 1.73 (7H, m, H2/H7/H8), 1.70 – 1.54 (3H, m, H1/H2), 1.45 (9H, s, H12), 1.24 
(12H, s, H5) ppm. Many of the small vicinal couplings on the 6-membered ring were not 






13C NMR (101 MHz, CDCl3): δ = 155.8 & 155.5 (C10), 83.0 & 82.5 (C4), 79.2 & 79.0 (C11), 
63.2 & 62.3 (C6), 47.9 (C9), 30.7 & 30.2 (C2), 28.5 (C12), 26.2 (C8), 24.8 (C5), 24.3 & 23.9 
(C7), 18.3 & 18.1 (C1) ppm. Compound exists as 1:1 mixture of rotamers at RT; 
IR (νmax/cm
-1, neat): 3675, 2973, 1687, 1381, 1260, 1066, 868, 764; 
HRMS (ESI) calc. for [C16H34BNO4 + Na]






311 was synthesised following GP4 using cyclobutyl 2,4,6- triisopropylbenzoate (1.00 eq.) and 
tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate 378 (111 
mg, 0.36 mmol, 1.50 eq.) as the starting boronic ester. The crude mixture was purified using 
flash column chromatography (5-15% Et2O/pentane) to afford the desired compound (42 mg, 
48%) as a clear oil. 
 
Rf = 0.64 (15% Et2O/pentane, anisaldehyde);  
1H NMR (400 MHz, CDCl3): δ = 4.17 (2H, br. s, H8), 2.58 (2H, br. t, J = 11.1 Hz, H8), 2.08 
(2H, br. t, J = 7.7 Hz, H2), 1.87-1.69 (4H, m, H1/H2), 1.56 (2H, br. d, J = 13.7 Hz, H7), 1.44 
(9H, s, H11), 1.43 (1H, m, H6), 1.24 (12H, s, H5), 1.15 (2H, qd, J = 12.7, 4.4 Hz, H7) ppm. 
Many of the small vicinal couplings on the 6-membered ring were not resolved and gave 
broad lines; 
13C NMR (101 MHz, CDCl3): δ = 155.2 (C9), 83.2 (C4), 79.2 (C10), 46.4 (C6), 44.9 (br. s, 
C8), 29.1 (C2), 28.6 (C11), 28.2 (C7), 24.9 (C5), 18.1 (C1) ppm. C4 (next to boron) not 






11B NMR (96 MHz): δ = 32.9 ppm; 
HRMS (ESI) calc. for [C20H36BNO4 + H]
+ 366.2810. Found 366.2804; 
IR (νmax/cm






312 was synthesised following GP4 using cyclobutyl 2,4,6- triisopropylbenzoate (1.00 eq.) and 
tert-butyl 2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate 379 (111 
mg, 0.36 mmol, 1.50 eq.) as the starting boronic ester. Solvent exchange to toluene was 
performed. The crude mixture was purified using flash column chromatography (5-15% 
Et2O/pentane) to afford the desired compound (40 mg, 46%) as a clear oil. 
 
Rf = 0.38 (10% Et2O/PE, p-anisaldehyde);  
1H NMR (400 MHz, CDCl3): δ = 4.03 (1H, br. s, H6), 3.79 (1H, br. s, H10), 3.09 (1H, br. s, 
H10), 2.11 – 1.93 (3H, m, H2/H7), 1.90 – 1.70 (4H, m, H1/H2), 1.69 – 1.52 (3H, m, H8/H9), 
1.43 (9H, s, H13), 1.47 – 1.39 (2H, m, H7/H8), 1.24 (12H, s, H5) ppm. Many of the small 
vicinal couplings on the 6-membered ring were not resolved and gave broad lines; 
13C NMR (101 MHz, CDCl3): δ = 155.9 (C11), 82.9 (C4), 79.3 (C12), 42.0 (br. s, C10), 29.9 
(C9), 29.2 (C2), 28.6 (C13), 25.8 (C7), 24.9 (C5), 20.9 (C8), 18.4 (C1) ppm. C3 (next to 
boron) not observed due to quadrupolar relaxation. C6 (next to nitrogen) broadened and not 
observed due to nitrogen quadrupolar relaxation; 
HRMS (ESI) calc. for [C20H36BNO4 + H]
+ 366.2809. found 366.2812;   
IR (νmax/ cm









321 was synthesised following GP4 using 2-(4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane 373 (88 mg, 0.30 mmol, 1.50 eq.) as the starting boronic ester, followed by 
oxidation using GP5. The oxidised crude mixture was purified using flash column 
chromatography (10-20% Et2O/pentane) to afford the title compound as a colourless oil (26 
mg, 66%). 
 
Rf = 0.30 (20% Et2O/pentane); 
1H NMR (400 MHz, CDCl3): δ = 7.42 (2H, d, J = 8.8 Hz, H6), 6.90 (2H, d, J = 8.8 Hz, H7), 
3.81 (3H, s, H9), 2.53 (2H, m, H2), 2.35 (2H, m, H2), 1.97 (1H, dtt, J = 11.1, 9.6, 5.0 Hz, H1), 
1.64 (1H, m, H1) ppm;  
13C NMR (101 MHz, CDCl3): δ = 158.8 (C8), 138.6 (C5), 126.5 (C6), 113.8 (C7), 76.8 (C3), 
55.4 (C9), 37.0 (C2), 13.0 (C1) ppm;  
IR (νmax/cm
-1, neat): 3397 (br. OH), 2938, 2836, 1611, 1512, 1464, 1299, 1132, 1108, 1068, 
957, 731; 
 
















322 was synthesised following GP4 using cyclobutyl 2,4,6- triisopropylbenzoate (1.00 eq.) and 
4,4,5,5-tetramethyl-2-(4-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane 374 (101 mg, 0.37 
mmol, 1.50 eq.) as the starting boronic ester. The crude mixture was purified using flash 
column chromatography (0-10% Et2O/pentane) to afford the desired compound (40 mg, 46%) 
as a white solid. 
 
Rf = 0.54 (5% Et2O/pentane); 
1H NMR (400 MHz, CDCl3): δ = 7.50 (2H, d, J = 7.9 Hz, H8), 7.20 (2H, d, J = 7.9 Hz, H7), 
2.57 (2H, m, H2), 2.27 (2H, m, H2), 2.08 (1H, m, H1), 1.85 (1H, m, H1), 1.19 (12H, s, H5) 
ppm;  
13C NMR (101 MHz, CDCl3): δ = 153.5 (C9), 144.9 (C6), 125.9 (C7), 125.0 (q, 
3JC-F = 3.8 
Hz, C8), 123.4 (C10), 83.8 (C4), 32.2 (C2), 24.6 (C5), 18.9 (C1) ppm; 
IR (νmax/cm
-1, neat): 2935, 1611, 1512, 1463, 1299, 1135, 731; 
M.P: 99-101°C (EtOAc); 
HRMS (ESI) calc. for [C17H22BF3O2 + Na]















325 was synthesised following GP4 using cyclobutyl 2,4,6- triisopropylbenzoate (1.00 eq.) and 
tert-butyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-3,6-dihydropyridine-1(2H)-
carboxylate 376 (117 mg, 0.38 mmol, 1.50 eq.) as the starting boronic ester. The crude mixture 
was purified using flash column chromatography (5-10% EtOAc/pentane) to afford the desired 
compound (39 mg, 43%) as a clear oil. 
 
Rf = 0.38 (30% Et2O/pentane, p-anisaldehyde);  
1H NMR (400 MHz, CDCl3): δ = 5.21 (1H, br. s, H7), 3.88 (2H, br. s, H8), 3.42 (2H, br. s, 
H10), 2.18 (2H, m, H2), 2.03–1.94 (4H, m, H2/H9), 1.90 (1H, m, H1), 1.71 (1H, m, H1), 1.45 
(9H, s, H13), 1.23 (12H, s, H5) ppm. Many of the small vicinal couplings on the 6-membered 
ring were not resolved and gave broad lines; 
13C NMR (101 MHz, CDCl3): δ = 155.2 (C11), 141.9 (C6), 114.6 & 114.0 (C7), 83.5 (C4), 
79.4 (C12), 43.8 & 43.2 (C7), 41.2 & 40.1 (C8), 29.6 (C2), 28.5 (C13), 26.1 (C9), 24.6 (C5), 
18.0 (C1) ppm. C3 (next to boron) not observed due to quadrupolar relaxation. Some peaks 
are doubled due to the presence of rotamers;  
11B NMR (96 MHz): δ = 34.4 ppm; 
HRMS (ESI) calc. for [C20H34BNO4 + Na]
+ 386.2477. Found 386.2476;  
IR (νmax/ cm










323 was synthesised following GP4 using cyclobutyl 2,4,6- triisopropylbenzoate (1.00 eq.) and 
2-(benzofuran-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 375 (92 mg, 0.38 mmol, 1.50 eq.) 
as the starting boronic ester. The crude mixture was purified using flash column 
chromatography (5-10% Et2O/pentane) to afford the desired compound (38 mg, 53%) as a 
colourless oil. 
 
Rf = 0.50 (10% Et2O/pentane, p-anisaldehyde); 
1H NMR (400 MHz, CDCl3): δ = 7.47 (1H, m, H9), 7.41 (1H, m, H12), 7.20 – 7.13 (2H, m, 
H10/H11), 6.44 (1H, d, J = 0.9 Hz, H7), 2.55-2.42 (4H, m, H2), 2.08 (2H, m, H1), 1.30 (12H, 
s, H5) ppm; 
13C NMR (101 MHz, CDCl3): δ = 164.1 (C6), 155.0 (C13), 129.5 (C8), 122.9 (C11), 122.3 
(C10), 120.3 (C9), 110.9 (C12), 100.4 (C7), 84.0 (C4), 30.1 (C2), 24.8 (C5), 18.9 (C1) ppm. 
C3 (next to boron) not observed due to quadrupolar relaxation;  
11B NMR (96 MHz): 33.4 ppm; 
HRMS (ESI+): mass ion not observed. 
IR (νmax/ cm















346 was synthesised following GP4 using 3-((tert-butoxycarbonyl)(methyl)amino)cyclobutyl 
2,4,6-triisopropylbenzoate 344 (1.00 eq.) and trimethylsilyl chloride (49 μL, 0.39 mmol, 2.00 
eq.) as the electrophile. The crude mixture was purified using flash column chromatography 
(5-10% Et2O/pentane) to afford the desired compound (39 mg, 43%) as a clear oil. 
 
Rf = 0.60 (10% Et2O/pentane, p-anisaldehyde); 
1H NMR (400 MHz, CDCl3): δ = 6.96 (2H, s, H4), 5.20 (1H, app. t, J = 7.0 Hz, H10), 4.76 
(1H, pent., J = 8.5 Hz, H12), 2.84 (1H, hept., J = 6.9 Hz, H2), 2.83 (2H, hept., J = 6.9 Hz, H6), 
2.66 (2H, s, H13), 2.65 (2H, m, H11), 2.38 (2H, dddd, J = 12.7, 6.3, 3.4, 1.4 Hz, H11), 1.40 
(9H, s, H16), 1.21 (12H, d, J = 6.9 Hz, H7), 1.19 (6H, d, J = 6.9 Hz, H1), 0.00 (9H, s, H17) 
ppm; 
13C NMR (101 MHz, CDCl3): δ = 170.8 (C9), 155.2 (C14), 150.4 (C3), 145.0 (C5), 130.4 
(C8), 120.0 (C4), 79.6 (C15), 67.9 (C10), 50.6 (C12), 36.0 (C11), 34.6 (C2), 31.6 (C6), 28.7 
(C13), 28.6 (C16), 24.3 (C7), 24.1 (C7), -1.40 (d, JC-Si = 1.6 Hz, C17) ppm; 
HRMS (ESI) calc. for [C29H49NO4Si + Na]
+ 526.3309. Found, 526.3303; 
IR (νmax/cm
−1, neat): 2962, 1723 (C=Oester), 1699 (C=Oamide), 1460, 1364, 1251, 1148, 1078; 
[𝜶]𝑫








3.3.4. Boronic Ester Functional Group Interconversions 
 




Freshly distilled 2-bromopropene (21 mg, 0.18 mmol, 1.3 eq.) was dissolved in THF (2 mL). 
The solution was cooled to -78 °C and a freshly titrated tert-butyllithium solution (0.29 mL, 
0.54 mmol, 1.9 M in pentane, 2.6 eq.) was added dropwise. After stirring at -78 °C for 1 hr, a 
solution of boronic ester 311 (50 mg, 0.14 mmol in 1.4 mL of THF, 1.0 eq.) was added dropwise 
at the same temperature. The reaction was stirred 5 mins at -78 °C, then warmed up to RT and 
stirred for 1 hr. The reaction was cooled down to -78 °C and a solution of iodine (106 mg in 
0.7 mL THF, 3.0 eq.) was added dropwise. The solution was stirred 15 mins at -78 °C, followed 
by further 15 mins at RT. The solution was cooled down again to -78 °C and NaOMe (59 mg, 
1.12 mmol, 8.0 eq.) was added under N2 flow, followed by anhydrous methanol (1.0 mL). The 
reaction was stirred 10 minutes at -78 °C followed by 1 hr at RT. The reaction was diluted with 
pentane (15 mL), washed with a sat. Na2S2O3 solution (5 mL) and brine (5 mL). The organic 
phase was dried over magnesium sulfate and the solvent evaporated. The residue was passed 
through a Pasteur/silica plug (~6 cm) using pure pentane as eluent. Next, the solvent was 
evaporated to afford the title compound 329 as a colourless oil (30 mg, 80%). 
Rf = 0.42 (5% Et2O/pentane, p-anisaldehyde); 
1H NMR (400 MHz, CDCl3): δ = 4.87 (1H, app. pent., J = 1.5 Hz, H6), 4.63 (1H, br. s, H6), 
4.17 (2H, br. s, H9), 2.60 (2H, br. t, J = 12.2 Hz, H9), 2.03-1.94 (4H, m, H2), 1.71 (2H, pent., 
J = 7.3 Hz, H1), 1.62 (2H, m, H8), 1.60 (3H, s, H5), 1.48 (1H, tt, J = 12.1, 3.0 Hz, H7), 1.45 
(9H, s, H12), 1.16 (2H, dq, J = 12.6, 4.5 Hz, H8) ppm. Many of the small vicinal couplings on 
the 6-membered ring were not resolved and gave broad lines; 
13C NMR (101 MHz, CDCl3): δ = 155.0 (C10), 150.3 (C4), 110.9 (C6), 79.3 (C11), 50.6 (C3), 





HRMS (ESI) calc. for [C17H29NO2 + Na]
+ 302.2090. Found, 302.2089; 
IR (νmax/ cm
−1, neat): 3675, 2973, 2901, 1692, 1451, 1415, 1276, 1066, 890, 764. 
 
tert-Butyl 4-(1-((4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-





According to a literature procedure,177 boronic ester 311 (50 mg, 0.14 mmol, 1.0 eq.) and 
iodochloromethane (30 µL, 0.41 mmol, 3.0 eq.) were dissolved in diethyl ether (1 mL) and 
cooled to -95 °C (methanol/liquid N2 cooling bath). nBuLi (0.39 mL, 0.63 mmol, 1.6 M solution 
in nhexane, 2.95 eq.) was added dropwise and the solution was stirred 10 minutes at -95 °C, 
followed by additional 1 hr at RT. The whole mixture was passed through a thin layer of silica 
and eluted with Et2O. Solvents were evaporated to afford the crude boronic ester, containing 
impurities of starting material and overhomologated product. The crude mixture was purified 
silica column chromatography, eluting with 5-15% EtOAc/pentane, afforded the title 
compound 330 (33 mg, 63%) as a colourless oil. 
Rf = 0.38 (10% EtOAc/pentane, p-anisaldehyde); 
1H NMR (400 MHz, CDCl3): δ = 4.15 (2H, br. d, J = 13.3 Hz, H9),  2.58 (2H, td, J = 12.8, 2.5 
Hz, H9), 1.92-1.78 (5H, m, H1/H2), 1.72 (2H, m, H1), 1.57 (2H, br. d, J = 12.8 Hz, H8), 1.44 
(9H, s, H12), 1.40 (1H, tt, J = 12.1, 3.1 Hz, H7), 1.24 (12H, s, H6), 1.17-1.01 (2H, dq, J = 12.5, 
4.5 Hz, H8), 0.89 (2H, s, H4) ppm. Many of the small vicinal couplings on the 6-membered 
ring were not resolved and gave broad lines; 
13C NMR (101 MHz, CDCl3): δ = 155.0 (C10), 83.0 (C5), 79.2 (C11), 46.5 (C7), 44.7 (C9), 





11B NMR (96 MHz): 34.0 ppm; 
HRMS (ESI) calc. for [C21H39BNO4 + Na]
+ 380.2971. Found, 380.2978; 
IR (νmax/ cm
−1, neat): 3675, 2974, 1693, 1410, 1364, 1275, 1144, 1057, 891, 764. 
 




According to a literature procedure,185 to a stirred solution of vinyl diisopropylcarbamate 381 
(30 mg, 0.18 mmol, 1.3 eq.) and boronic ester 311 (50 mg, 0.14 mmol, 1.0 eq.) in THF (0.5 
mL) under N2 at –78 °C was added freshly prepared LDA (0.86 M in THF, 0.21 mL, 0.18 mmol, 
1.3 eq.) dropwise at a rate of approximately 10 µL every 10 secs. The resulting solution was 
stirred for 1 hr at –78 °C before the addition of a solution of I2 (45 mg, 0.18 mmol, 1.3 eq.) in 
MeOH (0.5 mL) dropwise over 5 mins. The reaction was stirred for 5 mins at –78 °C before 
warming to RT and stirred for 1 hr. The reaction was quenched by the addition of 20% Na2S2O3 
(5 mL) and the aqueous phase extracted with Et2O (2 × 7.5 mL). The combined organic phases 
were washed with water (7.5 mL), dried over MgSO4, filtered through a short pad of silica gel 
(~1 cm) and concentrated in vacuo. The crude product was then re-dissolved in Et2O (1.5 mL) 
cooled to –78 °C and tBuLi (0.21 mL, 1.7 M, 0.36 mmol, 2.55 eq.) was added. The reaction 
was then transferred to a 0 °C bath and stirred for 30 min before the addition of saturated 
NH4Cl(aq.) (5 mL). The aqueous phase was extracted with Et2O (2 × 7.5 mL) and the combined 
organic phases dried over MgSO4, filtered and concentrated in vacuo. The crude product 
purified by flash column chromatography on silica gel (0-10% Et2O/pentane) to give the 





Rf = 0.53 (10% Et2O/pentane, KMnO4);  
1H NMR (400 MHz, CDCl3): δ = 4.16 (2H, br. d, J = 13.3 Hz, H8), 2.61 (2H, td, J = 13.4, 2.6 
Hz, H8), 2.23 – 2.07 (4H, m, H1/H2/H5), 2.01 (2H, m, H2), 1.81 (1H, m, H1), 1.58 (2H, br. d, 
J = 11.7 Hz, H7), 1.47 (1H, tt, J = 11.6, 3.3 Hz, H6), 1.44 (9H, s, H11), 1.31 (2H, dq, J = 12.5, 
4.5 Hz, H7) ppm. Some of the small vicinal couplings on the 6-membered ring were not 
resolved and gave broad lines; 
13C NMR (101 MHz, CDCl3): δ 155.0 (C9), 89.2 (C4), 79.4 (C10), 70.5 (C5), 45.3 (C6), 44.2 
(br. s, C8), 40.6 (C3), 33.1 (C2), 28.6 (C11), 26.5 (C7), 16.4 (C1) ppm; 
HRMS (ESI) calc. for [C16H25NO2 + Na]
+ 286.1777. Found, 286.1786; 
IR (νmax/ cm
−1, neat): 3675, 3305, 2973, 2106, 1688, 1412, 1276, 1066, 868, 764. 
 





According to a literature procedure outlined by Morken,277 boronic ester 311 (50 mg, 0.14 
mmol, 1.00 eq.), potassium tert-butoxide (77 mg, 0.70 mmol, 5.00 eq.) and O-
methylhydroxylamine (0.19 mL, 19 mg, 0.42 mmol, 3.00 eq.) in anhydrous toluene (0.61 mL) 
and anhydrous THF (0.07 mL) were heated to 80 °C for 16 hrs. Following this, the reaction 
was cooled to ambient temperature and di-tert-butyl dicarbonate (0.08 mL, 0.35 mmol, 2.50 
eq.) in THF (0.50 mL) was added concurrently with a solution of saturated aqueous NaHCO3 
(0.50 mL). The reaction was then reheated to 80 °C and stirred for a further 8 hrs before cooling 
to ambient temperature, adding water (10 mL) and extracting with EtOAc (3 × 10 mL). The 
combined organic fractions were then dried (MgSO4), filtered and concentrated in vacuo to 
give a crude residue, which was purified by silica column chromatography (0-20% 





Rf = 0.59 (20% EtOAc/pentane, ninhydrin); 
1H NMR (400 MHz, CDCl3): δ = 4.56 (1H, br. s, H13), 4.12 (2H, br. d, J = 12.8 Hz, H9), 2.64 
(2H, td, J = 13.0, 2.5 Hz, H9), 2.13 (4H, m, H2), 1.96 (1H, m, H1), 1.85 (1H, m, H7), 1.78-
1.59 (3H, m, H1/H8), 1.45 (9H, s, H6), 1.43 (9H, s, H12), 1.17 (2H, dq, J = 12.7, 4.4 Hz, H8) 
ppm. Many of the small vicinal couplings on the 6-membered ring were not resolved and gave 
broad lines; 
13C NMR (101 MHz, CDCl3): δ = 159.9 (C4), 155.0 (C10), 79.5 (C5/C11), 59.3 (C3), 44.3 
(C9), 42.7 (C7), 29.8 (C2), 28.6 (C12), 28.5 (C6), 26.2 (C8), 14.9 (C1) ppm; 
HRMS (ESI) calc. for [C19H34N2O4 + Na]
+ 377.2411. Found, 377.2411; 
IR (νmax/ cm
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